TW200413441A - Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display - Google Patents

Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display Download PDF

Info

Publication number
TW200413441A
TW200413441A TW092120689A TW92120689A TW200413441A TW 200413441 A TW200413441 A TW 200413441A TW 092120689 A TW092120689 A TW 092120689A TW 92120689 A TW92120689 A TW 92120689A TW 200413441 A TW200413441 A TW 200413441A
Authority
TW
Taiwan
Prior art keywords
bis
acid
liquid crystal
aminobenzoate
polymer
Prior art date
Application number
TW092120689A
Other languages
Chinese (zh)
Other versions
TWI319770B (en
Inventor
Shouichi Nakata
Yasuaki Mutsuga
Misa Kono
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200413441A publication Critical patent/TW200413441A/en
Application granted granted Critical
Publication of TWI319770B publication Critical patent/TWI319770B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nonlinear Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

This invention provides a liquid crystal alignment agent capable of not only exhibiting excellent alignment characteristics but also forming a liquid crystal alignment layer film with which the time from cancellation of voltage application to afterimage erasure in a liquid crystal display is short; a polymer thereof; and a diamine compound as a monomer thereof. For example, there are provided liquid crystal alignment agents comprising a diamine compound having an alicyclic group, such as methyl lithocholate (3, 5-diaminobenzoate), a polyamic acid being a product of reaction between the same and a tetracarboxylic anhydride and an imidized polymer therefrom, and a polymer thereof. Also, a liquid crystal display comprising the liquid crystal alignment layer film is provided.

Description

玖、發明說明: 【發明所屬之技術領域】 本發明係關於二胺化八物、取妒π A 入 化σ物來鼷胺酸、醯亞胺化聚合物、 含有此等之至少一者的液晶定向劑及具備由如此之液晶定 向d所形成的液晶定向膜之液晶顯示元件。 【先前技術】 以彺’具有正的介電異方性之向列型液晶在具有液晶定 向膜之附帶透明電極的基板上形成挾層構造,⑨晶分子之 長軸在基板間壬90度以上連續地扭轉而構成的W (Twisted说明, Description of the invention: [Technical field to which the invention belongs] The present invention relates to diamine eight compounds, πA and σσ compounds to make amino acids, fluorinated polymers, and compounds containing at least one of these. A liquid crystal alignment agent and a liquid crystal display element including a liquid crystal alignment film formed of such a liquid crystal alignment d. [Prior art] A pseudolayer structure is formed on a substrate with a liquid crystal alignment film and a transparent electrode by using a nematic liquid crystal with positive dielectric anisotropy. The major axis of the pseudocrystal molecules is 90 degrees or more between the substrates. W (Twisted

Nematic)型、或具有 STN (Super Twisted n觀型液晶格 室之液晶顯示元件已為人所知。在此等之液晶顯示元件中 的液aa配向 般係藉由在聚合物所構成的被膜表面實施 研摩處理等的配向處理而形成之液晶定向膜來控制。此 處,構成上述被膜之聚合物已知有聚醯胺酸及聚醯亞胺, 一般乃使用此等聚合物溶解於溶劑而成的液晶定向劑。 又,與上述不同的液晶顯示元件,已知有使具負介電異 方性之液晶分子垂直於基板排列而成的垂直配向(Vertical Alignment)型液晶格室,具有此液晶格之液晶顯示元件。即 使在如此之液晶顯示元件中,液晶之配向控制一般係以含 β水fe自文、聚酿亞胺等之聚合物的液晶定向劑所形成之 液晶定向膜構成者。 但’具備以習知液晶定向劑所形成之液晶定向膜的液晶 顯示元件中,係晝像顯示時(電壓施加時)所產生之離子性電 荷會被液晶定向膜吸附,即使在晝像消去後(電壓施加之解Nematic) or liquid crystal display elements with STN (Super Twisted n-view type liquid crystal cells) are known. The liquid aa alignment in these liquid crystal display elements is generally formed on the surface of the coating film composed of a polymer. It is controlled by a liquid crystal alignment film formed by performing an alignment treatment such as a rubbing treatment. Here, the polymers constituting the coating film are known as polyamic acid and polyimide. Generally, these polymers are dissolved in a solvent. In addition, a liquid crystal display element different from the above is known as a vertical alignment type liquid crystal cell in which liquid crystal molecules having negative dielectric anisotropy are arranged perpendicular to a substrate, and the liquid crystal display element has the liquid crystal. Grid liquid crystal display elements. Even in such liquid crystal display elements, the alignment control of liquid crystals is generally composed of a liquid crystal alignment film formed by a liquid crystal alignment agent containing a polymer such as β water fezine, polyimide, and the like. However, in a liquid crystal display device including a liquid crystal alignment film formed with a conventional liquid crystal alignment agent, the ionic charge generated during daylight image display (when a voltage is applied) is transferred by the liquid crystal. Adsorption to the film, even after the image erasing day (the voltage applied solution

〇:\37\.37061.CX)C 200413441 ,後),亦很難從液晶定向膜脫離,故電麼會殘留蓄積於帝 塵解除後之液a卞a 3一 , ^ 曰曰疋向胺,起因於此殘留電壓,而於電麼施 加解除後之顯示畫像會產生殘像的問題仍存在。 土 進而-右長恰間使用該液晶顯示元件,有時會產生白斑 狀之顯示缺陷’因& ’損及液晶顯示元件之可靠性。最近 如以液晶電視用途為代表般,持續長時間使用如此之液曰 顯示元件為必然,進一步提高可靠性之必要性遂漸增。日日 【發明内容】 發明之揭示 本發明之第1目的在於提供新顆的二胺化合物。 本發明之第2目的在於提供有用新穎之聚醯胺酸作為 晶定向劑。 … 本發明之第3目的在於提供有用新穎之聚醯亞胺化聚合 物作為液晶定向劑。 一 本發明之第4目的在於提供一種液晶定向劑,其係可_ 良好的配向特性’並且可形成—於液晶顯示現件中消除電 壓的施加至殘影消失之時間(以下稱為「殘影消失時間: 很短的液晶定向膜。 本發明之再另一目的及優點從以下說明可一目瞭然。 若依本發明,本發明之上述目的及優點,第丨係藉由至少 一種選自以下述式(I)〇: \ 37 \ .37061.CX) C 200413441, after), it is also difficult to detach from the liquid crystal alignment film, so electricity will remain in the liquid after the emperor dust is released. A 卞 a 3 ,, ^ Due to the residual voltage, the problem that the afterimage of the displayed image after the application of electric power is released will cause an afterimage still exists. Furthermore, the use of the liquid crystal display element between right and right sides may cause white spot-like display defects' to impair the reliability of the liquid crystal display element. Recently, as represented by the use of liquid crystal televisions, it is inevitable to use such a liquid for a long period of time, and it is necessary to further improve the reliability. [Abstract] Disclosure of the Invention A first object of the present invention is to provide a new diamine compound. A second object of the present invention is to provide a novel polyamidic acid as a crystal directing agent. ... A third object of the present invention is to provide a novel polyfluorene imine polymer as a liquid crystal aligning agent. A fourth object of the present invention is to provide a liquid crystal aligning agent, which can _ have good alignment characteristics ′ and can be formed-eliminating the application of voltage to the disappearance of afterimages (hereinafter referred to as "afterimages" in a liquid crystal display). Disappearance time: Very short liquid crystal alignment film. Another object and advantages of the present invention will be apparent from the following description. According to the present invention, the above objects and advantages of the present invention are based on at least one selected from the following formula: (I)

H2N-G1~A1-D1-CO-bi- (£i) i nh2H2N-G1 ~ A1-D1-CO-bi- (£ i) i nh2

OAS7\8706l.DOC 200413441 (其中,:D1係包含脂環之碳數5〜30的2價烴基,G1係3價之 有機基,A1係單鍵或2價之結合基,B1為單鍵、…-n(H)- 或 /OAS7 \ 8706l.DOC 200413441 (Where: D1 is a divalent hydrocarbon group containing 5 to 30 carbon atoms, G1 is a trivalent organic group, A1 is a single bond or a divalent bonding group, B1 is a single bond, … -N (H)-or /

一 N \ ,E1為1償之有機基,a為1或2) 所示之化合物及以下述式(II) H2N - G2-A2-D2 - CO - B2- (E2) b (II) 'One N \, E1 is a 1-compensated organic group, a is a compound represented by 1 or 2) and the following formula (II) H2N-G2-A2-D2-CO-B2- (E2) b (II) '

I A2 - G2 - NH2 (其中,D2係包含脂環之碳數5〜30的3價烴基,G2係2價之有 機基,A2係單鍵或2價之結合基,B2為單鍵、-〇-、-Ν(Η)-或 / 一 Ν ,护為1價之有機基,b為1或2) 與所示之化合物所構之群中的二胺化合物(以下,亦稱為 特定二胺化合物」)來達成。 依本發明’本發明之上述目的及優點,第2係藉由特定 一胺化合物之至少一種、與以下述式(III)I A2-G2-NH2 (wherein D2 is a trivalent hydrocarbon group having 5 to 30 carbon atoms in an alicyclic ring, G2 is a divalent organic group, A2 is a single bond or a divalent bonding group, B2 is a single bond,- 〇-, -N (Η)-or / -N, protected as a monovalent organic group, b is 1 or 2) and a diamine compound (hereinafter, also referred to as a specific two Amine compound "). According to the present invention, the above-mentioned object and advantages of the present invention are that the second system uses at least one specific monoamine compound and the following formula (III)

O:\87N3706ij D〇C (III) 200413441 (其中,G4為4價之有機基) 所示之四羧酸二酐的至少一種反應生成物即聚醯胺酸來達 成。 若依本發明,本發明之上述目的及優點,第3係藉由使上 述聚驢胺酸脫水閉環而得到之醯亞胺化聚合物來達成。 右依本發明,本發明之上述目的及優點,第4係藉由至少 種遥自上述聚醯胺酸及醯亞胺化聚合物所構成之化人物 而構成的液晶定向劑來達成。 , 若依本發明,本發明之上述目的及優點,第5係藉由含有 一具有至少一種選自以下述式(XI)〜(XIV)O: \ 87N3706ij Dooc (III) 200413441 (wherein G4 is a tetravalent organic group) is obtained by using at least one reaction product of tetracarboxylic dianhydride, namely polyamic acid. According to the present invention, the above-mentioned objects and advantages of the present invention are achieved by the third method by the hydrazone imidized polymer obtained by dehydrating and closing the polyaspartic acid. According to the present invention, the above-mentioned objects and advantages of the present invention are achieved by a fourth liquid crystal aligning agent composed of at least a kind of chemical character composed of a polyamic acid and a fluorinated polymer. According to the present invention, the above-mentioned object and advantages of the present invention, the fifth system is to contain at least one selected from the following formulae (XI) to (XIV)

(其中,A1、A2、b1、B2、D1、D2、E1、E2、G1、G2、G4、(Among them, A1, A2, b1, B2, D1, D2, E1, E2, G1, G2, G4,

0:、S7\87〇61.DOC 200413441 a及b之定義如同前述般) 分別所示之重複單元所構成的聚合物而構成之液晶定向齊丨 來達成。 若依本發明,本發明之上述目的及優點,第6係藉由一具 備從上述液晶定向劑所形成的液晶定向膜之液晶顯示元件 _ 來達成。 [貫施方式] 以下詳細說明有關本發明。 - 〈—胺化合物〉 本發明之二胺化合物係以上述式⑴或(π)來表示。 其中,在上述式(I)中以D1表示且在上述(II)中以D2表示, 含脂環之碳數5〜30的烴基係宜為含脂環之碳數10〜30的烴 基’更宜為含有巢類骨架之烴基。如此,2價之烴基(D 3具 體上可舉例分別以下述式(1-1)及(1-2)所示的構造。0 :, S7 \ 87〇61.DOC 200413441 The definitions of a and b are the same as above.) The liquid crystals composed of the polymers composed of the repeating units shown respectively are aligned. According to the present invention, the above-mentioned object and advantages of the present invention are achieved by a liquid crystal display element _ having a liquid crystal alignment film formed from the liquid crystal alignment agent described above. [Embodiment Mode] The present invention will be described in detail below. -<-Amine compound> The diamine compound of the present invention is represented by the above formula (I) or (π). Among them, D1 is represented by the above formula (I) and D2 is represented by the above (II), and the hydrocarbon group having 5 to 30 carbon atoms having an alicyclic ring is preferably a hydrocarbon group having 10 to 30 carbon atoms having an alicyclic ring. It is preferably a hydrocarbon group containing a nested skeleton. In this way, specific examples of the divalent hydrocarbon group (D 3) include structures represented by the following formulae (1-1) and (1-2).

又,3價之烴基(D2)具體上可舉例分別以下述式(II-1)及(II-4) 所示的構造。The trivalent hydrocarbon group (D2) can be specifically exemplified by structures represented by the following formulae (II-1) and (II-4).

O:\8T.S706 LDOC -10- 200413441O: \ 8T.S706 LDOC -10- 200413441

以G1所示之3價有機基可舉例如從碳數丨〜丨5之烴除去3個 氫原子之基、及分別以下述式(1-3)及下述式(1-4)所示之 基。又,以G2所示之2價有機基可舉例如從碳數丨〜丨5之烴除 去2個氫原子之基。Examples of the trivalent organic group represented by G1 include a group in which three hydrogen atoms are removed from a hydrocarbon having a carbon number of 5 to 5 and a formula represented by the following formula (1-3) and the following formula (1-4), respectively. The base. The divalent organic group represented by G2 is, for example, a group obtained by removing two hydrogen atoms from a hydrocarbon having 5 to 5 carbon atoms.

OCH 2~CH-CH2〇OCH 2 ~ CH-CH2〇

(Μ) 以Α及Α2所不之結合基具體上可舉例酮基、醚基、酯基、 醯胺基、胺基甲酸酯基及尿素基。 :碳數1〜30 又,以E1及E2所示之1價有機基具體上可舉例 之直鏈狀或分枝鏈狀烷基; 類固醇基、類固 基、苯乙基、三 %戊基、環己基、十氫萘基、雙環己基、 醇烷基等之脂環式基; 含苯基、甲笨基、二甲苯基、萘基、笨曱 苯甲基等之芳香環的基; 含^南基、四氫七南基、4吩基、四氫切基”比洛基、 吡啶基、哌啶基、“哌啶基、嗎啉代基、喳啉基、異喹啉 基、1-哌啶基甲基、嗎啉代基甲基等之雜環的有機基;(M) Specific examples of the bonding group other than A and A2 include keto group, ether group, ester group, amido group, carbamate group and urea group. : Carbon number 1 to 30. Examples of the monovalent organic group represented by E1 and E2 include linear or branched chain alkyl groups; steroid groups, steroid groups, phenethyl groups, and tri% amyl groups. , Cyclohexyl, decahydronaphthyl, dicyclohexyl, alcohol alkyl, and the like; alicyclic groups containing phenyl, methylbenzyl, xylyl, naphthyl, benzyl, and the like; containing ^ Southyl, tetrahydroheptanyl, 4-phenyl, tetrahydrocutyl, bilyl, pyridyl, piperidinyl, "piperidinyl, morpholinyl, fluorinyl, isoquinolinyl, 1 -A heterocyclic organic group such as piperidinylmethyl, morpholinylmethyl, etc .;

O:\S7\8706l.DOC -11 - 200413441 以下述式(IV) -Q4-T4 —s4(其中Q4為選自芳香環、脂環 (IV) 雜環及其取代基之2價環狀 有機基,T4為亦可被取代之2價脂環式基,s4為碳數丨〜3〇的 烧基)所示之基; 及,以i素取代上述有機基中之丨個或2個以上之氫原子所 得到的基。O: \ S7 \ 8706l.DOC -11-200413441 is represented by the following formula (IV) -Q4-T4- —s4 (where Q4 is a bivalent cyclic organic selected from the group consisting of aromatic ring, alicyclic (IV) heterocyclic ring and its substituents T4 is a divalent alicyclic group which may also be substituted, and s4 is a group represented by a carbon number of ˜30); and, one or two or more of the above-mentioned organic groups are substituted with i element. Radicals derived from hydrogen atoms.

此等之中,宜為碳數卜3〇之烷基、碳數丨〜川之氟烷基: 及以上述式(IV)所示的基之中,分別以下述式(IV-1)〜(IV-4) 所示之基。Among these, an alkyl group having a carbon number of 30 and a fluoroalkyl group having a carbon number of 1 to 4 are preferable: Among the groups represented by the above formula (IV), the following formulae (IV-1) to (IV-4).

(IV-1)(IV-1)

c7h15c7h15

(IV-3) (IV-2)(IV-3) (IV-2)

在上述式⑴中,B1為單鍵、-〇-或-N(H)-時,a為1, B1為In the above formula (1), when B1 is a single bond, -0-, or -N (H)-, a is 1 and B1 is

一 NOne N

吩’ a為2同樣地,在上述式(II)中,B2為單鍵、或-N(H)- 時,b為1 , B2為 /Phen 'a is 2 Similarly, when B2 is a single bond or -N (H)-in the above formula (II), b is 1 and B2 is /

一 N 時;b為2。 、v弋_(ι)所示之特定二胺化合物的具體例可舉出··石At N times; b is 2. Specific examples of the specific diamine compound represented by, v 弋 _ (ι) include:

〇:V87\8706 l.DOC -12 - 200413441 膽酸甲基(3,5-二胺基苯甲酸酯)、石膽酸乙基(3,5-二胺基苯 甲酸酯)、石膽酸丙基(3,5-二胺基苯甲酸酯)、石膽酸丁基 (3,5-二胺基苯甲酸酯)、石膽酸戊基(3,5-二胺基苯甲酸 酯)、石膽酸己基(3,5-二胺基苯甲酸酯)、石膽酸環己基(3,5-二胺基苯甲酸酯)、石膽酸十六烷基(3,5-二胺基苯甲酸酯)、 石膽酸十七统基(3,5 -二胺基苯甲酸自旨)、石膽酸十八烧基 (3,5-二胺基苯甲酸酯)、石膽酸苯基(3,5-二胺基苯甲酸 酯)、石膽酸苯甲基(3,5-二胺基苯甲酸酯)、石膽酸三氟甲i (3,5-二胺基苯甲酸酯)、石膽酸(2,2,2-三氟乙基)(3,5-二胺基 苯甲酸酯)、石膽酸(1,1,2,2,2-五氟乙基)(3,5-二胺基苯甲酸 酯)、石膽酸(4-氟苯基)(3,5-二胺基苯甲酸酯)、石膽酸(4-(三 氟甲基)苯基)(3,5-二胺基苯甲酸酯)、石膽酸(4-(4-戊基環己 基)苯基)(3,5-二胺基苯甲酸酯)、石膽酸(4-(4-庚基環己基) 苯基)(3,5-二胺基苯甲酸酯); N-甲基石膽醯胺(3,5-二胺基苯曱酸酯)、N-乙基石膽醯胺 (3,5-二胺基苯甲酸酯)、N,N-二甲基石膽醯胺(3,5-二胺基苯 甲酸酯)、N,N-二乙基石膽醯胺(3,5-二胺基苯甲酸酯)、N-丙基石膽醯胺(3,5-二胺基苯曱酸酯)、N-丁基石膽醯胺(3,5-二胺基苯甲酸酯)、N-戊基石膽醯胺(3,5-二胺基苯甲酸 酯)、1己基石膽醯胺(3,5-二胺基苯甲酸酯)、1^環己基石 膽醯胺(3,5-二胺基苯甲酸酯)、N-十六烷基石膽醯胺(3,5-二胺基苯曱酸酯)、N-十七烷基石膽醯胺(3,5-二胺基苯甲酸 酯)、N-十八烷基石膽醯胺(3,5-二胺基苯甲酸酯)、N-苯基 石膽醯胺(3&gt;5-二胺基苯甲酸酯)、N-甲基-N-苯基石膽醯胺 〇A87\.87061.DOC -13 - 200413441 (3,5-二胺基苯甲酸酯)、N-苯甲基石膽醯胺(3,5-二胺基苯甲 酸醋)、1^-三氣甲基石膽驢胺(3,5-二胺基苯甲酸|旨)、 义(2,2,2-三氟乙基)石膽醯胺(3,5-二胺基笨曱酸酯)、 N-(l,l,2,2,2-五氟乙基)石膽醯胺(3,5-二胺基苯甲酸酯)、 N-(4-(三氟甲基)苯基)石膽醯胺(3,5-二胺基苯甲酸酯)、 N-(4-(4-戊基環己基)苯基)石膽醯胺(3,5-二胺基苯甲酸 酯)、N-(4-(4-庚基環己基)苯基)石膽醯胺(3,5-二胺基笨甲酸 酯); ’ 3(2,4-二胺基苯氧基)膽烷-24-酸甲酯、3(2,4-二胺基苯氧基) 膽烷-24-酸乙酯、3(2,4-二胺基苯氧基)膽烷-24-酸丙酯、 3(2,4-二胺基苯氧基)膽烷-24-酸丁酯、3(2,4-二胺基苯氧基) 膽烧-24 -酸戊醋、3(2,4 -二胺基苯氧基)膽烧-24 -酸己g旨、 3(2,4-二胺基苯氧基)膽烷-24-酸環己酯、3(2,4-二胺基苯氧 基)膽烷-24-酸十六烷酯、3(2,4-二胺基苯氧基)膽烷-24-酸十 七烷酯、3(2,4-二胺基苯氧基)膽烷-24-酸十八烷酯、3(2,4-二胺基苯氧基)膽烷-24_酸苯基酯、3(2,4-二胺基苯氧基)膽 烷-24-酸苯甲基酯、3(2,4-二胺基苯氧基)膽烷-24-酸三氟甲 基酯、3(2,4-二胺基苯氧基)膽烷-24-酸(2,2,2-三氟乙基) 酯、3(2,4-二胺基苯氧基)膽烷-24-酸(1,2,2,2-四氟乙基)S旨、 3(2,4-二胺基苯氧基)膽烷-24-酸(1,1,2,2,2-五氟乙基)ί旨、 3(2,4-二胺基苯氧基)膽烷-24-酸(4-氟苯基)醋、3(2,4-二胺基 苯氧基)膽烷-24-酸(4-(三氟甲基)苯基)g旨、3(2,4-二胺基苯 氧基)膽烷-24-酸(4-(4-戊基環己基)苯基)§旨、3(2,4-二胺基 笨氧基)膽烷-24-酸(4-(4-庚基環己基)苯基)酯; O:\87v.37061.DOC -14- 200413441 N-曱基-3(2,4-二胺基苯氧基)膽烧-24-醯胺、N-乙基-3(2,4-二胺基苯氧基)膽烷-24-醯胺、N,N-二甲基-3(2,4-二胺基苯 氧基)膽烧- 24-¾&amp;胺、N,N -二乙基- 3(2,4 -二胺基苯氧基)膽烧 -24-醯胺、N-丙基-3(2,4-二胺基苯氧基)膽烷-24-醯胺、N-丁基-3(2,4-二胺基苯氧基)膽烷-24-醯胺、N-戊基-3(2,4-二 胺基苯氧基)膽烧-24-醯胺、N-己基- 3(2,4-二胺基苯氧基)膽 烷-24-醯胺、N-環己基-3(2,4-二胺基苯氧基)膽烷-24-醯 胺、N-十六烷基-3(2,4-二胺基苯氧基)膽烷-24-醯胺、N-十 七烷基-3(2,4-二胺基苯氧基)膽烷-24-醯胺、N-十八烷基 -3(2,4-二胺基苯氧基)膽烷-24-醯胺、N-苯基-3(2,4-二胺基 苯氧基)膽烷-24-醯胺、N-苯甲基-3(2,4-二胺基笨氧基)膽烷 -24-醯胺、N-三氟甲基-3(2,4-二胺基苯氧基)膽烷-24-醯 胺、N-(2,2,2-三氟乙基)-3(2,4-二胺基苯氧基)膽烷-24-醯 胺、(N_(2,2,2-三氟乙基)-3(2,4-二胺基苯氧基)膽烷-24-醯 胺)、1(1,1,2,2,2-五氟乙基)-3(2,4-二胺基苯氧基)膽烷-24-醯胺、N-(4-氟苯基)-3(2,4-二胺基苯氧基)膽烷-24-醯胺、 N-(4-(三氟曱基)苯基)-3(2,4-二胺基苯氧基)膽烷-24-醯 胺、N-(4-(4-戊基環己基)苯基)-3(2,4-二胺基苯氧基)膽烷 -24-醯胺、N-(4-(4-庚基環己基)苯基)-3(2,4-二胺基苯氧基) 膽烧-24-酿胺。 此等之中宜為石膽酸甲基(3,5-二胺基苯甲酸酯)、石膽酸 乙基(3,5-二胺基苯甲酸酯)、石膽酸丙基(3,5-二胺基苯曱酸 酯)、石膽酸丁基(3,5-二胺基苯甲酸醋)、石膽酸戊基(3,5-二胺基苯甲酸酯)、石膽酸己基(3,5-二胺基苯甲酸酯)、石膽 O:\87\87061.DOC -15 - 200413441 酸環己基(3,5-二胺基苯曱酸酯)、石膽酸十六烷基(3,5-二胺 基苯甲酸酯)、石膽酸十七烷基(3,5-二胺基苯甲酸酯)、石膽 酸十八烷基(3,5-二胺基苯甲酸酯)、石膽酸三氟甲基(3,5-二 胺基苯曱酸酯)、石膽酸(2,2,2-三氟乙基)(3,5-二胺基苯甲酸 酷)、石膽酸(1,1,2,2,2-五氟乙基)(3,5-二胺基苯甲酸酯)、石 膽酸(4-(4-戊基環己基)苯基)(3,5-二胺基苯甲酸酯)、石膽酸 (4-(4-庚基環己基)苯基)(3,5-二胺基苯甲酸酯); 3 (2,4-二胺基苯氧基)膽烷_2心酸甲酯、3(2,4-二胺基苯氧基_) 膽烷-24-酸乙酯、3(2,4-二胺基苯氧基)膽烷-24-酸丙酯、 3(2,4-二胺基苯氧基)膽烷-24-酸丁酯、3(2,4-二胺基苯氧基) 膽烷-24-酸戊酯、3(2,4-二胺基苯氧基)膽烷-24-酸己酯、 3(2,4-二胺基苯氧基)膽烷-24-酸環己酯、3(2,4-二胺基苯氧 基)膽烷-24-酸十六烷酯、3(2,4-二胺基苯氧基)膽烷-24-酸十 八烷酯、3(2,4-二胺基苯氧基)膽烷-24-酸三氟曱基酯、3(2,4-二胺基苯氧基)膽烷-24-酸(2,2,2-三氟乙基)S旨、3(2,4-二胺 基苯氧基)膽烷-24-酸(1,2,2,2-四氟乙基)g旨、3(2,4-二胺基苯 氧基)膽烷-24-酸(1,1,2,2,2-五氟乙基)§旨、3(2,4-二胺基苯氧 基)膽烷-24-酸(4-(4-戊基環己基)苯基)酯、3(2,4-二胺基苯 氧基)膽烷-24-酸(4-(4-庚基環己基)苯基)i旨;尤宜為石膽酸 丁基(3,5-二胺基苯甲酸酯)、石膽酸戊基(3,5-二胺基苯曱酸 酯)、石膽酸己基(3,5-二胺基苯曱酸酯)、石膽酸環己基(3,5-二胺基苯甲酸酯)、石膽酸十六烷基(3,5-二胺基笨曱酸酯)、 石膽酸十七烷基(3,5-二胺基苯曱酸酯)、石膽酸十八烷基 (3,5-二胺基苯甲酸酯)、石膽酸三氟甲基(3,5-二胺基苯甲酸〇: V87 \ 8706 l.DOC -12-200413441 methyl cholic acid (3,5-diaminobenzoate), ethyl lithocholic acid (3,5-diaminobenzoate), stone Cholic acid propyl (3,5-diaminobenzoate), lithocholic acid butyl (3,5-diaminobenzoate), pentyl lithocholic acid (3,5-diamine) Benzoate), hexyl lithocholic acid (3,5-diamino benzoate), cyclohexyl lithocholic acid (3,5-diamino benzoate), cetyl lithocholic acid (3,5-diaminobenzoate), lithocholic acid heptadyl group (3,5-diaminobenzoic acid), octadecyl lithocholic acid (3,5-diamine group) Benzoate), phenyl lithocholic acid (3,5-diaminobenzoate), benzyl lithocholic acid (3,5-diaminobenzoate), trifluoro lithocholic acid Formaldehyde (3,5-diaminobenzoate), lithocholic acid (2,2,2-trifluoroethyl) (3,5-diaminobenzoate), lithocholic acid (1 , 1,2,2,2-pentafluoroethyl) (3,5-diaminobenzoate), lithocholic acid (4-fluorophenyl) (3,5-diaminobenzoate) ), Lithocholic acid (4- (trifluoromethyl) phenyl) (3,5-diaminobenzoate), lithocholic acid 4- (4-pentylcyclohexyl) phenyl) (3,5-diaminobenzoate), lithocholic acid (4- (4-heptylcyclohexyl) phenyl) (3,5-di Aminobenzoate); N-methylcarboxamide (3,5-diaminobenzoate), N-ethylcarboxamine (3,5-diaminobenzoate) , N, N-Dimethylstilbamine (3,5-diaminobenzoate), N, N-Diethylstilbamine (3,5-diaminobenzoate), N-propylcarboxamide (3,5-diaminobenzoate), N-butylcarboxamine (3,5-diaminobenzoate), N-pentylcarboxamine ( 3,5-diaminobenzoate), 1 hexylcholineamine (3,5-diaminobenzoate), 1 ^ cyclohexylcholineamine (3,5-diaminobenzene) Formate), N-hexadecylcarboxamidine (3,5-diaminobenzoate), N-heptadecanylcarboxamide (3,5-diaminobenzoate) , N-octadecylcarboxamidine (3,5-diaminobenzoate), N-phenylcarboxamidine (3 &gt; 5-diaminobenzoate), N-methyl- N-phenylcarboxamidine 〇A87 \ .87061.DOC -13-200413441 (3,5-diaminobenzoate), N-benzyl cholestyramine (3,5-diaminobenzoic acid vinegar), 1 ^ -trimethylol cholestyramine (3,5-diaminobenzoic acid | Purpose), meaning (2 , 2,2-trifluoroethyl) cholestyramine (3,5-diaminobenzylate), N- (l, 1,2,2,2-pentafluoroethyl) cholestyramine (3,5-diaminobenzoate), N- (4- (trifluoromethyl) phenyl) lithochoramine (3,5-diaminobenzoate), N- (4 -(4-pentylcyclohexyl) phenyl) cholestyramine (3,5-diaminobenzoate), N- (4- (4-heptylcyclohexyl) phenyl) lithochoramine (3,5-diaminobenzylformate); '3 (2,4-diaminophenoxy) choline-24-acid methyl ester, 3 (2,4-diaminophenoxy) Cholan-24-acid ethyl ester, 3 (2,4-diaminophenoxy) cholan-24-acid propyl ester, 3 (2,4-diaminophenoxy) cholan-24-acid Butyl ester, 3 (2,4-diaminophenoxy) bile burn -24-pentyl acetate, 3 (2,4-diaminophenoxy) bile burn 24-g acid, 3 ( 2,4-diaminophenoxy) cholan-24-acid cyclohexyl ester, 3 (2,4-diaminophenoxy) cholan-24-acid hexadecyl ester, 3 (2,4 -Diaminophenoxy) choline-24-acyl heptadecanoate, 3 (2,4-diamine Phenylphenoxy) chole-24-octadecanoate, 3 (2,4-diaminophenoxy) choline-24_ acid phenyl ester, 3 (2,4-diaminophenoxy Group) choline-24-acid benzyl ester, 3 (2,4-diaminophenoxy) choline-24-acid trifluoromethyl ester, 3 (2,4-diaminophenoxy ) Cholan-24-acid (2,2,2-trifluoroethyl) ester, 3 (2,4-diaminophenoxy) cholan-24-acid (1,2,2,2-tetra Fluoroethyl) S, 3 (2,4-diaminophenoxy) choline-24-acid (1,1,2,2,2-pentafluoroethyl), 3 (2,4 -Diaminophenoxy) cholan-24-acid (4-fluorophenyl) vinegar, 3 (2,4-diaminophenoxy) cholan-24-acid (4- (trifluoromethyl) ) Phenyl) g, 3 (2,4-diaminophenoxy) choline-24-acid (4- (4-pentylcyclohexyl) phenyl) §, 3 (2,4-di Aminobenzyloxy) cholan-24-acid (4- (4-heptylcyclohexyl) phenyl) ester; O: \ 87v.37061.DOC -14- 200413441 N-fluorenyl-3 (2,4 -Diaminophenoxy) choline-24-amidamine, N-ethyl-3 (2,4-diaminophenoxy) choline-24-amidamine, N, N-dimethyl- 3 (2,4-diaminophenoxy) bile burner-24-¾ &amp; amine, N, N-diethyl-3 (2,4-diaminophenoxy) ) Cholesterol-24-amidamine, N-propyl-3 (2,4-diaminophenoxy) choline-24-amidamine, N-butyl-3 (2,4-diaminobenzene (Oxy) choline-24-amidamine, N-pentyl-3 (2,4-diaminophenoxy) choline-24-amidamine, N-hexyl-3 (2,4-diamine Phenoxy) choline-24-amidamine, N-cyclohexyl-3 (2,4-diaminophenoxy) choline-24-amidamine, N-hexadecyl-3 (2,4 -Diaminophenoxy) choline-24-amidamine, N-heptadecan-3 (2,4-diaminophenoxy) choline-24-amidamine, N-octadecyl -3 (2,4-diaminophenoxy) choline-24-amidamine, N-phenyl-3 (2,4-diaminophenoxy) choline-24-amidamine, N- Benzyl-3 (2,4-diaminobenzyloxy) cholane-24-amidamine, N-trifluoromethyl-3 (2,4-diaminophenoxy) cholane-24- Amidoamine, N- (2,2,2-trifluoroethyl) -3 (2,4-diaminophenoxy) choline-24-amidamine, (N_ (2,2,2-trifluoro Ethyl) -3 (2,4-diaminophenoxy) choline-24-amidamine), 1 (1,1,2,2,2-pentafluoroethyl) -3 (2,4- Diaminophenoxy) choline-24-amidamine, N- (4-fluorophenyl) -3 (2,4-diaminophenoxy) choline-24-amidamine, N- (4 -(Trifluorofluorenyl) phenyl) -3 (2,4- Diaminophenoxy) choline-24-amidamine, N- (4- (4-pentylcyclohexyl) phenyl) -3 (2,4-diaminophenoxy) choline-24- Ammonium amine, N- (4- (4-heptylcyclohexyl) phenyl) -3 (2,4-diaminophenoxy) bile burner-24-fermenting amine. Of these, methyl lithocholic acid (3,5-diaminobenzoate), ethyl lithocholic acid (3,5-diaminobenzoate), and propyl lithocholic acid ( 3,5-diaminobenzoate), butyl lithocholic acid (3,5-diaminobenzoate), pentyl lithocholic acid (3,5-diaminobenzoate), Hexyl lithocholic acid (3,5-diamino benzoate), stone bile O: \ 87 \ 87061.DOC -15-200413441 cyclohexyl acid (3,5-diamino benzoate), stone Hexadecanyl cholic acid (3,5-diaminobenzoate), Heptadecyl lithocholic acid (3,5-diaminobenzoate), Octadecyl lithocholic acid (3 , 5-diaminobenzoate), trifluoromethyl lithocholic acid (3,5-diaminobenzoate), lithocholic acid (2,2,2-trifluoroethyl) (3 , 5-diaminobenzoic acid), lithocholic acid (1,1,2,2,2-pentafluoroethyl) (3,5-diaminobenzoate), lithocholic acid (4- (4-pentylcyclohexyl) phenyl) (3,5-diaminobenzoate), lithocholic acid (4- (4-heptylcyclohexyl) phenyl) (3,5-diamino) Benzoate); 3 (2,4-diaminophenoxy) choline_2 methyl acid, 3 (2,4-di Aminophenoxy_) Choline-24-acid ethyl ester, 3 (2,4-diaminophenoxy) choline-24-acid propyl ester, 3 (2,4-diaminophenoxy ) Choline-24-acid butyl ester, 3 (2,4-diaminophenoxy) Choline-24-acyl pentyl ester, 3 (2,4-diaminophenoxy) choline-24- Hexyl acid ester, 3 (2,4-diaminophenoxy) cholane-24-acid cyclohexyl ester, 3 (2,4-diaminophenoxy) cholane-24-acid hexadecyl ester , 3 (2,4-diaminophenoxy) cholan-24-acid octadecyl ester, 3 (2,4-diaminophenoxy) cholan-24-acid trifluorofluorenyl ester, 3 (2,4-diaminophenoxy) choline-24-acid (2,2,2-trifluoroethyl) S, 3 (2,4-diaminophenoxy) choline- 24-acid (1,2,2,2-tetrafluoroethyl) g, 3 (2,4-diaminophenoxy) cholan-24-acid (1,1,2,2,2- Pentafluoroethyl) §, 3 (2,4-diaminophenoxy) cholan-24-acid (4- (4-pentylcyclohexyl) phenyl) ester, 3 (2,4-di Aminophenoxy) choline-24-acid (4- (4-heptylcyclohexyl) phenyl) i; especially butyllithocholic acid (3,5-diaminobenzoate) , Ammonium lithocholic acid (3,5-diaminophenylbenzoate), hexyl lithocholic acid (3,5-diaminobenzene) Acid esters), cyclohexyl lithocholic acid (3,5-diaminobenzoate), cetyl lithocholic acid (3,5-diaminobenzylate), heptadecyl lithocholic acid (3,5-diaminophenylbenzoate), octadecyl lithocholic acid (3,5-diaminobenzoate), trifluoromethyl lithocholic acid (3,5-diamine Benzoic acid

Ο:、'8·Λ87061.DOC -16- 200413441 酉曰)' 石膽g^(2,2,2 -二鼠乙基)(3,5 -二胺基苯曱酸g旨)、石膽 酸(1,1,2,2,2-五氟乙基)(3,5-二胺基苯甲酸酯)、石膽酸(4-(‘ 戊基環己基)苯基)(3,5-二胺基苯甲酸酯)、石膽酸(4-(4_庚基 環己基)苯基)(3,5-二胺基笨甲酸酯)。 又’以上述(II)所示之特定二胺化合物的具體例可舉出: 去氧(deoxy)膽酸甲基(雙(4-胺基苯甲酸酯))、去氧膽酸乙基 (雙(4-胺基苯甲酸酯))、去氧膽酸丙基(雙(4_胺基苯甲酸 酯))、去氧膽酸丁基(雙(4-胺基苯甲酸酯))、去氧膽酸戊基 (雙(4-胺基苯甲酸酯))、去氧膽酸己基(雙(4-胺基苯甲酸 酯))、去氧膽酸環己基(雙(4-胺基苯甲酸酯))、去氧膽酸十 六烷基(雙(4-胺基苯甲酸酯))、去氧膽酸十七烷基(霜(4-胺 基苯甲酸酯))、去氧膽酸十八烷基(雙(4-胺基苯甲酸酯))、 去氧膽酸苯基(雙(4-胺基苯曱酸酯))、去氧膽酸苯甲基(雙 (4-胺基苯曱酸酯))、去氧膽酸三氟甲基(雙(4-胺基苯甲酸 酯))、去氧膽酸(2,2,2-三氟乙基)(雙(4-胺基苯曱酸酯))、去 氧膽酸(1,1,2,2,2-五氟乙基)(雙(4-胺基苯曱酸酯))、去氧膽 酸(4-氟苯基)(雙(4-胺基苯曱酸酯))、去氧膽酸(4-(三氟甲基) 苯基)(雙(4-胺基苯甲酸酯))、去氧膽酸(4-(4-戊基環己基) 苯基)(雙(4-胺基苯甲酸酯))、去氧膽酸(4-(4-庚基環己基) 苯基)(雙(4-胺基苯甲酸酯)); N-甲基去氧膽醯胺(雙(4-胺基苯甲酸酯))、N-乙基去氧膽醯 胺(雙(4-胺基苯甲酸酯))、N,N-二甲基去氧膽醯胺(雙(4-胺 基苯曱酸酯))、N,N-二乙基去氧膽醯胺(雙(4-胺基苯曱酸 酯))、N-丙基去氧膽醯胺(雙(4_胺基苯甲酸酯))、N-丁基去 200413441 氧膽醯胺(雙(4-胺基苯甲酸酯))、N-戊基去氧膽醯胺(雙(4-胺基笨曱酸酯))、N-己基去氧膽酸胺(雙(4_胺基苯曱酸 酯))、N-環己基去氧膽醯胺(雙(4-胺基笨曱酸醋))、十六 院基去氧膽醯胺(雙(4-胺基苯甲酸醋))、N-十七烧去氧膽膽 醯胺(雙(4-胺基苯甲酸酯))、N-十八烷基去氧膽醯胺(雙(4-胺基苯甲酸酯))、N-苯基去氧膽醯胺(雙(4_胺基苯甲酸 酉旨))、N-曱基-N-苯基去氧膽酸胺(雙(4-胺基苯曱酸g旨))、N-苯甲基去氧膽醯胺(雙(4-胺基苯甲酸酯))、N-三氟甲基去氧 膽醯胺(雙(4-胺基苯甲酸酯))、N-(2,2,2-三氟乙基)去氧膽醯 胺(雙(4-胺基苯曱酸酯))、N-(l,l,2,2,2-五氟乙基)去氧膽醯 胺(雙(4-胺基苯甲酸酯))、N-(4-氟苯基)去氧膽醯胺(雙(4-胺基苯甲酸酯))、N-(4-(三氟曱基)苯基)去氧膽醯胺(雙(4_ 胺基苯甲酸酯))、N-(4-(4-戊基環己基)苯基)去氧膽醯胺(雙 (4-胺基苯曱酸酯))、N_(4-(4-庚基環己基)苯基)去氧膽醯胺 (雙(4-胺基苯曱酸酯; 去氧膽酸曱基(雙(3-胺基苯甲酸酯))、去氧膽酸乙基(雙(3-胺基苯甲酸酯))、去氧膽酸丙基(雙(3-胺基苯甲酸酯))、去 氧膽酸丁基(雙(3-胺基笨甲酸酯))、去氧膽酸戊基(雙(3-胺 基苯甲酸酯))、去氧膽酸己基(雙(3-胺基苯甲酸酯))、去氧 膽酸環己基(雙(3-胺基苯甲酸酯))、去氧膽酸十六烷基(雙 (3-胺基苯甲酸酯))、去氧膽酸十七烷基(霜胺基苯曱酸 酯))、去氧膽酸十八烷基(雙(3-胺基笨曱酸酯))、去氧膽酸 苯基(雙(3-胺基苯曱酸酯))、去氧膽酸苯曱基(雙(3-胺基苯 甲酸酯))、去氧膽酸三氟甲基(雙(3-胺基苯甲酸酯))、去氧 0:-87^87061.000 -18 - 200413441 膽酸(2,2,2-三氟乙基)(雙(3-胺基苯甲酸醋))、去氧膽酸 (1,1,2,2,2-五氟乙基)(雙(3-胺基苯甲酸酯))、去氧膽酸(4、氟 苯基)(雙(3-胺基苯甲酸酯))、去氧膽酸(4-(三氟甲基)笨 基)(雙(3-胺基苯甲酸酯)); N-甲基去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-乙基去氧膽醯 胺(雙(3-胺基苯曱酸酯))、N,N-二曱基去氧膽酸胺(雙(3-胺 基苯甲酸酯))、N,N-二乙基去氧膽醯胺(雙(3·胺基苯曱酸 酯))、N-丙基去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-丁基去 氧膽醯胺(雙(3-胺基苯甲酸酯))、N-戊基去氧膽醯胺(雙(3_ 胺基苯甲酸酯))、N-己基去氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-環己基去氧膽醯胺(雙(3-胺基笨甲酸酯))、N-十六 烷基去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-十七烷去氧膽膽 醯胺(雙(3-胺基苯甲酸酯))、N-十八烷基去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-苯基去氧膽醯胺(雙(3-胺基笨甲酸 酯))、N-甲基-N-苯基去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-笨甲基去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-三氟曱基去氧 膽醯胺(雙(3-胺基苯甲酸酯))、N-(2,2,2-三氟乙基)去氧膽醯 胺(雙(3-胺基苯甲酸酯))、N-(l,l,2,2,2-五氟乙基)去氧膽醯 胺(雙(3-胺基苯曱酸酯))、N-(4-氟苯基)去氧膽醯胺(雙 胺基苯甲酸酯))、N-(4-(三氟甲基)苯基)去氧膽醯胺(雙(3_ 胺基苯甲酸酯))、N-(4-(4-戊基環己基)苯基)去氧膽酿胺(雙 (3-胺基苯曱酸酯))、N-(4-(4-庚基環己基)苯基)去氧膽醯胺 (雙(3-胺基苯甲酸酯)); 鵝去氧膽酸-甲基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸乙基(雙 〇:'.87\87061.DOC -19- 200413441 (4-胺基苯甲酸酯))、鵝去氧膽酸丙基(雙(4_胺基苯甲酸 3曰))、鵝去氧膽酸丁基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸 戊基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸己基(雙(4_胺基笨 甲酸酯))、鵝去氧膽酸環己基(雙胺基苯曱酸酯))、鵝去 氧膽酸十六烷基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸十七烷 基(霜(4-胺基苯甲酸酯))、鵝去氧膽酸十八烷基(雙(4_胺基 笨曱酸酯))、鵝去氧膽酸苯基(雙(4-胺基苯曱酸酯))、鵝去 氧膽酸苯甲基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸三氟甲基 (雙(4-胺基苯甲酸酯))、鵝去氧膽酸(2,2,2_三氟乙基)(雙(‘ 胺基苯曱酸酯))、鵝去氧膽酸(丨丄^厂五氟乙基)(雙(4-胺 基苯甲酸酯))、鵝去氧膽酸(4_氟苯基)(雙(‘胺基苯曱酸 醋))、鵠去氧膽酸(4-(三氟曱基)苯基)(雙(4-胺基苯甲酸 酯))、鵝去氧膽酸(4-(4-戊基環己基)苯基)(雙(4-胺基苯甲酸 §曰))、鵝去氧膽酸(4-(4-庚基環己基)苯基)(雙(4_胺基苯甲酸 酯)); N-甲基鵝去氧膽醯胺(雙(4-胺基苯甲酸酯))、N-乙基鵝去氧 膽醯胺(雙(4_胺基笨甲酸酯))、N,N-二甲基鵝去氧膽醯胺(雙 (4-胺基笨甲酸酯N,N-二乙基鵝去氧膽醯胺(雙(心胺基苯 曱k酯))、N-丙基鵝去氧膽醯胺(雙(4-胺基笨曱酸酯))、N-丁基鶴去氧膽醯胺(雙(4_胺基苯曱酸酯))、戊基鵝去氧膽 胺(雙(4_胺基苯曱酸酯))、N-己基鵝去氧膽醯胺(雙(4-胺 基苯甲酸酯))、N-環己基鵝去氧膽醯胺(雙(4-胺基苯曱酸 酿))、N-十六烷基鵝去氧膽醯胺(雙(4-胺基苯曱酸酯))、N-十七燒鶴去氧膽膽醯胺(雙(4-胺基苯甲酸酯”、N- +八烷基 0'·'S^S7〇6 i.d〇c -20- 200413441 鵝去氧膽醯胺(雙(4-胺基苯曱酸酯))、苯基鵝去氧膽醯胺 (雙(4-胺基苯甲酸酯))、N-甲基苯基鵝去氧膽醯胺(雙(心 胺基苯甲酸酯))、N-笨甲基鵝去氧膽醯胺(雙胺基苯甲酸 酉曰))、N-二氟甲基鶴去氧膽酸胺(雙(4-胺基笨甲酸酯))、 N-(2,2,2-二氟乙基)鵝去氧膽酿胺(雙(4-胺基苯甲酸酯))、 N-( l,1,2,2,2 -五氟乙基)鶴去氧膽酿胺(雙(4 -胺基苯甲酸 酯))、N-(4-氟苯基)鵝去氧膽醯胺(雙胺基苯甲酸酯、 N-(4-(三氟甲基)苯基)鵝去氧膽醯胺(雙⑷胺基苯甲酸 醋))、N-(4-(4-戊基環己基)苯基)鵝去氧膽醯胺(雙(4-胺基苯 曱酸醋))、N-(4-(4-庚基環己基)苯基)鵝去氧膽醯胺(雙(4_ 胺基苯甲酸酯)); 鶴去氧膽酸曱基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸乙基(雙 (3-胺基苯甲酸酯))、鵝去氧膽酸丙基(雙胺基苯曱酸 酉旨))、鵝去氧膽酸丁基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸 戊基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸己基(雙胺基笨 甲酸酯))、鵝去氧膽酸環己基(雙(3-胺基苯甲酸酯))、鵝去 氧膽酸十六烷基(雙(3-胺基苯曱酸§旨))、鵝去氧膽酸十七烷 基(霜(3-胺基苯甲酸酯))、鵝去氧膽酸十八烷基(雙(3-胺基 苯甲酸酯))、鵝去氧膽酸苯基(雙(3-胺基苯甲酸酯))、鵝去 氧膽酸苯甲基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸三氟曱基 (雙(3-胺基苯甲酸酯))、鶴去氧膽酸(2,2,2-三氟乙基)(雙(3· 胺基笨甲酸酯))、鵝去氧膽酸(1,1,2,2,2-五氟乙基)(雙(3-胺 基苯甲酸酯))、鵝去氧膽酸(4-氟苯基)(雙(3-胺基苯甲酸 酯))、鵝去氡膽酸(4-(三氟甲基)苯基)(雙(3-胺基笨甲酸 O:\87\8706I.DOC -21 - 200413441 酿))、鵝去氧膽酸(4-(4-戊基環己基)苯基)(雙(3-胺基笨甲酸 _曰))鶴去氧膽酸(4-(4 -庚基環己基)苯基)(雙(3 -胺基苯曱酸 酯)); N-甲基鵝去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-乙基鵝去氧 膽酸胺(雙(3-胺基苯曱酸酯))、N,N-二甲基鵝去氧膽醯胺(雙 (3-胺基笨甲酸酯))、N,N-二乙基鵝去氧膽醯胺(雙(3-胺基苯 甲酸酯))、N-丙基鵝去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-丁基鵝去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-戊基鵝去氧月i 酸胺(雙(3-胺基苯甲酸酯))、N-己基鵝去氧膽醯胺(雙(3-胺 基笨甲酸酯))、N-環己基鵝去氧膽醯胺(雙(3-胺基苯甲酸 S旨))、N-十六烷基鵝去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-十七烷鵝去氧膽膽醯胺(雙(3-胺基苯曱酸酯))、N-十八烷基 鵝去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-苯基鵝去氧膽醯胺 (雙(3-胺基苯甲酸酯))、N-曱基-N-苯基鵝去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-笨甲基鵝去氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-三氟甲基鵝去氧膽醯胺(雙(3-胺基苯曱酸醋))、 N-(2,2,2-三氟乙基)鵝去氧膽醯胺(雙(3-胺基苯甲酸酯))、 N-(l,l,2,2,2-五氟乙基)鵝去氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-(4-氟苯基)鵝去氧膽醯胺(雙(3-胺基苯甲酸酯))、 N-(4-(三氟甲基)苯基)鵝去氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-(4-(4-戊基環己基)苯基)鵝去氧膽醯胺(雙(3-胺基苯 甲酸酯))、N-(4-(4-庚基環己基)苯基)鵝去氧膽醯胺(雙(3-胺基苯甲酸酯)); 脫氧(desoxyO膽酸甲基(雙(4-胺基苯甲酸酯))、脫氧膽酸乙 O:\87\87061.DOC -22- 200413441 基(雙(4-胺基苯甲酸酯))、脫氧膽酸丙基(雙(4_胺基苯甲酸 商曰))、脫氧膽酸丁基(雙(4-胺基苯甲酸g旨))、脫氧膽酸戊基 (雙(4-胺基苯甲酸酯))、脫氧膽酸己基(雙(4-胺基苯曱酸 酯))、脫氧膽酸環己基(雙(4-胺基苯甲酸酯))、脫氧膽酸十 六烷基(雙(4-胺基苯曱酸酯))、脫氧膽酸十七烷基(霜(4-胺 基苯曱酸酯))、脫氧膽酸十八烷基(雙(4-胺基苯甲酸酯》、 脫氧膽酸苯基(雙(4-胺基苯曱酸酯))、脫氧膽酸苯甲基(雙 (4_胺基苯甲酸酯))、脫氧膽酸三氟曱基(雙(4-胺基苯甲酸 酯))、脫氧膽酸(2,2,2-三氟乙基)(雙(4-胺基苯甲酸酯))、脫 氧膽酸(1,1,2,2,2-五氟乙基)(雙(4-胺基苯甲酸酯))、脫氧膽 酸(4-氟笨基)(雙(4-胺基苯甲酸酯))、脫氧膽酸(4-(三氟曱基) 苯基)(雙(4-胺基笨曱酸酯))、脫氧膽酸(4-(4-戊基環己基) 苯基)(雙(4-胺基苯曱酸酯))、脫氧膽酸(4-(4-庚基環己基) 苯基)(雙(4-胺基苯曱酸酯)); N-曱基脫氧膽醯胺(雙(4-胺基苯甲酸酯))、N-乙基脫氧膽醯 胺(雙(4-胺基笨曱酸酯))、N,N-二曱基脫氧膽醯胺(雙(4-胺 基苯曱酸S旨))、N,N -二乙基脫氧膽酸胺(雙(4-胺基笨曱酸 酯))、N-丙基脫氧膽酸胺(雙(4-胺基苯曱酸酯))、N-丁基脫 氧膽醯胺(雙(4-胺基苯甲酸酯))、N-戊基脫氧膽醯胺(雙(4-胺基苯曱酸酯))、N-己基脫氧膽醯胺(雙(心胺基笨甲酸 酯))、N-環己基脫氧膽醯胺(雙(4-胺基苯曱酸酷))、N-十六 烷基脫氧膽醯胺(雙(4-胺基苯曱酸酯))、N-十七烷脫氧膽膽 酿胺(雙(4-胺基苯曱酸酯))、N-十八烧基脫氧膽隨胺(雙(4-胺基苯曱酸·酯))、N-苯基脫氧膽醯胺(雙(心胺基笨曱酸 ΟΛ87Ν8706 丨.DOC -23 - 200413441 酯))、N-甲基-N-苯基脫氧膽醯胺(雙(4-胺基苯甲酸酯))、N-苯甲基脫氧膽醯胺(雙(4-胺基苯甲酸酯))、N-三氟甲基脫氧 膽醯胺(雙(4-胺基苯甲酸酯))、N-(2,2,2-三氟乙基)脫氧膽醯 胺(雙(4-胺基苯甲酸酯))、N-(l,l,2,2,2-五氟乙基)脫氧膽醯 胺(雙(4-胺基苯甲酸酯))、N-(4-氟苯基)脫氧膽醯胺(雙(4_ 胺基苯曱酸酯))、N-(4-(三氟甲基)苯基)脫氧膽醯胺(雙(4-胺基苯甲酸酯))、N-(4-(4-戊基環己基)苯基)脫氧膽醯胺(雙 (4-胺基苯甲酸酯))、N-(4-(4-庚基環己基)苯基)脫氧膽醯胺 (雙(4-胺基苯甲酸酯)); 脫氧膽酸甲基(雙(3-胺基苯甲酸酯))、脫氧膽酸乙基(雙(3-胺基苯甲酸酯))、脫氧膽酸丙基(雙(3-胺基苯甲酸酯))、脫 氧膽酸丁基(雙(3-胺基苯甲酸酯))、脫氧膽酸戊基(雙(3-胺 基苯曱酸酯))、脫氧膽酸己基(雙(3-胺基苯曱酸酯))、脫氧 膽酸環己基(雙(3-胺基苯甲酸酯))、脫氧膽酸十六烷基(雙 (3-胺基苯甲酸酯))、脫氧膽酸十七烷基(霜(3-胺基苯甲酸 酯))、脫氧膽酸十八烷基(雙(3-胺基苯甲酸酯))、脫氧膽酸 苯基(雙(3-胺基苯甲酸酯))、脫氧膽酸苯曱基(雙(3-胺基苯 甲酸酯))、脫氧膽酸三氟甲基(雙(3-胺基苯甲酸酯))、脫氧 膽酸(2,2,2-三氟乙基)(雙(3-胺基苯甲酸酯))、脫氧膽酸 (1,1,2,2,2-五氟乙基)(雙(3-胺基苯甲酸g旨))、脫氧膽酸(4-氟 苯基)(雙(3-胺基苯甲酸酯))、脫氧膽酸(4-(三氟曱基)苯 基)(雙(3-胺基苯甲酸酯))、脫氧膽酸(4-(4-戊基環己基)苯 基)(雙(3-胺基苯甲酸酯))、脫氧膽酸(4-(4-庚基環己基)苯 基)(雙(3-胺基苯曱酸酯)); 0.^8787061.DOC -24- 200413441 N-甲基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-乙基脫氧膽酸 胺(雙(3-胺基苯甲酸酯))、N,N-二甲基脫氧膽驢胺(雙(3_胺 基苯甲酸酯))、N,N-二乙基脫氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-丙基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-丁基脫 氧膽醯胺(雙(3-胺基苯甲酸酯))、N-戊基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-己基脫氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-環己基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-十六 烷基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-十七烷脫氧膽膽 醯胺(雙(3-胺基苯甲酸酯))、N-十八烷基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-苯基脫氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-甲基-N-苯基脫氧膽醯胺(雙(3-胺基苯甲酸酯))、N-苯甲基脫氧膽醯胺(雙(3-胺基苯曱酸酯))、N-三氟甲基脫氧 膽醯胺(雙(3-胺基苯甲酸酯))、N-(2,2,2-三氟乙基)脫氧膽醯 胺(雙(3-胺基苯甲酸酯))、&gt;^(1,1,2,2,2-五氟乙基)脫氧膽醯 胺(雙(3-胺基笨曱酸酯))、N-(4-氟笨基)脫氧膽醯胺(雙(3-胺基苯曱酸酯))、N-(4-(三氟甲基)苯基)脫氧膽酿胺(雙(3-胺基苯甲酸酯))、N-(4-(4-戊基環己基)苯基)脫氧膽酿胺(雙 (3-胺基苯曱酸酯))、N-(4-(4-庚基環己基)苯基)脫氧膽醯胺 (雙(3-胺基苯曱酸酯)); 豬去氧膽酸曱基(雙(4 -胺基苯曱酸酯))、豬去氧膽酸乙基(雙 (4-胺基苯曱酸酯))、豬去氧膽酸丙基(雙(4-胺基笨曱酸 酯))、豬去氧膽酸丁基(雙(4-胺基苯甲酸酯))、豬去氧膽酸 戊基(雙(4-胺基苯甲酸酯))、豬去氧膽酸己基(雙胺基笨 甲酸酯))、豬去氧膽酸環己基(雙(4-胺基笨甲酸酯))' 豬去 O:\87\8706l.DOC -25, 200413441 氧膽酸十六烷基(雙(4-胺基苯甲酸酯、豬去氧膽酸十七烷 基(霜(4-胺基苯甲酸酯))、豬去氧膽酸十八烷基(雙(‘胺基 苯甲酸酯))、豬去氧膽酸苯基(雙(4_胺基苯甲酸酯、豬去 氧膽酸苯甲基(雙(4-胺基苯甲酸酯))、豬去氧膽酸三氟甲基 (雙(4-胺基苯甲酸酯))、豬去氧膽酸(2,2,孓三氟乙基)(雙(心 胺基苯曱酸酯))、豬去氧膽酸(1,丨,2,2,2-五氟乙基)(雙(4-胺 基苯甲酸酯))、豬去氧膽酸(4-氟苯基)(雙(4-胺基苯甲酸 酉旨))、豬去氧膽酸(4-(三氟甲基)苯基)(雙(4-胺基苯甲酸 醋))、豬去氧膽酸(4-(4-戊基環己基)苯基)(雙(4-胺基苯甲酸 酯))、豬去氧膽酸(4-(4-庚基環己基)苯基)(雙(4-胺基苯甲酸 酯)); N-曱基豬去氧膽醯胺(雙(4-胺基苯曱酸酯))、N-乙基豬去氧 膽醯胺(雙(4-胺基苯曱酸酯))、N,N-二曱基豬去氧膽醯胺(雙 (4-胺基苯甲酸酯))、N,N-二乙基豬去氧膽醯胺(雙(4-胺基苯 甲酸酯))、N-丙基豬去氧膽醯胺(雙(4-胺基苯甲酸酯))、N-丁基豬去氧膽醯胺(雙(4-胺基苯曱酸酯))、N-戊基豬去氧膽 醯胺(雙(4-胺基苯甲酸酯))、N-己基豬去氧膽醯胺(雙(4-胺 基笨曱酸酯))、N-環己基豬去氧膽醯胺(雙(4-胺基苯曱酸 酯))、N-十六烷基豬去氧膽醯胺(雙(4-胺基苯曱酸酯))、N-十七烷豬去氧膽膽醯胺(雙(4-胺基苯甲酸酯))、N-十八烷基 豬去氧膽醯胺(雙(4-胺基苯曱酸酯))、N-笨基豬去氧膽醯胺 (雙(4-胺基苯曱酸酯))、N-曱基-N-苯基豬去氧膽醯胺(雙(4-胺基笨曱酸酯))、N-笨曱基豬去氧膽醯胺(雙(4-胺基苯曱酸 酯))、N-三氨甲基豬去氧膽醯胺(雙(4_胺基苯曱酸酯))、 O:\-87\8706l.DOC -26- 200413441 N-(2,2,2-二氟乙基)豬去氧膽醯胺(雙(4_胺基苯甲酸酯))、 N-(l,l,2,2,2-五氟乙基)豬去氧膽醯胺(雙(心胺基苯甲酸 S曰))、N-(4-氟苯基)豬去氧膽醯胺(雙(4_胺基苯甲酸酯))、 N-(4-(二氟f基)苯基)豬去氧膽醯胺(雙(4_胺基苯甲酸 酯))、N-(4-(4-戊基環己基)苯基)豬去氧膽醯胺(雙胺基苯 甲酸醋))、N-(4-(4-庚基環己基)苯基)豬去氧膽醯胺(雙(4-胺基苯甲酸酯)); 豬去氧膽酸甲基(雙(3-胺基苯甲酸酯))、豬去氧膽酸乙基 (3-胺基苯甲酸酯))、豬去氧膽酸丙基(雙(3_胺基苯甲酸 醋))、豬去氧膽酸丁基(雙(3_胺基苯甲酸酯、豬去氧膽酸 戊基(雙(3-胺基苯甲酸酯》、豬去氧膽酸己基(雙(3-胺基苯 甲酸醋))、豬去氧膽酸環己基(雙(3 _胺基苯甲酸酯))、豬去 氧膽酸十六烷基(雙(3-胺基苯甲酸酯))、豬去氧膽酸十七烷 基(箱(3-胺基本甲酸g旨))、豬去氧膽酸十八烧基(雙胺基 苯甲酸酯))、豬去氧膽酸苯基(雙(3-胺基笨曱酸酯))、豬去 氧膽酸苯甲基(雙(3-胺基苯甲酸酯))、豬去氧膽酸三氟甲基 (雙(3-胺基笨甲酸酯))、豬去氧膽酸(2,2,2_三氟乙基)(雙(3· 胺基笨甲酸酯))、豬去氧膽酸(1,1,2,2,2-五氟乙基)(雙(3_胺 基苯甲酸酯))、豬去氧膽酸(4-氟苯基)(雙(3-胺基苯甲酸 酯))、豬去氧膽酸(4-(三氟甲基)苯基)(雙(3-胺基苯甲酸 酉曰))、豬去氧膽酸(4-(4-戊基環己基)苯基)(雙(3-胺基苯甲酸 酯))、豬去氧膽酸(4-(4-庚基環己基)苯基)(雙(3-胺基苯甲 酸酯)); N-甲基豬去氧膽驢胺(雙(3 -胺基苯甲酸g旨))、N-乙基豬去氧 O:\S7\8706l.DOC -27- 200413441 膽醯胺(雙(3-胺基苯甲酸酯))、N,N-二甲基豬去氧膽醯胺(雙 (3-胺基笨甲酸酯))、N,N-二乙基豬去氧膽醯胺(雙(3-胺基苯 甲酸酯))、N-丙基豬去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-丁基豬去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-戊基豬去氧膽 醯胺(雙(3-胺基苯甲酸酯))、N-己基豬去氧膽醯胺(雙(3-胺 基笨甲酸酯))、N-環己基豬去氧膽醯胺(雙(3-胺基苯甲酸 酯))、N-十六烧基豬去氧膽酷胺(雙(3-胺基苯甲酸酯))、N-十七烷豬去氧膽膽醯胺(雙(3-胺基苯甲酸酯))、N-十八烷左 豬去氧膽醯胺(雙(3-胺基苯甲酸酯))、N-苯基豬去氧膽醯胺 (雙(3-胺基苯甲酸酯))、N-甲基-N-苯基豬去氧膽醯胺(雙(3-胺基苯曱酸酯))、N-苯甲基豬去氧膽醯胺(雙(3-胺基苯甲酸 酷))、N-三氟甲基豬去氧膽醯胺(雙(3-胺基苯甲酸酯))、 N-(2,2,2-三氟乙基)豬去氧膽醯胺(雙(3-胺基苯甲酸酯))、 N-(U,2,2,2-五氟乙基)豬去氧膽醯胺(雙(3-胺基苯甲酸 醋))、N-(4-氟苯基)豬去氧膽醯胺(雙(3-胺基笨曱酸酯))、 N-(4-(三氟甲基)苯基)豬去氧膽醯胺(雙(3_胺基苯甲酸 酯))、N-(4-(4-戊基環己基)苯基)豬去氧膽醯胺(雙(3-胺基苯 曱酸酯))、N-(4-(4-庚基環己基)苯基)豬去氧膽醯胺(雙(3-胺基苯曱酸酯; 3,6-雙(4-胺基苯氧基)膽烧- 24-酸甲酯、3,6-雙(4-胺基苯氧 基)膽烷-24-酸乙酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸丙 靡、3,6-雙(4-胺基苯氧基)膽烷-24-酸丁酯、3,6-雙(4-胺基 笨氧基)膽烧-24-酸戊酯、3,6-雙(4-胺基苯氧基)膽烧-24-酸 己酉旨、3,6-雙(4-胺基苯氧基)膽烷-24-酸環己酯、3,6-雙(4- 〇:、..87\87061-D〇C -28 - 200413441 胺基苯氧基)膽烷-24-酸十六烷酯、3,6-雙(4-胺基苯氧基)膽 烷-24-酸十七烷酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸十八烷 酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸苯基酯、3,6-雙(4-胺 基苯氧基)膽烷-24-酸苯甲基酯、3,6-雙(4-胺基苯氧基)膽烷 -24-酸三氟甲基酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(2,2,2-三氟乙基)i旨、(3,6-雙(4-胺基苯氧基)膽烷-24-酸(2,2,2-四氟 乙基)醋)、3,6-雙(4-胺基苯氧基)膽烷-24-酸(1,1,2,2,2-五氟 乙基)S旨、3,6-雙(4-胺基苯氧基)膽烷-24-酸(4-氟苯基)S旨、 3,6-雙(4-胺基苯氧基)膽烷-24-酸(4-(三氟甲基)笨基)S旨、 3,6-雙(4-胺基苯氧基)膽烷-24-酸(4-(4-戊基環己基)苯基) 酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(4-(4-庚基環己基)苯 基)酯; 仏曱基-3,6-雙(4-胺基苯氧基)膽烷-24-醯胺、&gt;^乙基-3,6-雙(4-胺基苯氧基)膽烷-24-醯胺、N,N-二甲基-3,6-雙(4-胺基 苯氧基)膽烷-24-醯胺、N,N-二乙基-3,6-雙(4-胺基苯氧基) 膽烧-24-驢胺、N-丙基-3,6 -雙(4-胺基苯氧基)膽烧-24-酉藍 胺、N- 丁基-3,6-雙(4-胺基苯氧基)膽烧- 24-fe胺、N -戍基 -3,6 -雙(4 -胺基笨氧基)膽烧- 24 -S蠢胺、N-己基-3,6 -雙(4 -胺基 本氧基)膽烧- 24-酸胺、Ν-ί哀己基-3,6-雙(4 -胺基苯乳基)膽 烷-24-醯胺、Ν-十六烷基-3,6-雙(4-胺基苯氧基)膽烷-24-醯 胺、Ν-十七烷基-3,6-雙(4-胺基苯氧基)膽烷-24-醯胺、Ν-十 八烷基-3,6-雙(4-胺基苯氧基)膽烷-24-醯胺、Ν-苯基-3,6-雙 (4-胺基苯氧基)膽烷-24-醯胺、Ν-苯甲基-3,6-雙(4-胺基苯氧 基)膽烷-24,醯胺、Ν-三氟曱基-3,6-雙(4-胺基苯氧基)膽烷 O:\87\8706l.DOC -29 - 200413441 -24-ii胺、N-(2,2,2-三氟乙基)-3,6-雙(4-胺基苯氧基)膽烧 -24-醯胺、(N-(2,2,2 -四氟乙基)-3,6-雙(4-胺基苯氧基)膽烷 -24-醯胺)、!^(1,1,2,2,2-五氟乙基)-3,6-雙(4-胺基苯氧基) 膽烧- 24-驢胺、N-(4 -氟苯基)-3,6-雙(4-胺基苯氧基)膽烧_24_ 酿胺、N-(4-(三氟甲基)苯基)-3,6-雙(4-胺基苯氧基)膽烧_24_ 醯胺、N-(4-(4-戊基環己基)苯基)-3,6-雙(4-胺基苯氧基)膽 烷-24-醯胺、N-(4-(4-庚基環己基)苯基)-3,6-雙(4-胺基苯氧 基)膽烧-2 4 -酸胺, 3.6- 雙(3-胺基苯氧基)膽烷-24-酸甲酯、3,6-雙(3-胺基苯氧 基)膽烷-24-酸乙酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸丙 酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸丁酯、3,6-雙(3-胺基 苯氧基)膽烷-24-酸戊酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸 己酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸環己酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸十六烷酯、3,6-雙(3-胺基苯氧基)膽 烷-24-酸十七烷酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸十八烷 酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸苯基酯、3,6-雙(3-胺 基苯氧基)膽烷-24-酸苯甲基酯、3,6-雙(3-胺基苯氧基)膽烷 -24-酸三氟曱基酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸(2,2,2-二氟乙基)S旨、(3,6 -雙(3 -胺基苯氧基)膽烧- 24 -酸(2,2,2 -四氟 乙基)酯)、3,6-雙(3-胺基苯氧基)膽烷-24-酸(1,1,2,2,2-五氟 乙基)醋、3,6-雙(3-胺基苯氧基)膽烷-24-酸(4-氟苯基)g旨、 3.6- 雙(3-胺基笨氧基)膽烷-24-酸(4-(三氟甲基)笨基)酯、 3,6-雙(3-胺基苯氧基)膽烷-24-酸(4-(4-戊基環己基)苯基) 醋、3,6-雙(3-胺基苯氧基)膽烷—24-酸(4-(4-庚基環己基)苯 O:\87.8706 i.iX)C -30- 200413441 基)酯; N-甲基-3,6-雙(3-胺基苯氧基)膽烷-24-醯胺、N-乙基-3,6- 雙(3-胺基苯氧基)膽烷-24-醯胺、N,N-二甲基-3,6-雙(3-胺基 本氧基)膽烧- 24 -酿胺、N,N-二乙基- 3,6 -雙(3-胺基苯氧基) 膽烷-24-醯胺、N-丙基-3,6-雙(3-胺基苯氧基)膽烷-24-醯 胺、N-丁基-3,6-雙(3-胺基苯氧基)膽烷-24-醯胺、N-戊基 -3,6-雙(3-胺基苯氧基)膽烷-24-醯胺、N-己基-3,6-雙(3-胺基 苯氧基)膽烷-24-醯胺、N-環己基-3,6-雙(3-胺基苯氧基)膽 烧-24-酿胺、N-十六烷基-3,6-雙(3-胺基苯氧基)膽烷-24-醯 胺、N-十七烧基_3,6-雙(3-胺基苯氧基)膽烷-24-醯胺、N-十 八烷基-3,6-雙(3-胺基苯氧基)膽烷-24-醯胺、N-苯基-3,6-雙 (3-胺基苯氧基)膽烷-24-醯胺、N-苯曱基-3,6-雙(3-胺基苯氧 基)膽烷-24-醯胺、N-三氟甲基-3,6-雙(3-胺基苯氧基)膽烷 -24-醯胺、N-(2,2,2-三氟乙基)-3,6-雙(3-胺基苯氧基)膽烷 -24-醯胺、(N-(2,2,2-四氟乙基)-3,6-雙(3-胺基苯氧基)膽烷 -24-醯胺)、仏(1,1,2,2,2-五氟乙基)_3,6-雙(3_胺基苯氧基) 膽烷-24-醯胺、N-(4-氟苯基)-3,6-雙(3-胺基苯氧基)膽烷-24- 醯胺、N-(4-(三氟曱基)笨基)-3,6-雙(3_胺基苯氧基)膽烷_24_ 醯胺、N-(4-(4-戊基環己基)苯基)_3,6_雙(3_胺基苯氧基)膽 烷-24-醯胺、N'(4-(4-庚基環己基)苯基&gt;3,6-雙(3-胺基苯氧 基)膽烧-24-酸胺。 其中宜為鵝去氧膽酸曱基(雙(4_胺基苯甲酸酯))、鵝去氧 膽酸乙基(雙(4-胺基笨甲酸酯))、鵝去氧膽酸丙基(雙(‘胺 基苯甲酸S曰·))、鵝去氧膽酸丁基(雙(4_胺基苯甲酸酯))、鵝Ο :, '8 · Λ87061.DOC -16- 200413441 酉)' gallstone g ^ (2,2,2-diratethyl) (3,5-diaminophenylbenzoic acid g), stone gall Acid (1,1,2,2,2-pentafluoroethyl) (3,5-diaminobenzoate), lithocholic acid (4-('pentylcyclohexyl) phenyl) (3, 5-diaminobenzoate), lithocholic acid (4- (4-heptylcyclohexyl) phenyl) (3,5-diaminobenzate). Specific examples of the specific diamine compound represented by the above (II) include deoxycholic acid methyl (bis (4-aminobenzoate)) and ethyl deoxycholate (Bis (4-aminobenzoate)), propyldeoxycholate (bis (4-aminobenzoate)), butyldeoxycholate (bis (4-aminobenzoate) Ester)), amyl deoxycholate (bis (4-aminobenzoate)), hexyl deoxycholate (bis (4-aminobenzoate)), cyclohexyl deoxycholate ( Bis (4-aminobenzoate)), cetyl deoxycholate (bis (4-aminobenzoate)), heptadecyl deoxycholate (4-amino Benzoate)), octadecyl deoxycholate (bis (4-aminobenzoate)), phenyl deoxycholate (bis (4-aminobenzoate)), Benzyloxycholate (bis (4-aminobenzoate)), trifluoromethyl deoxycholate (bis (4-aminobenzoate)), deoxycholate (2,2 , 2-trifluoroethyl) (bis (4-aminophenylbenzoate)), deoxycholic acid (1,1,2,2,2-pentafluoroethyl) (bis (4-aminobenzene) Phosphonate)) , Deoxycholic acid (4-fluorophenyl) (bis (4-aminophenylbenzoate)), Deoxycholic acid (4- (trifluoromethyl) phenyl) (bis (4-aminophenyl) Formate)), deoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (4-aminobenzoate)), deoxycholic acid (4- (4-heptyl) Cyclohexyl) phenyl) (bis (4-aminobenzoate)); N-methyldeoxycholamine (bis (4-aminobenzoate)), N-ethyldeoxycholate Amidoamine (bis (4-aminobenzoate)), N, N-dimethyldeoxycholamine (bis (4-aminobenzoate)), N, N-diethyl Oxycholamine (bis (4-aminobenzoate)), N-propyldeoxycholamine (bis (4-aminobenzoate)), N-butyldeoxybenzidine 200413441 Amine (bis (4-aminobenzoate)), N-pentyldeoxycholic acid amine (bis (4-aminobenzoic acid)), N-hexyldeoxycholic acid amine (bis (4 (4) _Aminobenzoic acid esters)), N-cyclohexyldeoxycholic acid amine (bis (4-aminobenzyl acetic acid vinegar)), hexadecyldeoxycholic acid amine (bis (4-aminophenylbenzene) Formic acid vinegar)), N-seven burned deoxycholate (Bis (4-aminobenzoate)), N-octadecyldeoxycholamide (bis (4-aminobenzoate)), N-phenyldeoxycholamine (bis (4-Aminobenzoic acid)), N-fluorenyl-N-phenyldeoxycholic acid amine (bis (4-aminophenylbenzoic acid g)), N-benzyldeoxycholic acid Amine (bis (4-aminobenzoate)), N-trifluoromethyldeoxycholamine (bis (4-aminobenzoate)), N- (2,2,2-tris Fluoroethyl) Deoxycholamide (bis (4-aminophenylbenzoate)), N- (l, 1,2,2,2-pentafluoroethyl) deoxycholamine (bis (4 -Aminobenzoate)), N- (4-fluorophenyl) deoxycholamine (bis (4-aminobenzoate)), N- (4- (trifluorofluorenyl) benzene Group) deoxycholamide (bis (4-aminobenzoate)), N- (4- (4-pentylcyclohexyl) phenyl) deoxycholamide (bis (4-aminophenylphenyl) Acid ester)), N_ (4- (4-heptylcyclohexyl) phenyl) deoxycholamine (bis (4-aminophenylbenzoate); deoxycholate (bis (3-amino) Benzoate)), ethyl deoxycholate (bis (3-aminobenzoate)), propyl deoxycholate (bis 3-aminobenzoate)), butyldeoxycholate (bis (3-aminobenzyl)), amyl deoxycholate (bis (3-aminobenzoate)) , Hexyl deoxycholate (bis (3-aminobenzoate)), cyclohexyl deoxycholate (bis (3-aminobenzoate)), cetyl deoxycholate (bis (3-Aminobenzoate)), Heptadecyl Deoxycholate (Crystalline Benzoate)), Octadecyl Deoxycholate (bis (3-Aminobenzoate) )), Deoxycholate Phenyl (bis (3-aminobenzoate)), Deoxycholate Phenyl (bis (3-aminobenzoate)), Deoxycholate trifluoro Methyl (bis (3-aminobenzoate)), deoxygenation 0: -87 ^ 87061.000 -18-200413441 Cholic acid (2,2,2-trifluoroethyl) (bis (3-aminobenzene) Formic acid vinegar)), deoxycholic acid (1,1,2,2,2-pentafluoroethyl) (bis (3-aminobenzoate)), deoxycholic acid (4, fluorophenyl) (Bis (3-aminobenzoate)), deoxycholic acid (4- (trifluoromethyl) benzyl) (bis (3-aminobenzoate)); N-methyldeoxy Choline (bis (3-amino Phenylacetate)), N-ethyldeoxycholestyramine (bis (3-aminophenylbenzoate)), N, N-Difluorenyldeoxycholamine (bis (3-aminophenylbenzene) Formate)), N, N-diethyldeoxycholamide (bis (3-aminophenylbenzoate)), N-propyldeoxycholamine (bis (3-aminobenzyl) Esters)), N-butyldeoxycholestyramine (bis (3-aminobenzoate)), N-pentyldeoxycholestyramine (bis (3-aminobenzoate)), N-hexyldeoxycholamine (bis (3-aminobenzoate)), N-cyclohexyldeoxycholamine (bis (3-aminobenzoate)), N-hexadecane Deoxycholestyramine (bis (3-aminophenylbenzoate)), N-heptadecane decholcholamine (bis (3-aminobenzoate)), N-octadecane Deoxycholestyramine (bis (3-aminophenylbenzoate)), N-phenyldeoxycholamine (bis (3-aminobenzoate)), N-methyl-N- Phenyldeoxycholamine (bis (3-aminophenylbenzoate)), N-benzylmethyldeoxycholamine (bis (3-aminophenylbenzoate)), N-trifluorofluorene Deoxycholinamine (bis (3-aminobenzoate)), N- (2,2,2-trifluoroethyl) deoxycholamide (bis (3-aminobenzoate)), N- (l, 1,2,2,2-pentafluoroethyl ) Deoxycholamide (bis (3-aminophenylbenzoate)), N- (4-fluorophenyl) deoxycholamine (bisaminobenzoate)), N- (4- (Trifluoromethyl) phenyl) deoxycholamide (bis (3-aminobenzoate)), N- (4- (4-pentylcyclohexyl) phenyl) deoxycholamine (bis (3-aminophenylbenzoate)), N- (4- (4-heptylcyclohexyl) phenyl) deoxycholamine (bis (3-aminobenzoate)); chenodeoxy Cholic acid-methyl (bis (4-aminobenzoate)), ethyl chenodeoxycholate (bis0: '. 87 \ 87061.DOC -19- 200413441 (4-aminobenzoate )), Chenodeoxypropyl (bis (4-aminobenzoic acid 3)), Chenodeoxybutyl (bis (4-aminobenzoate)), Chenodeoxycholic acid Amyl (bis (4-aminobenzoate)), hexyl chenodeoxycholate (bis (4-aminobenzyl ester)), cyclohexyl chenodeoxycholate (bisaminobenzoic acid) Esters)), cetyl chenodeoxycholate (bis (4-aminobenzoate) , Hepadeoxycholic acid heptadecyl (cream (4-aminobenzoate)), Chenodeoxycholic acid octadecyl (bis (4-aminobenzoate)), chenodeoxy Phenylcholine (bis (4-aminobenzoate)), benzyl chenodeoxycholate (bis (4-aminobenzoate)), trifluoromethyl cheodeoxycholate ( Bis (4-aminobenzoate)), chenodeoxycholic acid (2,2,2-trifluoroethyl) (bis ('aminophenylbenzoate)), chenodeoxycholic acid (丨丄 ^ Pentafluoroethyl) (bis (4-aminobenzoate)), chenodeoxycholic acid (4-fluorophenyl) (bis ('aminophenylbenzoate)), trioxane Cholic acid (4- (trifluorofluorenyl) phenyl) (bis (4-aminobenzoate)), chenodeoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis ( 4-aminobenzoic acid §)), chenodeoxycholic acid (4- (4-heptylcyclohexyl) phenyl) (bis (4-aminobenzoate)); N-methyl chelate Oxycholamine (bis (4-aminobenzoate)), N-ethyl chenodeoxycholamine (bis (4-aminobenzoate)), N, N-dimethyl goose Deoxycholamide (bis (4-amino Formate N, N-diethylchoridoxamine (bis (cardioaminophenylbenzyl ester)), N-propyl chenodeoxycholamine (bis (4-aminobenzylate) )), N-Butyldeoxycholestamine (bis (4-aminophenylbenzoate)), Amylchoodeoxycholamine (bis (4-aminophenylbenzoate)), N- Hexyl chenodeoxycholamine (bis (4-aminobenzoate)), N-cyclohexyl chenodeoxycholamine (bis (4-aminophenylbenzoate)), N-hexadecane Chenodeoxycholamine (bis (4-aminophenylbenzoate)), N-heptadecanyldeoxycholcholamine (bis (4-aminobenzoate), N- + octadecyl Alkyl 0 '·' S ^ S7〇6 id〇c -20- 200413441 Chenodeoxycholamine (bis (4-aminophenylbenzoate)), phenylchoodeamine (bis (4 (4) -Aminobenzoate)), N-methylphenyl chenodeoxycholamine (bis (cardioaminobenzoate)), N-benzyl chenodeoxycholamine (diamine) Benzoic acid)), N-difluoromethyl hedeoxycholic acid amine (bis (4-aminobenzylformate)), N- (2,2,2-difluoroethyl) chenodeoxy Cholestyramine (bis (4-aminobenzoate)), N- ( l, 1,2,2,2-pentafluoroethyl) hedeoxycholamine (bis (4-aminobenzoate)), N- (4-fluorophenyl) chenodeoxycholamine (Bisaminobenzoate, N- (4- (trifluoromethyl) phenyl) chenodeoxycholamine (bisamidobenzoate)), N- (4- (4-pentyl Cyclohexyl) phenyl) chenodeoxycholamine (bis (4-aminophenylphenylacetate)), N- (4- (4-heptylcyclohexyl) phenyl) chenodeoxycholamine (bis (4-Aminobenzoate)); Cysteoxycholate (bis (3-aminobenzoate)), Chenodeoxycholic acid ethyl (bis (3-aminobenzoate) )), Chenodeoxypropyl (diaminobenzoic acid)), Chenodeoxybutyl (bis (3-aminobenzoate)), Amyl chenodeoxycholate (Bis (3-aminobenzoate)), hexylcholate (diaminobenzyl)), cyclohexyl chelate (bis (3-aminobenzoate)) ), Hexadeoxycholic acid cetyl (bis (3-aminobenzoic acid § intent)), hepoxycholic acid heptadecyl (cream (3-aminobenzoate)), goose Octadecyl deoxycholate (bis (3-Aminobenzoate)), phenyl chenodeoxycholate (bis (3-aminobenzoate)), benzyl cheodeoxycholate (bis (3-aminobenzoate) Acid ester)), chenodeoxycholic acid trifluorofluorenyl (bis (3-aminobenzoate)), cheldeoxycholic acid (2,2,2-trifluoroethyl) (bis (3 · Amino stearic acid ester)), chenodeoxycholic acid (1,1,2,2,2-pentafluoroethyl) (bis (3-aminobenzoate)), chenodeoxycholic acid ( 4-fluorophenyl) (bis (3-aminobenzoate)), chenodeoxycholic acid (4- (trifluoromethyl) phenyl) (bis (3-aminobenzoic acid O: \ 87 \ 8706I.DOC -21-200413441)), chenodeoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (3-aminobenzylcarboxylic acid _)) hedeoxycholic acid ( 4- (4-heptylcyclohexyl) phenyl) (bis (3-aminophenylbenzoate)); N-methyl chenodeoxycholamine (bis (3-aminobenzoate)) , N-ethyl chenodeoxycholamine (bis (3-aminophenylbenzoate)), N, N-dimethyl chenodeoxycholamine (bis (3-aminobenzylate)) ), N, N-diethyl chenodeoxycholamine (bis (3-amine Formate)), N-propyl chenodeoxycholamine (bis (3-aminobenzoate)), N-butyl chenodeoxycholamine (bis (3-aminobenzoate) Ester)), N-pentyl chenodeoxyamine bis (3- (aminoaminobenzoate)), N-hexyl chenodeoxycholamine (bis (3-aminobenzoate)) ), N-cyclohexyl chenodeoxycholamine (bis (3-aminobenzoic acid S)), N-hexadecyl chenodeoxycholamine (bis (3-aminophenylbenzoate) ), N-Heptadecanylcholinecholamine (bis (3-aminophenylbenzoate)), N-octadecylcholineamine (bis (3-aminophenylbenzoate) (Ester)), N-phenyl chenodeoxycholamine (bis (3-aminobenzoate)), N-fluorenyl-N-phenyl chenodeoxycholamine (bis (3-amino) Benzoate)), N-benzylmethyl chenodeoxycholamine (bis (3-aminobenzoate)), N-trifluoromethyl chenodeoxycholamine (bis (3-amine Phenylbenzoate vinegar)), N- (2,2,2-trifluoroethyl) chenodeoxycholamine (bis (3-aminobenzoate)), N- (l, l, 2 , 2,2-pentafluoroethyl) chenodeoxycholamine (bis (3-aminobenzoate) N- (4-fluorophenyl) chenodeoxycholamine (bis (3-aminobenzoate)), N- (4- (trifluoromethyl) phenyl) chenodeoxycholamine (Bis (3-aminobenzoate)), N- (4- (4-pentylcyclohexyl) phenyl) chenodeoxycholamine (bis (3-aminobenzoate)), N- (4- (4-heptylcyclohexyl) phenyl) chenodeoxycholamine (bis (3-aminobenzoate)); deoxy (desoxyO cholic acid methyl (bis (4-amino) Benzoate)), ethyl deoxycholate O: \ 87 \ 87061.DOC -22- 200413441 (bis (4-aminobenzoate)), propyl deoxycholate (bis (4-amino Benzoic acid)), butyl deoxycholate (bis (4-aminobenzoic acid g)), pentyl deoxycholate (bis (4-aminobenzoate)), hexyl deoxycholate ( Bis (4-aminobenzoate)), cyclohexyl deoxycholate (bis (4-aminobenzoate)), cetyl deoxycholate (bis (4-aminobenzoate) )), Heptadecyl deoxycholate (cream (4-aminobenzoate)), Octadecyl deoxycholate (bis (4-aminobenzoate), Phenyl deoxycholate ( (4-aminobenzoate)), benzyl deoxycholate (bis (4-aminobenzoate)), trifluoroamido deoxycholate (bis (4-aminobenzoate) )), Deoxycholic acid (2,2,2-trifluoroethyl) (bis (4-aminobenzoate)), deoxycholic acid (1,1,2,2,2-pentafluoroethyl) ) (Bis (4-aminobenzoate)), deoxycholic acid (4-fluorobenzyl) (bis (4-aminobenzoate)), deoxycholic acid (4- (trifluorofluorenyl) ) Phenyl) (bis (4-aminobenzyl ester)), deoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (4-aminobenzyl ester)), deoxy Cholic acid (4- (4-heptylcyclohexyl) phenyl) (bis (4-aminophenylbenzoate)); N-fluorenyldeoxycholamine (bis (4-aminobenzoate)) ), N-ethyldeoxycholamine (bis (4-aminobenzylate)), N, N-diamidodeoxycholamine (bis (4-aminophenylbenzoate S))), N, N -diethyldeoxycholic acid amine (bis (4-aminobenzoate)), N-propyldeoxycholic acid amine (bis (4-aminophenylbenzoate)), N-butyl Deoxycholamidamine (bis (4-amino Formate)), N-pentyldeoxycholic acid amine (bis (4-aminophenylbenzoate)), N-hexyldeoxycholic acid amine (bis (cardioaminobenzoate)), N- Cyclohexyl deoxycholamine (bis (4-aminophenylbenzoate)), N-hexadecyldeoxycholamine (bis (4-aminophenylbenzoate)), N-heptadecan deoxy Cholesterol (Bis (4-Aminophenylbenzoate)), N-octadecyldeoxycholic acid (bis (4-Aminophenylbenzoate · ester)), N-phenyldeoxycholic acid Amine (bis (cardioaminobenzyl acid Λ 87N8706 丨 .DOC -23-200413441 ester)), N-methyl-N-phenyldeoxycholamine (bis (4-aminobenzoate)), N -Benzyldeoxycholamine (bis (4-aminobenzoate)), N-trifluoromethyldeoxycholamine (bis (4-aminobenzoate)), N- (2 , 2,2-trifluoroethyl) deoxycholamine (bis (4-aminobenzoate)), N- (l, 1,2,2,2-pentafluoroethyl) deoxycholamine (Bis (4-aminobenzoate)), N- (4-fluorophenyl) deoxycholamine (bis (4-aminophenylbenzoate)), N- (4- (trifluoromethyl) ) Phenyl) deoxycholamide ( (4-aminobenzoate)), N- (4- (4-pentylcyclohexyl) phenyl) deoxycholamine (bis (4-aminobenzoate)), N- (4 -(4-heptylcyclohexyl) phenyl) deoxycholamine (bis (4-aminobenzoate)); methyl deoxycholate (bis (3-aminobenzoate)), deoxy Ethyl cholic acid (bis (3-aminobenzoate)), propyl deoxycholate (bis (3-aminobenzoate)), butyl deoxycholate (bis (3-aminobenzoate) Formate)), amyl deoxycholate (bis (3-aminophenylbenzoate)), hexyl deoxycholate (bis (3-aminophenylbenzoate)), cyclohexyl deoxycholate (bis (3-aminobenzoate)), cetyl deoxycholate (bis (3-aminobenzoate)), heptadecyl deoxycholate (cream (3-aminobenzoic acid) Ester)), deoxycholic acid stearyl (bis (3-aminobenzoate)), deoxycholic acid phenyl (bis (3-aminobenzoate)), deoxycholic acid phenylfluorenyl (Bis (3-aminobenzoate)), trifluoromethyl deoxycholate (bis (3-aminobenzoate)), deoxycholic acid (2,2,2-trifluoro (Bis (3-aminobenzoate)), deoxycholic acid (1,1,2,2,2-pentafluoroethyl) (bis (3-aminobenzoic acid g)), deoxy Cholic acid (4-fluorophenyl) (bis (3-aminobenzoate)), deoxycholic acid (4- (trifluorofluorenyl) phenyl) (bis (3-aminobenzoate) ), Deoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (3-aminobenzoate)), deoxycholic acid (4- (4-heptylcyclohexyl) phenyl) (Bis (3-aminophenylbenzoate)); 0. ^ 8787061.DOC -24-200413441 N-methyldeoxycholamine (bis (3-aminobenzoate)), N-ethyl Deoxycholate (bis (3-aminobenzoate)), N, N-dimethyldeoxycholamine (bis (3-aminobenzoate)), N, N-diethyl Deoxycholamide (bis (3-aminobenzoate)), N-propyldeoxycholamine (bis (3-aminobenzoate)), N-butyldeoxycholamine (bis (3-Aminobenzoate)), N-pentyldeoxycholamine (bis (3-aminobenzoate)), N-hexyldeoxycholamine (bis (3-aminobenzoate) Acid ester)), N-cyclohexyl Oxycholamine (bis (3-aminobenzoate)), N-hexadecyldeoxycholamine (bis (3-aminobenzoate)), N-heptadecan deoxycholate Amidoamine (bis (3-aminobenzoate)), N-octadecyldeoxycholamine (bis (3-aminobenzoate)), N-phenyldeoxycholamine (bis (3-Aminobenzoate)), N-methyl-N-phenyldeoxycholamine (bis (3-aminobenzoate)), N-benzyldeoxycholamine (bis (3-Aminophenylbenzoate)), N-trifluoromethyldeoxycholamine (bis (3-aminobenzoate)), N- (2,2,2-trifluoroethyl) Deoxycholamine (bis (3-aminobenzoate)), &gt; ^ (1,1,2,2,2-pentafluoroethyl) deoxycholamine (bis (3-aminobenzyl) Acid esters)), N- (4-fluorobenzyl) deoxycholamine (bis (3-aminophenylphenyl)), N- (4- (trifluoromethyl) phenyl) deoxycholamine (Bis (3-aminobenzoate)), N- (4- (4-pentylcyclohexyl) phenyl) deoxycholamine (bis (3-aminophenylbenzoate)), N- (4- (4-heptylcyclohexyl) phenyl) deoxycholamine (bis (3-aminophenylbenzoic acid) Esters)); cysoxycholate (bis (4-aminophenylbenzoate)), ethyl chlooxycholate (bis (4-aminophenylbenzoate)), cholestyrylcholine Propyl (bis (4-aminobenzyl ester)), butyldeoxycholate (bis (4-aminobenzoate)), pentylcholodeoxycholate (bis (4- Aminobenzoate)), Hexylchododeoxycholate (diaminobenzylformate)), Cyclohexyl hyodeoxycholate (bis (4-aminobenzylformate)) 'Iguano : \ 87 \ 8706l.DOC -25, 200413441 Hexadecyl oxycholate (bis (4-aminobenzoate, hepoxydeoxycholate heptadecyl (cream) (4-aminobenzoate )), Hogodeoxycholic acid stearyl (bis ('aminobenzoate)), Hogodeoxycholic acid phenyl (bis (4-aminobenzoate, phenyldeoxycholate) Methyl (bis (4-aminobenzoate)), trifluoromethyl chodooxycholate (bis (4-aminobenzoate)), hyodeoxycholic acid (2,2, 孓Trifluoroethyl) (bis (cardioaminobenzoate)), hyodeoxycholic acid (1, 丨, 2,2,2-pentafluoroethyl) (bis (4-aminobenzoate) )) Hododeoxycholic acid (4-fluorophenyl) (bis (4-aminobenzoic acid)), Hododeoxycholic acid (4- (trifluoromethyl) phenyl) (bis (4-amino) Benzoic acid vinegar)), hyodeoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (4-aminobenzoate)), hyodeoxycholic acid (4- (4- Heptylcyclohexyl) phenyl) (bis (4-aminobenzoate)); N-fluorenylchododeoxycholamine (bis (4-aminobenzoate)), N-ethyl Hododeoxycholamine (bis (4-aminobenzoic acid ester)), N, N-difluorenyl choridoamine (bis (4-aminobenzoic acid ester)), N, N -Diethylchodrocholamine (bis (4-aminobenzoate)), N-propylchodrocholamine (bis (4-aminobenzoate)), N- Butyl myodeoxycholamine (bis (4-aminophenylbenzoate)), N-pentylchoodeoxyamine (bis (4-aminobenzoate)), N-hexyl pig Deoxycholestyramine (bis (4-aminobenzylate)), N-cyclohexylchondrioxamine (bis (4-aminophenylbenzoate)), N-hexadecyl pig Deoxycholamine (bis (4-aminophenyl benzoate) ), N-heptadecanylcholinecholamine (bis (4-aminobenzoate)), N-octadecylcholoxycholamine (bis (4-aminophenylbenzoate) (Ester)), N-benzylchododeoxycholamine (bis (4-aminophenylbenzoate)), N-fluorenyl-N-phenylchododeoxycholamine (bis (4-amino) Benzamate)), N-benzylchododeoxycholamine (bis (4-aminophenylbenzoate)), N-triaminomethyl-cholestyramine (bis (4-amine Phenylbenzoate)), O: \-87 \ 8706l.DOC -26- 200413441 N- (2,2,2-difluoroethyl) myodeoxycholamine (bis (4-aminobenzyl) Acid ester)), N- (l, 1,2,2,2-pentafluoroethyl) myodeoxycholamine (bis (cardioaminobenzoic acid S)), N- (4-fluorophenyl ) Hododeoxycholamine (Bis (4-Aminobenzoate)), N- (4- (difluorofyl) phenyl) Hododeoxycholamine (Bis (4-Aminobenzoate) Acid ester)), N- (4- (4-pentylcyclohexyl) phenyl) myodeoxycholamide (diaminobenzoate)), N- (4- (4-heptylcyclohexyl) Phenyl) chododeoxycholamine (bis (4-aminobenzoate)); Methyldeoxycholate (bis (3-amine Benzoate)), ethyl hyodeoxycholate (3-aminobenzoate)), propyl hyodeoxycholate (bis (3-aminobenzoate)), hyodeoxycholate Acid butyl (bis (3-aminobenzoate), amyl hyodeoxycholate (bis (3-aminobenzoate), hexyl hyodeoxycholate (bis (3-aminobenzoic acid) Vinegar)), cyclohexyl hyodeoxycholate (bis (3-aminobenzoate)), cetyl hyodeoxycholate (bis (3-aminobenzoate)), and Heptadecyl oxycholate (box (3-amine basic formic acid g)), Octadecyl hyodeoxycholate (bisamino benzoate)), Phenyl hyodeoxycholate (bis ( 3-Aminobenzylate)), benzylcholodeoxycholate (bis (3-aminobenzoate)), Trifluoromethylchodeoxycholate (bis (3-aminobenzyl) Formate)), Hododeoxycholic acid (2,2,2_trifluoroethyl) (Bis (3 · Aminobenzylformate)), Hododeoxycholic acid (1,1,2,2 , 2-pentafluoroethyl) (bis (3-aminobenzoate)), hyodeoxycholic acid (4-fluorophenyl) (bis (3-aminobenzoate)), pork Oxycholic acid 4- (trifluoromethyl) phenyl) (bis (3-aminobenzoic acid)), hyodeoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (3-amine Benzoate)), hyodeoxycholic acid (4- (4-heptylcyclohexyl) phenyl) (bis (3-aminobenzoate)); N-methyl pig deoxycholate Amine (bis (3-aminobenzoic acid g)), N-ethyl pig deoxy O: \ S7 \ 8706l.DOC -27- 200413441 Choline (bis (3-aminobenzoate)) , N, N-Dimethylchododeoxycholamine (bis (3-aminobenzylformate)), N, N-Diethylchodeoxycholamine (bis (3-aminobenzyl) Acid esters)), N-propyl hododeoxycholamine (bis (3-aminobenzoate)), N-butyl hododeoxycholamine (bis (3-aminobenzoate) )), N-pentylchododeoxycholamine (bis (3-aminobenzoate)), N-hexylchododeoxycholamine (bis (3-aminobenzoate)), N-cyclohexylchododeoxycholamine (bis (3-aminobenzoate)), N-hexadecylcholodeoxycholamine (bis (3-aminobenzoate)), N-heptadecane cholinecholamine (bis (3-amine (Formate)), N-octadecyl-l-choletamine (bis (3-aminobenzoate)), N-phenyl-choletamine (bis (3-aminobenzene) Formate)), N-methyl-N-phenylchododeoxycholamine (bis (3-aminophenylbenzoate)), N-benzylchododeoxycholamine (bis (3 -Aminobenzoic acid)), N-trifluoromethylchododeoxycholamine (bis (3-aminobenzoate)), N- (2,2,2-trifluoroethyl) pig Deoxycholestyramine (bis (3-aminobenzoate)), N- (U, 2,2,2-pentafluoroethyl) Hododeoxycholamine (bis (3-aminobenzoate) Vinegar)), N- (4-fluorophenyl) hyodeoxycholamine (bis (3-aminobenzyl ester)), N- (4- (trifluoromethyl) phenyl) hyodeoxy Choline (bis (3-aminobenzoate)), N- (4- (4-pentylcyclohexyl) phenyl) myodeoxycholamine (bis (3-aminophenylbenzoate) )), N- (4- (4-heptylcyclohexyl) phenyl) hyodeoxycholamine (bis (3-aminophenylbenzoate; 3,6-bis (4-aminophenoxy) ) Bile burning-methyl 24-acid, 3,6-bis (4-aminophenoxy) cholan-24-acid ethyl ester, 3,6-bis (4-aminobenzene Based) choline-24-acid propionate, 3,6-bis (4-aminophenoxy) choline-24-acid butyl ester, 3,6-bis (4-aminobenzyloxy) -24-Pentyl acid, 3,6-bis (4-aminophenoxy) bile burn-24-Acid hexadecyl, 3,6-bis (4-aminophenoxy) chole-24- Cyclohexyl acid, 3,6-bis (4- 〇 :, .. 87 \ 87061-DOC -28-200413441 Aminophenoxy) choline-24-acyl hexadecyl, 3,6- Bis (4-aminophenoxy) choline-24-acid heptadecanoate, 3,6-bis (4-aminophenoxy) cholan-24-acid stearyl, 3,6- Bis (4-aminophenoxy) choline-24-acid phenyl ester, 3,6-bis (4-aminophenoxy) choline-24-acid phenylmethyl ester, 3,6-bis (4-Aminophenoxy) cholan-24-acid trifluoromethyl ester, 3,6-bis (4-aminophenoxy) cholan-24-acid (2,2,2-trifluoro Ethyl), (3,6-bis (4-aminophenoxy) choline-24-acid (2,2,2-tetrafluoroethyl) vinegar), 3,6-bis (4- Aminophenoxy) choline-24-acid (1,1,2,2,2-pentafluoroethyl) S, 3,6-bis (4-aminophenoxy) choline-24- Acid (4-fluorophenyl) S, 3,6-bis (4-aminophenoxy) choline-24-acid (4- (tri Methyl) benzyl) S, 3,6-bis (4-aminophenoxy) cholan-24-acid (4- (4-pentylcyclohexyl) phenyl) ester, 3,6-bis (4-Aminophenoxy) cholan-24-acid (4- (4-heptylcyclohexyl) phenyl) ester; fluorenyl-3,6-bis (4-aminophenoxy) bile Alkane-24-fluorenamine, &gt; Ethyl-3,6-bis (4-aminophenoxy) choline-24-fluorenamine, N, N-dimethyl-3,6-bis (4 -Aminophenoxy) choline-24-amidamine, N, N-diethyl-3,6-bis (4-aminophenoxy) bile burning-24-donkey amine, N-propyl- 3,6-bis (4-aminophenoxy) bile burner-24-osmamine, N-butyl-3,6-bis (4-aminophenoxy) bile burner- 24-feamine, N-fluorenyl-3,6-bis (4-aminobenzyloxy) cholera -24-S amine, N-hexyl-3,6-bis (4-aminebasic oxy) cholera-24- Acid amine, N-hexyl-3,6-bis (4-aminophenyllactyl) cholan-24-amidamine, N-hexadecyl-3,6-bis (4-aminophenoxy) ) Choline-24-fluorenamine, N-heptadecyl-3,6-bis (4-aminophenoxy) cholan-24-fluorenamine, N-octadecyl-3,6- Bis (4-aminophenoxy) choline-24-amidamine, N-phenyl-3,6-bis (4- Phenylphenoxy) choline-24-fluorenamine, N-benzyl-3,6-bis (4-aminophenoxy) choline-24, fluorenamine, N-trifluorofluorenyl-3, 6-bis (4-aminophenoxy) cholane O: \ 87 \ 8706l.DOC -29-200413441 -24-iiamine, N- (2,2,2-trifluoroethyl) -3,6 -Bis (4-aminophenoxy) bile burner-24-amidamine, (N- (2,2,2-tetrafluoroethyl) -3,6-bis (4-aminophenoxy) bile Alk-24-amidine) ,! ^ (1,1,2,2,2-pentafluoroethyl) -3,6-bis (4-aminophenoxy) bile burning-24-donylamine, N- (4-fluorophenyl)- 3,6-bis (4-aminophenoxy) bile burn_24_ Brewing amine, N- (4- (trifluoromethyl) phenyl) -3,6-bis (4-aminophenoxy) Cholesterol_24_ Amidine, N- (4- (4-pentylcyclohexyl) phenyl) -3,6-bis (4-aminophenoxy) choline-24-amidine, N- (4 -(4-heptylcyclohexyl) phenyl) -3,6-bis (4-aminophenoxy) cholamine-2 4-acidamine, 3.6-bis (3-aminophenoxy) cholane -24-acid methyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid ethyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid Propyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid butyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid pentyl ester, 3 , 6-Bis (3-aminophenoxy) cholan-24-acid hexyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid cyclohexyl ester, 3,6- Bis (3-aminophenoxy) cholan-24-acid hexadecyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid hexadecyl ester, 3,6- Bis (3-Aminophenoxy) choline-24-acid stearyl, 3,6-bis (3-aminophenoxy) choline-24-acid Ester, 3,6-bis (3-aminophenoxy) choline-24-acid benzyl ester, 3,6-bis (3-aminophenoxy) choline-24-acid trifluoro Fluorenyl ester, 3,6-bis (3-aminophenoxy) choline-24-acid (2,2,2-difluoroethyl) S, (3,6-bis (3-amino Phenoxy) bile burner-24-acid (2,2,2-tetrafluoroethyl) ester), 3,6-bis (3-aminophenoxy) cholan-24-acid (1,1, 2,2,2-pentafluoroethyl) vinegar, 3,6-bis (3-aminophenoxy) cholane-24-acid (4-fluorophenyl) g, 3.6-bis (3-amine (4- (trifluoromethyl) benzyl) ester, 3,6-bis (3-aminophenoxy) cholan-24-acid (4- (4 -Pentylcyclohexyl) phenyl) vinegar, 3,6-bis (3-aminophenoxy) choline-24-acid (4- (4-heptylcyclohexyl) benzene O: \ 87.8706 i.iX ) C -30- 200413441) ester); N-methyl-3,6-bis (3-aminophenoxy) choline-24-amidamine, N-ethyl-3,6-bis (3- Aminophenoxy) choline-24-amidamine, N, N-dimethyl-3,6-bis (3-amine basic oxy) bile burner-24-amine, N, N-diethyl -3,6 -bis (3-aminophenoxy) choline-24-amidamine, N-propyl-3,6- Bis (3-aminophenoxy) choline-24-amidamine, N-butyl-3,6-bis (3-aminophenoxy) choline-24-amidamine, N-pentyl- 3,6-bis (3-aminophenoxy) choline-24-amidamine, N-hexyl-3,6-bis (3-aminophenoxy) choline-24-amidamine, N- Cyclohexyl-3,6-bis (3-aminophenoxy) cholamine-24-Bromoamine, N-hexadecyl-3,6-bis (3-aminophenoxy) cholane-24 -Fluorenamine, N-heptadecanyl_3,6-bis (3-aminophenoxy) choline-24-fluorenamine, N-octadecyl-3,6-bis (3-amino Phenoxy) choline-24-fluorenamine, N-phenyl-3,6-bis (3-aminophenoxy) choline-24-fluorenamine, N-phenylfluorenyl-3,6-bis (3-Aminophenoxy) choline-24-amidamine, N-trifluoromethyl-3,6-bis (3-aminophenoxy) choline-24-amidamine, N- (2 , 2,2-trifluoroethyl) -3,6-bis (3-aminophenoxy) choline-24-amidamine, (N- (2,2,2-tetrafluoroethyl) -3 , 6-bis (3-aminophenoxy) choline-24-fluorenamine), hydrazone (1,1,2,2,2-pentafluoroethyl) _3,6-bis (3-aminobenzene (Oxy)) choline-24-amidamine, N- (4-fluorophenyl) -3,6-bis (3-aminophenoxy) choline-24-amidamine, N- (4- (tri Fluorenyl) benzyl -3,6-bis (3-aminophenoxy) choline_24_ pinamine, N- (4- (4-pentylcyclohexyl) phenyl) _3,6_bis (3-aminophenoxy Group) choline-24-amidamine, N '(4- (4-heptylcyclohexyl) phenyl) &gt; 3,6-bis (3-aminophenoxy) choline-24-acidamine. Among them, chenodeoxycholate (bis (4-aminobenzoate)), ethyl cheodeoxycholate (bis (4-aminobenzylate)), chenodeoxycholic acid Propyl (bis ('aminobenzoic acid)), butyl chenodeoxycholate (bis (4-aminobenzoate)), goose

0:'.8 7\8706l.DOC -31 - 200413441 去氧膽酸戊基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸己基(雙 (4-胺基苯甲酸酯))、鵝去氧膽酸環己基(雙(4_胺基苯甲酸 S旨))、鵝去氧膽酸十六烷基(雙(4-胺基苯曱酸酯))、鵝去氧 膽酸十七烷基(霜(4-胺基苯甲酸酯))、鵝去氧膽酸十八烷基 (雙(4-胺基苯曱酸酯))、鵝去氧膽酸三氟甲基(雙(4-胺基苯 曱酸酯))、鵝去氧膽酸(2,2,2-三氟乙基)(雙(4-胺基苯甲酸 醋))、鵝去氧膽酸(1,1,2,2,2-五氟乙基)(雙(4-胺基苯甲酸 酉旨))、鵝去氧膽酸(4-(4-戊基環己基)苯基)(雙(4-胺基苯曱酸 酯))、鵝去氧膽酸(4-(4-庚基環己基)苯基)(雙(4-胺基苯甲酸 酯)); 鵝去氧膽酸甲基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸乙基(雙 (3-胺基苯甲酸酯))、鵝去氧膽酸丙基(雙(3-胺基苯甲酸 酯))、鵝去氧膽酸丁基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸 戊基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸己基(雙胺基苯 甲酸酯))、鵝去氧膽酸十六烷基(雙(3-胺基苯甲酸酯))、鵝 去氧膽酸十七烷基(霜(3-胺基苯甲酸酯))、鵝去氧膽酸十八 烷基(雙(3-胺基苯甲酸酯))、鵝去氧膽酸三氟甲基(雙(3-胺 基苯曱酸酯))、鵝去氧膽酸(2,2,2-三氟乙基)(雙(3-胺基苯甲 酸酯))、鵝去氧膽酸(1,1,2,2,2-五氟乙基)(雙(3-胺基苯甲酸 酯))、鵝去氧膽酸(4-(4-戊基環己基)苯基)(雙(3-胺基苯甲酸 酯))、鵝去氧膽酸(4-(4-庚基環己基)苯基)(雙(3-胺基苯甲酸 酯)); 3,6-雙(4-胺基苯氧基)膽烷-2‘酸甲酯、3,6-雙(4-胺基苯氧 基)膽烷-24·-酸乙酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸丙 O:\87\S706I.DOC -32 - 200413441 酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸丁酯、3,6-雙(4-胺基 苯氧基)膽烷-24-酸戊酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸 己酯、3,6 -雙(4 -胺基苯氧基)膽烧- 24-酸十六烧酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸十七烷酯、3,6-雙(4-胺基苯氧基)膽 烷-24-酸十八烷酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸三氟甲 基酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(2,2,2-三氟乙基) 酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(1,2,2,2-四氟乙基) 酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(1,1,2,2,2-五氟乙基') 酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(4-(4-戊基環己基)苯 基)酯、3,6-雙(4-胺基苯氧基)膽烷-24-酸(4-(4-庚基環己基) 本基)δ旨; 3,6-雙(3 -胺基苯氧基)膽烧- 24-酸曱酷、3,6 -雙(3 -胺基苯氧 基)膽烷-24-酸乙酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸丙 酯、3,6-雙(3-胺基笨氧基)膽烷-24-酸丁酯、3,6-雙(3-胺基 笨氧基)膽烧-24-酸戊i旨、3,6-雙(3-胺基苯氧基)膽烧-24-酸 己酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸十六烷酯' 3,6-雙(3-胺基笨氧基)膽烷-24-酸十七烷酯、3,6-雙(3-胺基笨氧基)膽 烷-24-酸十八烷酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸三敗曱 基酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸(2,2,2-三氟乙基) 酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸(1,2,2,2-四氟乙基) 酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸(1,1,2,2,2-五1乙基) 酯、3,6-雙(3-胺基苯氧基)膽烷-24-酸(4-(4-戊基環己基)苯 基)S旨、3,6-雙(3-胺基笨氧基)膽烧-24-酸(4-(4-庚基環己基) 苯基)S旨;. O:\STx8706I.CXDC -33 - 200413441 尤宜為鵝去氧膽酸丁基(雙(4-胺基苯尹酸酯))、鵝去氧膽酸 戊基(雙(4-胺基苯甲酸酯))、鵝去氧膽酸己基(雙(4_胺基苯 甲酸酯))、鵝去氧膽酸十六烷基(雙(4_胺基苯f酸酯))、鵝 去氧膽酸十七烷基(霜(4-胺基苯γ酸酯))、鵝去氧膽酸十八 烷基(雙(4-胺基苯f酸酯、鵝去氧膽酸三氟f基(雙(‘胺 基本甲S文g曰))、我|去氧膽酸(2,2,2-三氟乙基)(雙胺基苯甲 酸S曰))、鵝去氧膽酸(1,1,2,2,2-五氟乙基)(雙(4_胺基苯甲酸 酉曰))、鵝去氧膽酸(4-(4-戊基環己基)苯基)(雙(4-胺基苯甲故 酯))、鵝去氧膽酸(4-(4-庚基環己基)苯基)(雙(4-胺基苯甲酸 酯))。 特定一胺化合物係例如可從具有1個或2個之氫氧基的膽 酸衍生物來合成。例如,使用醇與羧酸之酯化反應或鹵化 烷基與羧酸鹽之酯化反應,依需要可併用酸觸媒或鹼觸 媒、二環己基碳二醯亞胺等之脫水劑,可得到前驅體即二 硝基化合物,還原此,可得到目的之二胺。具體上,例如 石膽酸曱酯(3,5-二胺基笨甲酸酯)係可從石膽酸(丨)依下述 之反應式來合成。0: '. 8 7 \ 8706l.DOC -31-200413441 Pentyl deoxycholate (bis (4-aminobenzoate)), hexyl chenodeoxycholate (bis (4-aminobenzoate) Ester)), cyclohexyl chenodeoxycholate (bis (4-aminoaminobenzoic acid S)), cetyl chenodeoxycholate (bis (4-aminophenylbenzoate)), chelate Heptadecyl oxycholate (cream (4-aminobenzoate)), octadecyl cheodeoxycholate (bis (4-aminobenzoate)), triodes Fluoromethyl (bis (4-aminobenzoate)), chenodeoxycholic acid (2,2,2-trifluoroethyl) (bis (4-aminobenzoate)), chenodeoxy Cholic acid (1,1,2,2,2-pentafluoroethyl) (bis (4-aminobenzoic acid)), chenodeoxycholic acid (4- (4-pentylcyclohexyl) phenyl ) (Bis (4-aminophenylbenzoate)), chenodeoxycholic acid (4- (4-heptylcyclohexyl) phenyl) (bis (4-aminobenzoate)); chelation Methyloxycholate (bis (3-aminobenzoate)), ethyl chenodeoxycholate (bis (3-aminobenzoate)), propyl chenodeoxycholate (bis ( 3-aminobenzoate)), goose Oxycholic acid butyl (bis (3-aminobenzoate)), Chenodeoxycholic acid amyl (bis (3-aminobenzoate)), Chenodeoxycholic acid hexyl (bisamino) Benzoate)), hexadecylcholate (bis (3-aminobenzoate)), heptadecylcholate (3-aminobenzoate) )), Octadecyl chenodeoxycholate (bis (3-aminobenzoate)), trifluoromethyl chenodeoxycholate (bis (3-aminophenylbenzoate)), goose Deoxycholic acid (2,2,2-trifluoroethyl) (bis (3-aminobenzoate)), chenodeoxycholic acid (1,1,2,2,2-pentafluoroethyl) ) (Bis (3-aminobenzoate)), chenodeoxycholic acid (4- (4-pentylcyclohexyl) phenyl) (bis (3-aminobenzoate)), chelation Oxycholic acid (4- (4-heptylcyclohexyl) phenyl) (bis (3-aminobenzoate)); 3,6-bis (4-aminophenoxy) choline-2 ' Methyl ester, 3,6-bis (4-aminophenoxy) choline-24 · -acid ethyl ester, 3,6-bis (4-aminophenoxy) choline-24-acid propionate O : \ 87 \ S706I.DOC -32-200413441 ester, 3,6-bis (4-aminophenoxy) Alkane-24-acid butyl ester, 3,6-bis (4-aminophenoxy) choline-24-acid amyl ester, 3,6-bis (4-aminophenoxy) choline-24- Hexyl acid ester, 3,6-bis (4-aminophenoxy) bile burner-hexadecanoate 24-acid, 3,6-bis (4-aminophenoxy) chole-24-acid ten Heptadecyl ester, 3,6-bis (4-aminophenoxy) cholan-24-acid stearyl, 3,6-bis (4-aminophenoxy) cholan-24-acid Fluoromethyl ester, 3,6-bis (4-aminophenoxy) cholan-24-acid (2,2,2-trifluoroethyl) ester, 3,6-bis (4-aminobenzene) (Oxy) choline-24-acid (1,2,2,2-tetrafluoroethyl) ester, 3,6-bis (4-aminophenoxy) choline-24-acid (1,1, 2,2,2-pentafluoroethyl ') ester, 3,6-bis (4-aminophenoxy) cholane-24-acid (4- (4-pentylcyclohexyl) phenyl) ester, 3,6-bis (4-aminophenoxy) choline-24-acid (4- (4-heptylcyclohexyl) benzyl) δ purpose; 3,6-bis (3-aminophenoxy ) Bile Burn-24-Acid, 3,6-bis (3-aminophenoxy) cholane-24-acid ethyl ester, 3,6-bis (3-aminophenoxy) cholane- 24-acid propyl ester, 3,6-bis (3-aminobenzyloxy) cholane-24-acid butyl ester, 3,6-bis (3 -Amino-benzyloxy) cholera-24-pentyl acid, 3,6-bis (3-aminophenoxy) cholera-24-acid hexyl ester, 3,6-bis (3-amine Phenoxy) choline-24-acid hexadecyl '3,6-bis (3-aminobenzyloxy) cholan-24-acid heptadecyl, 3,6-bis (3-amino Stupidoxy) cholan-24-acid octadecyl ester, 3,6-bis (3-aminophenoxy) cholan-24-acid tridecyl ester, 3,6-bis (3-amine Phenylphenoxy) cholan-24-acid (2,2,2-trifluoroethyl) ester, 3,6-bis (3-aminophenoxy) cholan-24-acid (1,2, 2,2-tetrafluoroethyl) ester, 3,6-bis (3-aminophenoxy) cholane-24-acid (1,1,2,2,2-penta-1ethyl) ester, 3 , 6-Bis (3-aminophenoxy) choline-24-acid (4- (4-pentylcyclohexyl) phenyl) S, 3,6-bis (3-aminobenzyloxy) Cholesterol-24-acid (4- (4-heptylcyclohexyl) phenyl) S;. O: \ STx8706I.CXDC -33-200413441 Especially preferred is chenodeoxycholic acid butyl (bis (4-amine Phenyl phenyl yinate)), amyl chenodeoxycholate (bis (4-aminobenzoate)), hexyl chenodeoxycholate (bis (4-aminobenzoate)), goose Cetyl deoxycholate (bis (4-amine Phenylbenzene fate)), chenodeoxycholic acid heptadecyl (cream (4-aminophenyl γ ester)), chenodeoxycholic acid octadecyl (bis (4-aminobenzene f acid) Ester, chenodeoxycholic acid trifluoro f group (bis ('amine basic methyl S)), I | deoxycholic acid (2,2,2-trifluoroethyl) (diaminobenzoic acid S )), Chenodeoxycholic acid (1,1,2,2,2-pentafluoroethyl) (bis (4-aminobenzoic acid)), chenodeoxycholic acid (4- (4- Amylcyclohexyl) phenyl) (bis (4-aminobenzyl ester)), chenodeoxycholic acid (4- (4-heptylcyclohexyl) phenyl) (bis (4-aminobenzyl) Acid ester)). The specific monoamine compound can be synthesized, for example, from a bile acid derivative having one or two hydroxyl groups. For example, using an esterification reaction of an alcohol with a carboxylic acid or an esterification reaction of a halogenated alkyl group with a carboxylate, a dehydrating agent such as an acid catalyst or a base catalyst, dicyclohexylcarbodiimide, etc. The precursor is a dinitro compound, and the desired diamine can be obtained by reducing this. Specifically, for example, fluorescein lithocholic acid (3,5-diaminobenzylformate) can be synthesized from lithocholic acid (丨) according to the following reaction formula.

O:\87\8706l.DOC '34- 200413441O: \ 87 \ 8706l.DOC '34-200413441

又,提供於聚醯胺酸之合成反應的二胺化合物,可在不 損及本發明之效果的範圍内併用特定二胺化合物以外的二 胺化合物。此處,提供於合成反應之二胺化合物佔有的特 定二胺化合物之比例宜為莫耳%,尤佳之比例,在 TN型及STN型液晶顯示元件中,為〇5〜3〇莫耳%’在垂直配 向型液晶顯示元件中,為10〜1⑻莫耳%。 可併用之二胺化合物可舉出例如:對苯二胺、間苯二胺、 4,4 -一胺基一笨基甲烧' 二胺基二苯基乙烧、4,4、二 胺基一苯基硫醚、4,4’-二胺基二苯基颯、3,3,_二甲基-4,4、 二胺基聯苯基、4,4’-二胺参N-笨曱醯苯胺、4,4,-二胺基二 苯基醚、1,5-二胺基萘、3,3-二甲基-4,4,-二胺基聯苯基、5-月女基-1-(4 -胺基本基)-1,3,3-三甲基雖滿(indane)、3,4,-二胺 基一笨基驗、3,3’-二胺基二笨曱酮、3,4,-二胺基二笨曱酮、 4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙 烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基 苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]瑕、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、ι,3-雙(3-胺基笨氧基) 笨、9,9-雙(4-胺基笨基)-1〇_氫蒽、2,7-二胺基芴、9,9-雙(4-胺基苯基)芴、4,4’-亞曱基-雙(2_氣苯胺)、2,2,,5,5,-四氯 O:\S7\S706l.DOC -35- 200413441 -4,4 -一胺基聯二甲氧基苯、2,2、二氣_4,4,-二胺基-5,5、二 甲氧基聯苯、3,3’-二甲氧基-4,4,-二胺基聯苯、ι,4,4,-(對苯 一異亞丙基)雙苯胺、4,4’-(間苯二異亞丙基)雙苯胺、2,2、 雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4、二胺 基-2,2’-雙[三氟甲基]聯苯、4,4、雙[(4_胺基三氟甲基)苯 氧基]-八氟聯苯等之芳香族二胺; 1,1-間二曱苯二胺、1,3_丙烷二胺、四亞甲基二胺、五亞甲 基二胺、六亞甲基二胺、七亞甲基二胺、八亞甲基二胺、 九亞甲基一胺、4,4 -二胺基七亞甲基二胺、ι,4 -二胺基環己 烷、異佛爾酮二胺、四氫二環戊二烯基二胺、六氫-4,7-甲 醇茚滿撐基二亞甲基二胺、三環[6.21.02,7]-十一碳烯撐二 甲基二胺、4,4’-亞曱基雙(環己基胺)等之脂肪族及脂環式二 胺; 2,3 - -一 fe基p比σ定、2,6 -二胺基p比。定、3,4 -二胺基说σ定、2,4 _ 二胺基吡啶、5,6-二胺基-2,3-二胺基-外匕啶、5,6-二胺基-2,4-二羥基吹啶、2,4-二胺基-6-二甲基胺基-1,3,5-三嗔 (triazine)、1,4-雙(3-胺基丙基)哌啶、2,4-二胺基-6-異丙氧 基-1,3,5-三嗔、2,4-二胺基-6-曱氧基-1,3,5-三唤、2,4·二胺 基-6-苯基-1,3,5-三嗔、2,4-二胺基-6-甲基二嗓、2,4-一月女 基-1,3,5-三嗪' 4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺基-5_ 苯基噻唑、2,6-二胺基嘌呤、5,6-二胺基-1,3-二曱基尿嘴 啶、3,5-二胺基-1,2,4-三唑、6,9-二胺基-2-乙氧基阿啶乳酸 酯、3,8-二胺基-6-笨基菲啶、1,4_二胺基哌唤、3,6-二胺基 阿啶、雙(4-胺基苯基)苯基胺及以下述式(V)及(VI)之任一 O:\87\8706l.DOC -36- 413441 級胺基及該1級胺 者所示的化合物等、在分子内具有2個一 基以外之氮原子的二胺;The diamine compound provided in the synthesis reaction of polyamic acid can be used in combination with a diamine compound other than the specific diamine compound within a range that does not impair the effect of the present invention. Here, the proportion of the specific diamine compound occupied by the diamine compound provided in the synthesis reaction is preferably Mohr%, and the ratio is particularly preferable. In the TN-type and STN-type liquid crystal display elements, it is 0.05 to 30 Moll%. 'In a vertical alignment type liquid crystal display element, it is 10 to 1 mol%. Examples of diamine compounds that can be used in combination include: p-phenylenediamine, m-phenylenediamine, 4,4-monoamino-benzylmethan ', diaminodiphenylethyl, 4,4, and diamine Monophenyl sulfide, 4,4'-diaminodiphenylphosphonium, 3,3, -dimethyl-4,4, diaminobiphenyl, 4,4'-diamine, N-benzyl Aniline, 4,4, -diaminodiphenyl ether, 1,5-diaminonaphthalene, 3,3-dimethyl-4,4, -diaminobiphenyl, 5-monthly female 1- (4-amine basic group) -1,3,3-trimethylindane, 3,4, -diamino-dibenzyl, 3,3'-diaminodibenzyl Fluorenone, 3,4, -diaminodibenzone, 4,4'-diaminobenzophenone, 2,2-bis [4- (4-aminophenoxy) phenyl] propane , 2,2-bis [4- (4-aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 2,2-bis [4- (4-Aminophenoxy) phenyl], 1,4-bis (4-aminophenyl) benzene, 1,3-bis (4-aminophenyl) benzene, ι, 3-bis ( 3-aminobenzyloxy) benzyl, 9,9-bis (4-aminobenzyl) -10-hydroanthracene, 2,7-diaminophosphonium, 9,9-bis (4-aminobenzyl) Sulfonium) hydrazone, 4,4'-fluorenylene-bis (2-aniline) 2,2,, 5,5, -tetrachloro O: \ S7 \ S706l.DOC -35- 200413441 -4,4 -monoaminodidimethoxybenzene, 2,2, digas-4,4, -Diamino-5,5, dimethoxybiphenyl, 3,3'-dimethoxy-4,4, -diaminobiphenyl, ι, 4,4,-(p-phenylene diisoprene Propyl) bisaniline, 4,4 '-(m-phenylenediisopropylidene) bisaniline, 2,2, bis [4- (4-amino-2-trifluoromethylphenoxy) phenyl] Hexafluoropropane, 4,4, diamino-2,2'-bis [trifluoromethyl] biphenyl, 4,4, bis [(4-aminotrifluoromethyl) phenoxy] -octafluoro Aromatic diamines such as biphenyl; 1,1-m-diphenylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, hepta Methylene diamine, octamethylene diamine, unamethylene monoamine, 4,4-diamino heptamethylene diamine, ι, 4-diamino cyclohexane, isophorone di Amine, tetrahydrodicyclopentadienyldiamine, hexahydro-4,7-methanolindanyl dimethylene diamine, tricyclo [6.21.02,7] -undecene dimethyl Aliphatic and alicyclic diamines such as diamine, 4,4'-amidinobis (cyclohexylamine), etc .; 2,3--fe group p ratio σ, 2,6 -Diamino p ratio. Stilbene, 3,4-diaminosigma, stilbene, 2,4-diaminopyridine, 5,6-diamino-2,3-diamino-exopyridine, 5,6-diamino- 2,4-dihydroxypyridine, 2,4-diamino-6-dimethylamino-1,3,5-triazine, 1,4-bis (3-aminopropyl) Piperidine, 2,4-diamino-6-isopropyloxy-1,3,5-triamidine, 2,4-diamino-6-fluorenyloxy-1,3,5-triamine, 2,4 · diamino-6-phenyl-1,3,5-triamidine, 2,4-diamino-6-methyldihydrogen, 2,4-monoethynyl-1,3, 5-triazine '4,6-diamino-2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-di Amino-1,3-diamidinouracil, 3,5-diamino-1,2,4-triazole, 6,9-diamino-2-ethoxyaridine lactate, 3,8-diamino-6-benzylphenanthridine, 1,4-diamino piperidine, 3,6-diamino aridine, bis (4-aminophenyl) phenylamine and the following Any one of the formulas (V) and (VI): O: \ 87 \ 8706l.DOC -36- 413441 Grade amine group and the compound shown by the grade amine, etc., have two nitrogen atoms other than one radical in the molecule Diamine

(式中’R5表示具有環構造之1價有機基,而該環構造係含 有k自吡(噹。疋、三嗪、哌啶及哌嗪之氮原子;X表示2 價之有機基) H2O^Sc-0-NH2 (VI) (式中,R6表示具有環構造之二價有機基,而該環構造係含 有遥自吡。疋、嘴啶、三嗪、哌啶及哌嗪之氮原子;X表示2 價之有機基’複數存在之X可為相同,亦可為相異) 以下述式(VII)所不之單取代笨二胺類;以下述式(VIII)所示 之二胺基有機矽氧烷; F^~R8 H2N NH2 (VII) (式中’ R7表示選自-〇-、-C0〇_、〇c〇…-NHC〇-…C〇NH-及-CO-之2價有機基,R8表示具有選自巢類骨架、三氟甲基 及氟基之基·的1價有機基或碳數6〜30的烷基。) O:\87\8706l.DOC -37- 200413441(In the formula, 'R5 represents a monovalent organic group having a ring structure, and the ring structure contains k autopyridine (when. Hydrazone, triazine, piperidine, and piperazine nitrogen atoms; X represents a divalent organic group) H2O ^ Sc-0-NH2 (VI) (In the formula, R6 represents a divalent organic group having a ring structure, and the ring structure contains a telepyridine. Pyridine, acetidine, triazine, piperidine, and piperazine nitrogen atoms ; X represents a bivalent organic group, X may be the same or different.) Mono-substituted diamines are not replaced by the following formula (VII); Diamines are represented by the following formula (VIII) Organosiloxane; F ^ ~ R8 H2N NH2 (VII) (wherein 'R7 represents selected from -0-, -C0〇_, 〇c〇 ...- NHC〇 -... C〇NH- and -CO- Divalent organic group, R8 represents a monovalent organic group selected from a nested skeleton, a trifluoromethyl group and a fluoro group, or an alkyl group having 6 to 30 carbon atoms.) O: \ 87 \ 8706l.DOC -37 -200413441

(式中’ R9表示碳數1〜12的烴基,複數存在之R9係可分別為 相同或相異,^為}。的整數,之整數。) 可舉例分別以下述式(2)〜(6)表示的化合物等。此等之二 胺化合物可單獨或組合二種以上而使用。(In the formula, 'R9 represents a hydrocarbon group having 1 to 12 carbons, and the plural R9 systems may be the same or different, and ^ is an integer. The integer is.) For example, the following formulae (2) to (6) ) And the like. These diamine compounds can be used alone or in combination of two or more kinds.

(式中,y為2〜12的整數,z為1〜5的整數。) 此等之中_,宜為對笨一胺、4,4,·二胺基二苯基甲烷、4,4 •38 - 0:^8706, ^ 200413441 -—胺基二本基硫鍵、1,5 -二胺基奈、2,7 -»一胺基勿、4,4 - &gt;一 胺基二苯甲醚、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、9,9-雙(4-胺基苯基)苟、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙 院、2,2-雙(4-胺基苯基)六氟丙烧、4,4’-(對苯二異亞丙基) 雙苯胺、4,4’-(間苯二異亞丙基)雙苯胺、1,4-環己烷二胺、 4,4’-亞甲基(環己胺)、1,4-雙(胺基苯氧基)苯、4,4’-雙(4-胺 基苯氧基)聯苯、以上述式(2)〜(6)分別所示之化合物、2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基吡啶、3,6-二胺 基阿啶、以上述式(V)所示的化合物之中以下述式(7)所示之 化合物、以上述式(VI)所示的化合物之中以下述式(8)所示 之化合物、以上述式(VII)所示的化合物之中以下述式 (9)〜(1 8)分別所示之化合物及以上述式(VIII)所示的化合物 之中以下述式(19)所示之化合物。 yo-CH2CH2—(ch2)3—(In the formula, y is an integer from 2 to 12, and z is an integer from 1 to 5.) Among these, _ is preferably p-monoamine, 4, 4, diaminodiphenylmethane, 4, 4 • 38-0: ^ 8706, ^ 200413441 --- aminodibenzyl sulfur bond, 1,5-diaminonaphthalene, 2,7-»monoamino group, 4,4-&gt; monoaminodiphenyl group Methyl ether, 2,2-bis [4- (4-aminophenoxy) phenyl] propane, 9,9-bis (4-aminophenyl) go, 2,2-bis [4- (4 -Aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 4,4 '-(p-phenylenediisopropylidene) bisaniline, 4,4 '-(m-phenylenediisopropylidene) bisaniline, 1,4-cyclohexanediamine, 4,4'-methylene (cyclohexylamine), 1,4-bis (aminobenzene) Oxy) benzene, 4,4'-bis (4-aminophenoxy) biphenyl, compounds represented by the above formulae (2) to (6), 2,6-diaminopyridine, 3, Among the compounds represented by the following formula (V), 4-diaminopyridine, 2,4-diaminopyridine, 3,6-diaminopyridine, a compound represented by the following formula (7), Among the compounds represented by the formula (VI), a compound represented by the following formula (8) and a compound represented by the above formula (V Among the compounds represented by II), the compounds represented by the following formulae (9) to (18) and the compounds represented by the formula (VIII) are represented by the following formula (19). yo-CH2CH2— (ch2) 3—

Ο:\3·Λ8706 丨 DOC -39- 200413441Ο: \ 3 · Λ8706 丨 DOC -39- 200413441

&lt;四魏酸二if &gt; 使用於本發明之聚醯胺酸合成的四羧酸二酐,可舉例: 脂肪族四魏酸二酐、脂環式四魏酸二針及芳香族四魏酸二 酐。此等之具體化合物可舉例:丁烷四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二 酐、1,3-二曱基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯 _1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷 四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3,,4,4,-二環己 烷四羧酸二酐、2,3,5-三羧基環戊醋酸二酐、3,5,6-三羧基 原波烧(norbornane)-2 -醋酸二Sf、2,3,4,5,四氫卩夫續四竣酸 二酐、1,3,3&amp;,4,5,91)-六氫-5(四氫-2,5-二氧-3-呋喃基)-萘並 [1,2-(:]-咬喃-1,3-二酮、1,3,3&amp;,4,5,913-六氫-5-甲基-5(四氫 -2,5-二氧-3-^7夫°南基)-奈並[丨,2-。]-咬喃-丨,3-二酮、 1,3,3&amp;,4,5,913-六氫-5-乙基胃5(四氫-2,5-二氧-3-咬喃基)-萘 並[l,2-c]-啥·喃-1,3-二酮、l,3,3a,4,5,9b-六氫-7 -甲基-5(四氫 O:\87\87061.DOC -40- 200413441 -2,5,二氧-3-呋喃基)-萘並[1,2七 χ ^ _ c]、呋喃-1,3-二酮、 1,3,3&amp;,4,5,91&gt;-六氫-7-乙基-5(四氫、2&lt;^ ^ ^ ^ 二氧_3-呋喃基)-萘 並[l,2-c]-呋喃-1,3-二酮、l,3,3a54,5 qk ^ ^ ,9b、六氫-8-曱基-5(四氫 -2,5-二氧-3-呋喃基)-萘並[1,2七 ^ + 〇 c」、呋喃-1,3-二酮、 並n,2-C]-咬。南-1,3-二鋼、以山心別-六氫-”-二甲基 -5(四氫-2,5-二氧-3-咬喃基)-萘並「19 L吱喃-1,3-二酮、 5-(2,5-二氧四氫呋喃甲叉基)-3-甲基1 ^ , T卷、3、環己烯-丨,2_二羧酸 二酐、二環[2,2,2]-辛並-7-烯-2,3,5 6 m △ ’四幾酸二酐、分別以 下述求(IX)及(X)所示之化合物等的脂奸&gt; π 1 月曰肪族及脂壞式四緩酸 二酐; 0 〇&lt; Tetraweilic acid diif &gt; Examples of the tetracarboxylic dianhydride used in the synthesis of the polyphosphonic acid of the present invention include aliphatic tetraweilic acid dianhydride, alicyclic tetraweilic acid needle and aromatic tetrawei Acid dianhydride. Specific examples of these compounds include butanetetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclo Butanetetracarboxylic dianhydride, 1,3-diamidino-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dichloro_1,2,3,4-cyclobutane Alkanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic acid Dianhydride, 3,3,, 4,4, -dicyclohexanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentaneacetic dianhydride, 3,5,6-tricarboxy ) -2 -Diacetic acid di Sf, 2,3,4,5, tetrahydrocoanthonic acid dianhydride, 1,3,3 &amp;, 4,5,91) -hexahydro-5 (tetrahydro-2 , 5-dioxo-3-furanyl) -naphtho [1,2-(:]-octane-1,3-dione, 1,3,3 &amp;, 4,5,913-hexahydro-5-methyl -5 (tetrahydro-2,5-dioxo-3- ^ 7 °° southern group) -neo [丨, 2-.]-Octane- 丨, 3-dione, 1,3,3 &amp; , 4,5,913-hexahydro-5-ethyl gastric 5 (tetrahydro-2,5-dioxo-3-octyl) -naphtho [l, 2-c] -Ha · an-1,3- Dione, l, 3,3a, 4,5,9b-hexahydro-7-methyl-5 (tetrahydro O: \ 87 \ 87061.DOC -40- 200413441 -2,5, dioxo-3-furan ) -Naphtho [1,2,7 ^ _c], furan-1,3-dione, 1,3,3 &amp;, 4,5,91 &gt; -hexahydro-7-ethyl-5 (tetrahydro, 2 &lt; ^^^^^ 3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a54,5 qk ^^, 9b, hexahydro-8-fluorenyl-5 (tetrahydro -2,5-dioxo-3-furyl) -naphtho [1,2,7 ^ + occ ", furan-1,3-dione, and n, 2-C] -bite. South-1, 3-Second Steel, Yamashimbetsu-hexahydro-"-dimethyl-5 (tetrahydro-2,5-dioxo-3-branyl) -naphtho" 19 L squeeze 1,3- Dione, 5- (2,5-dioxotetrahydrofuranyl) -3-methyl 1 ^, T-roll, 3, cyclohexene- 丨, 2-dicarboxylic dianhydride, bicyclo [2,2 , 2] -octino-7-ene-2,3,5 6 m △ 'tetrakidic acid dianhydride, and the compound shown by the following formula (IX) and (X), etc.> π January Fatty and fat-type tartaric acid dianhydride; 0 〇

(IX)(IX)

(X)(X)

(其中,R1及R3表示具有芳香環之2價有機基,R2&amp;R4表示 氫原子或烷基,複數存在之r2及R4係分別可為相同或相異) 苯四甲酸二酐、3,3’54,4、二苯曱酮四羧酸二酐、3,3,,4,4,_ 二苯基颯四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四 叛酸二酐、_3,3’,4,4’-聯本基趟四魏酸一 if、3,3’,4,4,-二苯 -41 -(Wherein R1 and R3 represent a divalent organic group having an aromatic ring, R2 &amp; R4 represents a hydrogen atom or an alkyl group, and the plural r2 and R4 systems may be the same or different, respectively) pyromellitic dianhydride, 3,3 '54, 4, benzophenone tetracarboxylic dianhydride, 3,3,, 4,4, _diphenylfluorene tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic acid dianhydride, _3,3 ', 4,4'-bibenzyltetraweitraic acid-if, 3,3', 4,4, -diphenyl-41-

0· 87\S7061.DOC 200413441 基甲烷四羧酸二酐、3,3’,4,4’-二甲基二苯基矽烷四羧酸二 酐、3,3’,4,4,-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸 二酐、4,4、雙(3,4-二羧基苯氧基)二苯基硫醚二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基颯二酐、4,4’-雙(3,4-二羧基苯 氧基)二苯基丙烷二酐、3,3’,4,4’-全氟異亞丙基二苯二甲酸 二酐、3,3’,4,4,-聯苯基四羧酸二酐、雙(苯二甲酸)苯基磷氧 化物二酐、對-苯撐基-雙(三苯基苯二甲酸)二酐、間-苯撐 基-雙(三苯基苯二甲酸)二酐、雙(三苯基苯二甲酸)-4,4’-二 苯基醚二酐、雙(三苯基苯二曱酸)-4,4’-二苯基甲烷二酐、 乙二醇-雙(無氫偏苯三酸酯)、丙二醇-雙(無氫偏苯三酸 酯)、1,4-丁二醇-雙(無氫偏苯三酸酯)、1,6-己二醇-雙(無氫 偏苯三酸酯)、1,8-辛二醇-雙(無氫偏苯三酸酯)、2,2-雙(4-氫氧基苯基)丙烷-雙(無氫偏苯三酸酯)、2,3,4,5-吡啶四羧酸 二酐、2,6-雙(3,4-二羧基苯基)说啶、分別以下述式(20)〜(23) 所示之化合物等的四魏酸二酐。此等係可一種單獨或二種 以上組合而使用。0 · 87 \ S7061.DOC 200413441 Methane tetracarboxylic dianhydride, 3,3 ', 4,4'-dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3', 4,4, -tetra Phenylsilane tetracarboxylic dianhydride, 1,2,3,4-furantetracarboxylic dianhydride, 4,4, bis (3,4-dicarboxyphenoxy) diphenyl sulfide dianhydride, 4, 4'-bis (3,4-dicarboxyphenoxy) diphenylphosphonium dianhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylpropane dianhydride, 3,3 ' , 4,4'-Perfluoroisopropylidene diphthalic dianhydride, 3,3 ', 4,4, -biphenyltetracarboxylic dianhydride, bis (phthalic acid) phenyl phosphorus oxide di Anhydride, p-phenylene-bis (triphenylphthalic acid) dianhydride, m-phenylene-bis (triphenylphthalic acid) dianhydride, bis (triphenylphthalic acid) -4, 4'-diphenyl ether dianhydride, bis (triphenylphthalic acid) -4,4'-diphenylmethane dianhydride, ethylene glycol-bis (non-hydrogen trimellitate), propylene glycol- Bis (hydrogen-free trimellitate), 1,4-butanediol-bis (hydrogen-free trimellitate), 1,6-hexanediol-bis (hydrogen-free trimellitate), 1 , 8-octanediol-bis (hydrogen-free trimellitate), 2,2-bis (4-hydrooxyphenyl) propane-bis (non-hydrogen trimellitate), 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-bis (3, 4-Dicarboxyphenyl) is tetrapyric acid dianhydride such as pyridine and compounds represented by the following formulae (20) to (23). These can be used singly or in combination of two or more kinds.

O:\8T-8706l.DOC 200413441O: \ 8T-8706l.DOC 200413441

此等之中,就可顯現良好液晶配向性之觀點,宜為丁烧 四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、l,3-二甲基 -1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、 2,3,5-三羧基環戊基醋酸二酐、5-(2,5-二氧四氫呋喃甲叉 基)-3-甲基-3-環己烯-1,2-二羧酸二酐、1,3,3&amp;,4,5,91)-六氫 -5-(四氫-2,5-二氧-3-吱喃基)-萘並[1,2-〇]吱喃-1,3-二酮、 1,3,3&amp;,4,5,91)-六氫-8-甲基-5(四氫-2,5-二氧-3-吱喃基)-萘 並[l,2-c]咬喃— 嗣、1,3,3冱,4,5,913-六氮-5,8-二曱基 -5-(四氫-2,5-二氧-3-吱喃基)-萘並[l,2_c]吱喃-1,3-二酮、雙 環[2,2,2]-辛-7-烯-2,3,5,6-四幾酸二酐、苯四甲酸二酐、 3,3,,4,4,-二笨甲酮四羧酸二酐、3,3,,4,4,-二苯基石風四羧酸 二酐、1,4,5,8-萘四魏酸二奸、以上述式(〗X)所示的化合物 之中分別以下述式(2句〜(26)所示之化合物及以上述式(X) 所示的化合物之中以下述式(27)所示之化合物,尤其佳者可 舉例1,2,3,4-環丁烷四羧酸二酐、丨,3_二甲基-1,2,3〆·環丁烷 四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、丨,3,3^4,5,9^ 六氫-5-(四氫_2,5-二氧呋喃基)·萘並[l,2_c]呋喃_1,3-二 酮、l,3,3a,4,5,9卜六氫甲基'5(四氫-2,5-二氧·3_呋喃基)-萘並[l,2-c]呔喃-1,3-二酮、I,3,3 a,4,5,9b·六氫 _8·甲基- 5-(四 -43,Among these, from the viewpoint of showing good liquid crystal alignment, butanedioic tetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, and 1,3-dimethyl- 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 5 -(2,5-dioxotetrahydrofuranmethylidene) -3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, 1,3,3 &amp;, 4,5,91) -hexa Hydrogen-5- (tetrahydro-2,5-dioxo-3-creanyl) -naphtho [1,2-〇] crean-1,3-dione, 1,3,3 &amp;, 4, 5,91) -Hexahydro-8-methyl-5 (tetrahydro-2,5-dioxy-3-creanyl) -naphtho [l, 2-c] bran — 嗣, 1, 3, 3 冱, 4,5,913-hexaaza-5,8-difluorenyl-5- (tetrahydro-2,5-dioxy-3-creanyl) -naphtho [l, 2_c] crean-1, 3-diketone, bicyclo [2,2,2] -oct-7-ene-2,3,5,6-tetrakidic acid dianhydride, pyromellitic dianhydride, 3,3,, 4,4,- Dibenzyl ketone tetracarboxylic dianhydride, 3,3,, 4,4, -diphenyl stone wind tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetraweilic acid dianhydride, according to the above formula () Among the compounds represented by X), the compounds represented by the following formulae (2 sentences to (26) and the compounds represented by the above formula (X) are Among the compounds, compounds represented by the following formula (27) are particularly preferred. Examples include 1,2,3,4-cyclobutanetetracarboxylic dianhydride, and 3-dimethyl-1,2,3. 〆 · cyclobutane tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 丨, 3,3 ^ 4,5,9 ^ hexahydro-5- (tetrahydro_2,5 -Dioxyfuryl) · naphtho [l, 2_c] furan_1,3-dione, 1,3,3a, 4,5,9 hexahydromethyl'5 (tetrahydro-2,5-di Oxygen · 3-furanyl) -naphtho [l, 2-c] pyran-1,3-dione, 1,3,3 a, 4,5,9b · hexahydro-8-methyl-5 (IV-43,

〇:'87\.87061.DOC 200413441 氫-2,5-—氧呋喃基)-萘並[12^]咬喃^,3_二酮、苯四甲 酸二酐及以下述式(24)所示的化合物。〇: '87 \ .87061.DOC 200413441 Hydrogen-2,5--oxyfuryl) -naphtho [12 ^] anan ^, 3-dione, pyromellitic dianhydride and the following formula (24) Shown compound.

&lt;聚醯胺酸之合成〉 供給於本發明之聚醯胺酸合成反應之四羧酸二酐與二胺 化合物之使用比例,係相對於二胺化合物所含有之胺基1當 量,宜四羧酸二酐之酸酐基為〇.2〜2當量的比例,進一步宜 為0.3〜12當量。 聚酸胺酸之合成反應係在有播、、交Ϋ丨^&lt; Synthesis of polyamic acid> The proportion of tetracarboxylic dianhydride and diamine compound provided in the polyamino acid synthesis reaction of the present invention is 1 equivalent to the amine group contained in the diamine compound, preferably four The ratio of the acid anhydride group of the carboxylic dianhydride is 0.2 to 2 equivalents, and more preferably 0.3 to 12 equivalents. Synthetic reaction of polyamic acid

3伐/夺劑中,宜在-20〜150 C 下、更宜在〇〜1 〇 〇 C之溫度條件下彳隹 打。此處’有機溶劑儀 只要可溶解所合成之聚醯胺酸即、, ’、 p τ,亚無特別限定,例如 可例示Ν-甲基-2-吡咯烷酮、Ν Ν_ -兩* —甲基乙醯胺、N,N-二 基甲醯胺 '二甲基亞石風、γ- 丁内舻 鬥酉曰、四甲基尿素、六甲基 〇:'.8Τ·37061.DOC -44 - 200413441 胺寻之非質子系極性溶劑;間甲酚、二甲苯酚、酚、 鹵化_溶劑。又有機溶劑之使用量⑷宜四竣酸二 酣及二胺化合物之總量⑻相對於反應⑧液之全量(: 0· 1〜30重量%之量。 “'、 又,在上述有機溶齊丨中,可使聚酸胺酸之弱溶劑即醇、 同斤酉曰_南化烯及烯類等在所生成之聚酸胺酸不析出 之粑圍併用。如此之弱溶劑的具體例可舉出:甲醇、乙醇 異丙醇、環己醇、乙二醇、丙二醇、丨,心丁二醇、三乙二醇: 乙二醇單甲酯、乳酸乙醋、乳酸丁酯、丙酮、甲乙_、甲 基異丁酮、環己酮、醋酸甲_、醋酸乙酉旨、醋酸丁酯、甲 基甲氧基丙酸酯、乙基乙氧基丙酸酯、草酸二乙酯、丙二 酸二乙酯、二乙基醚、乙二醇甲醚、乙二醇乙 ^ —畔 正丙醚、乙二醇異丙醚、乙二醇正丁醚、乙二醇二甲醚、 乙二醚乙醚乙酸酯、二乙二醇二甲醚、二乙二醇二乙醚、 二乙二醇單甲乙二醇單乙醚、二乙二醇單甲驗乙酸 酯、二乙二醚單乙醚乙酸酯、四氫呋喃、二氯甲烷、1 ' 二氣乙烷、1,4-二氯丁烷、三氣乙烷、氯苯、鄰二氯笨、己 烷、庚烷、辛烷、笨、曱苯、二甲笨等。 如以上般做法,可得到溶解聚醯胺酸而成之反應溶液。 繼而,將此反應溶液注入大量之弱溶劑中而得到析出物, 藉由在減壓下乾燥此析出物可得到聚醯胺酸。又,再使此 聚醯胺酸溶解於有機溶劑中,然後,在弱溶解中析出之步 驟進行1次或數次,可精製聚醯胺酸。 所得到之·聚驢胺酸係以前述式⑴所示之二胺化合物與以In the case of 3 cuttings / captures, it is preferable to beat at -20 ~ 150 C, and more preferably at a temperature of 0 ~ 100 C. Here, the organic solvent meter is not particularly limited as long as it can dissolve the synthesized polyamic acid. For example, N-methyl-2-pyrrolidone and N Ν_-two * -methyl ethyl can be exemplified. Ammonium amine, N, N-dimethylformamide, dimethylphosphine, γ-butyrobutane, tetramethyl urea, hexamethyl 〇: '. 8T · 37061.DOC -44-200413441 Aprotic polar solvents; m-cresol, xylenol, phenol, halogenated solvents. The amount of the organic solvent used is preferably the total amount of the diisocyanate and the diamine compound relative to the total amount of the reaction solution (: an amount of 0.1 to 30% by weight.丨, the weak solvent of the polyamic acid can be used in combination with alcohols, alkalene and alkene, etc. in the area where the generated polyamic acid does not precipitate. The specific examples of such weak solvents can be Examples: Methanol, ethanol isopropanol, cyclohexanol, ethylene glycol, propylene glycol, chlorobutanediol, triethylene glycol: ethylene glycol monomethyl ester, ethyl lactate, butyl lactate, acetone, methyl ethyl _, Methyl isobutanone, cyclohexanone, methyl acetate_, ethyl acetate, butyl acetate, methyl methoxypropionate, ethyl ethoxy propionate, diethyl oxalate, malonic acid Diethyl ether, diethyl ether, ethylene glycol methyl ether, ethylene glycol ^ -n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene diethyl ether Acetate, Diethylene glycol dimethyl ether, Diethylene glycol diethyl ether, Diethylene glycol monomethyl glycol monoethyl ether, Diethylene glycol monomethyl acetate, Diethylene glycol monoethyl ether Acetate, tetrahydrofuran, dichloromethane, 1 'digas ethane, 1,4-dichlorobutane, trigas ethane, chlorobenzene, o-dichlorobenzyl, hexane, heptane, octane, benzyl, Benzene, dimethylbenzyl, etc. As described above, a reaction solution obtained by dissolving polyamic acid can be obtained. Then, the reaction solution is poured into a large amount of a weak solvent to obtain a precipitate, which is dried under reduced pressure. A polyamic acid can be obtained from this precipitate. The polyamino acid is dissolved in an organic solvent, and then the step of precipitating in a weak solution is performed once or several times to refine the polyamino acid. -Poly donkey acid is a diamine compound represented by the formula ⑴ and

O:\87\8706I.DOC -45- 200413441 前述式(III)所示之四羧酸二酐之反應中,具有以下述式(XI) 所示之重複單元及在以前述式(II)所示之二胺化合物與以 前述式(III)所示的四羧酸二酐之反應中,具有以下述式(XII) 所示之重複單元。O: \ 87 \ 8706I.DOC -45- 200413441 The reaction of the tetracarboxylic dianhydride represented by the aforementioned formula (III) includes a repeating unit represented by the following formula (XI) and a reaction unit represented by the aforementioned formula (II): The reaction of the diamine compound shown with the tetracarboxylic dianhydride represented by the said Formula (III) has a repeating unit represented by a following formula (XII).

•••(XI) 上述式中,G4、A1、D1、B1、E1、a及G1之定義如前述 般0••• (XI) In the above formula, the definitions of G4, A1, D1, B1, E1, a, and G1 are as described above.

COOHCOOH

Γ H—G2—A: 0-βΜΕ2)ϋ 2一 上述式中,G4、G2、A2、D2、B2、E2及b之定義如前述般。 &lt;醯亞胺化聚合物〉 本發明之傭亞胺化聚合物可藉由使上述聚醯胺酸脫水閉 環來調製。聚醯胺酸之脫水閉環係依如下方法;(1)加熱聚 醯胺酸之方法;或(II)使聚醯胺酸溶解於有機溶劑中,在此 溶液中添加脫水劑及脫水閉環觸媒,依需要而加熱之方法。 在加熱上述⑴之聚醯胺酸之方法中的反應溫度,宜為 5 0〜200°C,更宜為60〜170°C。反應溫度在50°C以下時,脫 水閉環反應無法充分進行,若反應溫度超過200°C,所得到 之醯亞胺聚·合物的分子量會降低。 O:\37\8706 l.EX)C -46- 200413441 w另外,在上述(π)之聚醯胺酸溶液中添加脫水劑及脫水閉 裱觸媒的方法中’脫水劑可使用例如醋酸酐、丙酸酐、三 弗)酷酸針等之酸奸。脫水劑之使用量相對於聚酿胺酸重複 早兀1莫耳宜為0.01〜2〇莫耳。又’脫水閉環觸媒可使用例 比定—甲基吡啶、二甲基吡啶、三乙胺等之3級胺。但 限於此專。脫水閉環觸媒之使用量相對於所使用之脫水 J 1莫耳宜為0·01〜10莫耳。又,使用於脫水閉環反應之有 機溶劑係可舉例例示來作為聚醯胺酸之合成所使用者的有 機溶劑。再者’脫水閉環反應之反應溫度宜為〇〜1 8〇它,更 宜為10〜150。(:。對於如此所得到之反應溶液,藉由進行與 聚酿胺酸之精製方法相同的操作,可精致醯亞胺化聚合物。 所得到之聚醯亞胺化聚合物係分別以前述式(XI)及以前 述式(XII)所示之聚醯胺酸重複單元被醯亞胺化之例如分別 以下述式(XIII)及(XIV)所示之醯亞胺化單元。 &lt;;&gt;&lt; 〇Γ H-G2-A: 0-βΜΕ2) ϋ 2-In the above formula, the definitions of G4, G2, A2, D2, B2, E2, and b are as described above. &lt; Pyrimidinated polymer> The piridimidized polymer of the present invention can be prepared by dehydrating and closing the polyphosphonic acid as described above. The dehydration ring closure of polyamic acid is as follows; (1) the method of heating polyamic acid; or (II) the polyamic acid is dissolved in an organic solvent, and a dehydrating agent and a dehydration ring-closing catalyst are added to the solution , The method of heating as needed. The reaction temperature in the method of heating the polyphosphonic acid of the foregoing arsenic is preferably 50 to 200 ° C, and more preferably 60 to 170 ° C. When the reaction temperature is below 50 ° C, the dehydration ring-closure reaction cannot proceed sufficiently, and if the reaction temperature exceeds 200 ° C, the molecular weight of the obtained fluorene imine polymer will decrease. O: \ 37 \ 8706 l.EX) C -46- 200413441 w In addition, in the method of adding a dehydrating agent and a dehydration closing catalyst to the polyamine solution of (π) above, the acetic anhydride can be used as the dehydrating agent. , Propionic anhydride, sulphur, etc.). The amount of the dehydrating agent used is preferably 0.01 to 20 moles relative to the repetition of polyamino acid. Examples of the dehydration ring-closing catalyst include tertiary amines such as pyridine, methylpyridine, dimethylpyridine, and triethylamine. But limited to this special. The amount of dehydrated closed-loop catalyst used should be from 0.01 to 10 moles relative to the dehydrated J 1 used. The organic solvent used in the dehydration ring-closing reaction can be exemplified as an organic solvent used for the synthesis of polyamic acid. Furthermore, the reaction temperature of the dehydration ring-closing reaction is preferably 0 to 180, and more preferably 10 to 150. (:. With respect to the reaction solution thus obtained, by performing the same operation as the method for purifying polyamic acid, the amidine polymer can be refined. The obtained polyimide polymers are each represented by the aforementioned formula. (XI) and the polyamidoacid repeating unit represented by the aforementioned formula (XII) are imidized with fluorene, for example, the fluorenimidated units represented by the following formulae (XIII) and (XIV), respectively. &Lt;; &gt; &lt; 〇

A1—D1—-CO-eME1)^ ...(XIII) 上述式中,G、G1、A1、D1、B1、E1及a之定義係同於前 述般。A1—D1—-CO-eME1) ^ (XIII) In the above formula, the definitions of G, G1, A1, D1, B1, E1, and a are the same as described above.

Y Ν—G~A' CO—Β^ 一 A2- ...(XIV) -47 - 200413441 上述式中,G4、G2、A2、D2、B2、定義係同於前 述般。 構成本發明液晶定向劑時之本發明醯亞胺化聚合物中的 較佳醯亞胺化率為10〜100%,更宜為30〜98%。此處,所謂 「醯亞胺化率」係以%表示形成醯亞胺環而構成的重複單 元之數目對在聚合物中之重複單元的總數之比率。此時, 醯亞胺環之一部分亦可為異醯亞胺環。醯亞胺化率可藉由 5周節上述脫水閉環反應之反應條件來控制。 , &lt;末端修飾型之聚合物〉 本务明之聚醯胺酸及醯亞胺化聚合物亦可為分子量被調 即之末端修飾型者。藉由使用此末端修飾型之聚合物,無 損本發明之效果,而可改善液晶定向劑之塗佈特性等。如 此之末端修飾型者係當合成聚醯胺酸時,可藉由在反應系 中添加酸酐、單胺化合物、單異氰酸酯化合物等來合成。 此處,酸酐可舉例如:馬來酸酐、苯二曱酸酐、衣康酸酐、 正癸基丁二酸酐、正十二烷基丁二酸酐、正十四烷基丁二 西文酐、正十六烷基丁二酸酐等。又,單胺化合物可舉例如: 苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛 胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三 烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷 月女正十八烷胺、正二十烷胺等。又,單異氰酸酯化合物 可舉例:苯基異氰酸酯、萘基異氰酸酯等。 &lt;聚合物之對數黏度〉 本电明之·聚驢胺酸及驢亞胺化聚合物,其對數黏度i n) 0:.37^87061.DOC -48 - 200413441 之值一般為0·05〜10dl/g,宜為0.1〜5dl/g。 本發明之對數黏度㈡1 n)之值係使用N _甲基-2 _ P比咯烷酮作 為溶劑,有關濃度為0.5 g/ι 〇〇毫升的溶液係在3(rc下測定 黏度,依下述式⑴而求得者。Y Ν—G ~ A 'CO—Β ^ A A2 -... (XIV) -47-200413441 In the above formula, G4, G2, A2, D2, B2, and the definitions are the same as the foregoing. The preferable fluorinated imidization ratio of the fluorinated imidization polymer of the present invention when constituting the liquid crystal aligning agent of the present invention is 10 to 100%, more preferably 30 to 98%. Here, the "fluorene imidization ratio" refers to the ratio of the number of repeating units formed by forming a fluorene imine ring to the total number of repeating units in the polymer in%. At this time, a part of the fluorene imine ring may be an isofluorene ring. The rate of imidization can be controlled by the reaction conditions of the above-mentioned dehydration ring-closing reaction in the 5th week. &Lt; Terminal-modified polymer> The polyamidic acid and amidine imidized polymer of the present invention may also be terminal-modified type whose molecular weight is adjusted. By using this terminal-modified polymer, the effect of the present invention is not impaired, and the coating characteristics of the liquid crystal aligning agent can be improved. Such a terminal-modified type can be synthesized by adding an acid anhydride, a monoamine compound, a monoisocyanate compound, or the like to the reaction system when synthesizing a polyamic acid. Here, the acid anhydride may be, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride, n-deca Hexyl succinic anhydride and the like. Examples of the monoamine compound include aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decylamine, n-undecaneamine, and n-deca Dialkylamine, n-tridecylamine, n-tetradecanylamine, n-pentadecanylamine, n-hexadecylamine, n-hexadecylamine, n-octadecylamine, n-eicosylamine, etc. Examples of the monoisocyanate compound include phenyl isocyanate and naphthyl isocyanate. &lt; Logarithmic Viscosity of Polymers> The logarithmic viscosity of Poly-Donamic Acid and Donkey Aminated Polymers of Benming Ming in) 0: .37 ^ 87061.DOC -48-200413441 The value is generally 0.05 ~ 10dl / g, preferably 0.1 to 5 dl / g. The value of the logarithmic viscosity ㈡1 n) of the present invention is the use of N_methyl-2_P than pyrrolidone as the solvent, and the solution with a concentration of 0.5 g / ml is measured at 3 (rc, viscosity, below). Those who described the formula and obtained it.

In = 1 η (溶液流了時間/溶劑流下時間) 71 (聚合物之重量濃度) (i) &lt;液晶定向劑〉 本發明之液晶定向劑係宜本發明之聚醯胺酸及/或驢亞 胺化聚合物溶解含於有機溶劑中而構成的。亦即,本發明 之液晶定向劑係含有聚合物,而該聚合物係有具有至少一 種遠自分別以上述式(XI)〜(XIV)所示之重複單元所構成的 群。 又,本發明之液晶定向劑進一步亦可含有一不具有分別 以上述式(XI)〜(XIV)所示之重複單元的聚醯胺酸及/或醯亞 胺化聚合物(以下,亦稱為「其他之聚合物」)。其他之聚合 物如使上述特定二胺化合物以外的二胺化合物與四羧酸二 酐反應所得到的聚醯胺酸、及使該聚醯胺酸脫水閉環所得 到的醯亞胺化聚合物中選出至少一種。較佳之聚合物的組 合可舉例:具有以上述式(xm)所示之重複單元及/或以 ()所示之重複單元的聚合物(本發明之酸亞胺化聚合 物)、與不具有以上述式(XI)〜(xiv)之任一者所示的重複單 兀之聚醯胺酸的組合。含有如此聚合物之組合的液晶定向 劑,就可得到長期可靠性優、殘影消失時間特別短之液晶 ,厂、元件而5,尤佳。在該液晶定向劑中之聚合物含有比In = 1 η (time when the solution flows / time when the solvent flows down) 71 (weight concentration of polymer) (i) &lt; Liquid crystal aligning agent> The liquid crystal aligning agent of the present invention is suitable for the polyamic acid and / or donkey of the present invention. The imidized polymer is constituted by being dissolved in an organic solvent. That is, the liquid crystal aligning agent of the present invention contains a polymer, and the polymer has at least one group consisting of repeating units respectively represented by the above formulae (XI) to (XIV). In addition, the liquid crystal aligning agent of the present invention may further contain a polyfluorinated acid and / or a fluorinated polymer (hereinafter, also referred to as a polyimide) which does not have a repeating unit represented by the formulae (XI) to (XIV), respectively. "Other polymers"). Other polymers include polyamidic acid obtained by reacting a diamine compound other than the above-mentioned specific diamine compound with tetracarboxylic dianhydride, and polyimide polymer obtained by dehydrating and closing the polyamidic acid. Pick at least one. Examples of the combination of preferable polymers include a polymer having a repeating unit represented by the above formula (xm) and / or a repeating unit represented by () (acidimidized polymer of the present invention), A combination of a repeating unit of polyamic acid represented by any one of the above formulae (XI) to (xiv). A liquid crystal aligning agent containing such a polymer can obtain a liquid crystal with excellent long-term reliability and a particularly short afterimage disappearance time. 5 Polymer content ratio in the liquid crystal aligning agent

O:\S7\S706LDOC -49- 200413441 1〜99 率^系相對於聚合物全量’本發明之醒亞胺化聚合物為 重里%、宜為2〜50%。尤宜為1〇〜3〇重量%。 调製本發明之液晶定向劑時的溫度宜為〇。〇〜2㈧。c ’更宜 為 20°C 〜6CTC。 | 構成本發明之液晶定向劑的有機溶劑係可舉例··例示作 為聚醯胺酸之合成反應所使用者的溶劑。X,亦可適當選 擇併用例示來作為可於聚醯胺酸之合成反應時併用者= 溶劑。 , 本發明之液晶定向劑中的固形分濃度係考慮黏性、揮發 性等而選擇,但宜為1〜10重量%之範圍。亦即,本發明^ 液晶定向劑係塗佈於基板表面,且形成成為液晶定向膜之 塗膜,但固形分濃度為1重量%以下時,此塗膜之膜厚會過 小而無法得到良好液晶定向膜。又,固形分濃度超過10重 量%時,塗膜之膜厚會過大而無法得到良好的液晶定向 膜,而且,液晶定向劑之黏性會增大而塗佈特性變差。 在本發明之液晶定向劑中,就提高對於基板表面之接著 性的觀點’亦可含有含官能性矽烷的化合物或含環氧基的 化合物。含如此之官能性矽烷的化合物可舉例:3_胺基丙 基二甲氧基石夕烧、3-胺基丙基三乙氧基矽院、2-胺基丙基三 甲氧基石夕烧、2-胺基丙基三乙氧基石夕烧、胺基乙基)-3_ 胺基丙基三曱氧基矽烷、N-(2-胺基乙基)-3-胺基丙基曱基 二甲氧基矽烷、3-脲(ureido)基丙基三甲氧基矽烷、%脲 (urei do)基丙基三乙氧基石夕統、N-乙氧基羰基-3-胺基丙基三 曱氧基矽烷·、N-乙氧基羰基-3-胺基丙基三乙氧基石夕烧、 O:\87\8706l.DOC -50- 200413441 三乙氧基甲矽烷基丙基三乙烯基三胺、N-三甲氧基甲矽烷 基丙基三乙烯基三胺、10-三甲氧基甲矽烷基4,4,7-三氮雜 癸烧、10-三乙氧基甲矽烷基-;1,4,7_三氮雜癸烷、、三甲氧 基甲石夕烧基-3,6-二氮雜壬基乙酸酯、9-三乙氧基甲矽烷基 -3,6-二氮雜壬基乙酸酯、N_苯甲基胺基丙基三甲氧基矽 烷、N-苯甲基胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙 基二甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、^雙 (氧乙烯基)-3-胺基丙基三甲氧基矽烷、仏雙(氧乙烯基)-3 — 胺基丙基三乙氧基矽烷等。 又’含環氧基的化合物可舉例如:乙二醇二縮水甘油基 醚、聚乙二醇二縮水甘油基醚、丙二醇二縮水甘油基醚、 二丙二醇二縮水甘油基醚、聚丙二醇二縮水甘油基醚、新 戊二醇二縮水甘油基醚、丨,6—己二醇二縮水甘油基醚、甘油 二縮水甘油基醚、2,2_二溴新戊二醇二縮水甘油基醚、 1,3,5,6-四縮水甘油基醚-2,心己二醇,n,n,n,,n、四縮水甘 油基醚-間二甲苯二胺、—雙(N,N-二縮水甘油基胺基甲基) 環己烷、\,1^3,-四縮水甘油基-4,4、二胺基二苯基甲烷 等。含有此等官能性矽烷的化合物或含有環氧基的化合物 之調配比率,相對於聚合物1〇〇重量份,宜為糾重量份以 下’更且為0.1〜30重量份。 &lt;液晶顯不元件&gt; 本發明之液晶顯示元件例如可依如下之方法來製造。 ⑴在設有被圖案化之透明導電膜的基板一面,藉例如輥 塗法、旋塗-法、;刷法等之方法而塗佈本發明之液晶定向O: \ S7 \ S706LDOC -49- 200413441 1 ~ 99 The ratio ^ is relative to the total amount of the polymer. The awakened imidized polymer of the present invention is% by weight, preferably 2 to 50%. It is particularly preferably 10 to 30% by weight. The temperature when preparing the liquid crystal aligning agent of the present invention is preferably 0. 〇 ~ 2㈧. c 'is more preferably 20 ° C to 6CTC. The organic solvent constituting the liquid crystal aligning agent of the present invention can be exemplified as a solvent for a synthetic reaction of polyamic acid. X can also be appropriately selected and used as an example to be used as a solvent in the synthesis reaction of polyamic acid. The solid content concentration in the liquid crystal aligning agent of the present invention is selected in consideration of viscosity, volatility, etc., but it is preferably in the range of 1 to 10% by weight. That is, the liquid crystal aligning agent of the present invention is coated on the substrate surface and forms a coating film that becomes a liquid crystal alignment film, but when the solid content concentration is 1% by weight or less, the film thickness of the coating film is too small to obtain a good liquid crystal. Orientation film. In addition, when the solid content concentration exceeds 10% by weight, the film thickness of the coating film becomes too large to obtain a good liquid crystal alignment film, and the viscosity of the liquid crystal alignment agent increases and the coating characteristics deteriorate. The liquid crystal aligning agent of the present invention may contain a functional silane-containing compound or an epoxy group-containing compound from the viewpoint of improving the adhesion to the substrate surface. Examples of compounds containing such functional silanes include 3-aminopropyldimethoxylithium, 3-aminopropyltriethoxy silicon, 2-aminopropyltrimethoxylithium, 2 -Aminopropyltriethoxylite, aminoamino) -3_aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropylfluorenyldimethyl Oxysilane, 3-ureidopropyltrimethoxysilane,% ureidopropyltriethoxylithium, N-ethoxycarbonyl-3-aminopropyltrioxane Silane, N-ethoxycarbonyl-3-aminopropyltriethoxylate, O: \ 87 \ 8706l.DOC -50- 200413441 triethoxysilylpropyltrivinyltriamine , N-trimethoxysilylpropyltrivinyltriamine, 10-trimethoxysilyl 4,4,7-triazadecane, 10-triethoxysilyl-, 1, 4,7_triazadecane, trimethoxymethoxanyl-3,6-diazanonyl acetate, 9-triethoxysilyl-3,6-diaza Nonylacetate, N-benzylaminopropyltrimethoxysilane, N-benzylaminopropyltriethoxysilane, N-phenyl-3-amine Propyldimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, bis (oxyvinyl) -3-aminopropyltrimethoxysilane, tris (bis (oxyethylene) ) -3 —aminopropyltriethoxysilane and so on. Examples of the epoxy-containing compound include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, dipropylene glycol diglycidyl ether, and polypropylene glycol diglycidyl. Glyceryl ether, neopentyl glycol diglycidyl ether, 6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo neopentyl glycol diglycidyl ether, 1,3,5,6-Tetraglycidyl ether-2, cardiohexanediol, n, n, n ,, n, tetraglycidyl ether-m-xylylenediamine, -bis (N, N-di Glycidylaminomethyl) cyclohexane, \, 1 ^ 3, -tetraglycidyl-4,4, diaminodiphenylmethane and the like. The compounding ratio of the compound containing these functional silanes or the compound containing epoxy groups is preferably 0.1 to 30 parts by weight based on 100 parts by weight of the polymer. &lt; Liquid crystal display element &gt; The liquid crystal display element of the present invention can be produced, for example, by the following method.涂布 The liquid crystal alignment of the present invention is applied on the side of a substrate provided with a patterned transparent conductive film by, for example, a roll coating method, a spin coating method, or a brush method.

O:\87\S7061.DOC 200413441 j ’、、丨彳交,藉由加熱塗佈面以形成塗膜。於此,基板係可 使用例如碌灰石玻璃、鈉飼玻等之玻璃;由聚對苯二甲酸 乙-酉曰、聚對苯二甲酸丁二酉旨、聚趟石風、聚碳酸醋等之塑 膠所構成的透明玻璃。設於基板之一面的透明導電膜可使 1由氧化錫(Sn〇2)所構成的NESA膜(美國ppg公司註冊商 Μ、乳化銦氧化錫(In2〇3_Sn〇2)所構成的ιτ〇膜等。此等 透月導%膜的圖案化係可使用光#刻法或預先使用掩模 的方法。在液晶定向劑的塗佈時,為進一步使基板表面及 透明導電膜與塗膜之接著性良好’在基板之表面亦可預先 塗佈含官能性石夕院的化合物、含宫能性鈦的化合物等。液 晶定向劑塗佈後之加熱溫度宜為8〇〜则。c,更宜為12〇〜25〇 C。又,含有聚醢胺酸之本發明液晶定向劑係藉由塗佈後 除去有機溶劑而形成一成為定向膜之塗膜,但進一步藉由 加熱而進行脫水閉環’亦可形成更被酿亞胺化之塗膜。曰所 形成之塗膜的膜厚宜為請Η㈣,更宜為請5〜Q5㈣。 (2)使所形成之塗膜面以由例如耐隆、螺縈、棉花等之纖維 所構成的布卷繞成的__定方向摩擦之研磨處理。藉 此,可對塗膜賦予液晶配向能。 又,對以本發明之液晶定向劑所形成的液晶定向膜,藉 由如示於例如特開平卜222366號公報或特開平㈣撕號 ,報所:般,以部分照射紫外線而進行如改變前仰角之處 或错由如示於特開平5_107544號公報,對實施研磨處 之液晶定向膜表面部分地形成光阻膜,朝與先前之研磨 處理相異的.方向進行研磨處理後,除去光阻膜,進行改變O: \ 87 \ S7061.DOC 200413441 j ′,, 丨 cross, and the coating surface is formed by heating. Here, the substrate can be made of glass such as limestone glass, soda glass, etc .; plastics made of polyethylene terephthalate, polybutylene terephthalate, polystone, polycarbonate, etc. Composition of transparent glass. The transparent conductive film provided on one side of the substrate can make a NESA film composed of tin oxide (SnO2) (a registrar of American ppg company M, an indium tin oxide emulsified (In2〇3_Sn〇2)) Etc. The patterning of these permeable membranes can use photolithography or a method using a mask in advance. In the application of the liquid crystal aligning agent, in order to further adhere the substrate surface and the transparent conductive film to the coating film, Good performance 'The surface of the substrate can also be coated with a compound containing a functional Shixiyuan, a compound containing a functional titanium, etc. The heating temperature after the application of the liquid crystal aligning agent should be 80 ~. C, more preferably It is 12 ~ 25 ° C. In addition, the liquid crystal aligning agent of the present invention containing polyamino acid forms a coating film which becomes an alignment film by removing the organic solvent after coating, but further dehydrates and closes the ring by heating. It is also possible to form a coating film that is more imidized. The film thickness of the coating film to be formed should preferably be Η㈣, more preferably 5 to Q5 ㈣. (2) The surface of the formed coating film should be made of, for example, Nalon. __ Abrasive rubbing in a certain direction made of a cloth made of fibers such as snails, snails, and cotton The liquid crystal alignment ability formed by the liquid crystal aligning agent of the present invention can be imparted to the coating film. For example, as shown in, for example, Japanese Patent Application Laid-Open No. 222366 or Japanese Patent Application Laid-Open Newspaper: Normally, partly irradiated with ultraviolet rays, such as changing the front elevation angle or wrongly, as shown in Japanese Patent Application Laid-Open No. 5_107544, a photoresist film is partially formed on the surface of the liquid crystal alignment film where the polishing is performed, and the previous polishing is performed. The processing is different. After the polishing process is performed, the photoresist film is removed and changed.

〇:'87\370ό 1.DOC -52 - 200413441 液曰日疋向膜之液晶配向能的處理,可改善液晶顯示元件之 視界特性。 又,視情況,不採用研磨而藉由偏光或無偏光之紫外線、 或離子束等照射於塗膜上,亦可賦予液晶配向能。 另外,在製造垂直配向型之液晶顯示元件時,必未要進 订研磨處理’而亦可直接使用上述塗膜作為液晶定向膜。 (3)如上述般而製作2片形成液晶定向膜之基板,在液晶定向 膜的研磨方向分別成為特定角度,介由間隙(格室間距)而對 向配置2片基板,使用彌封劑而貼合2片基板的周邊部,在 基板表面及以彌封劑所區隔出之格室間距内注入充填液 晶,嘧封注入孔而構成液晶格室。繼而,在液晶格室之外 表面亦即構成液晶格室之各基板的他面側,以使其偏光方 向形成於該基板的一面之液晶定向膜研磨方向一致或正交 的方式,貼合偏光板,可得到液晶顯示元件。 於此,彌封劑可使用例如含有作為硬化劑與間隙物的氧 化链球之環氧樹脂等。 液晶可舉例如:向列型液晶及距列型液晶。其中,宜為 2列土液日日,可舉例如:席夫鹼系液晶、氧化偶氮基系液 :曰:、聯苯基系液晶、苯基環己烷系液晶、i旨系液晶、聯三 苯基系液晶、聯苯基環己烷系液晶、嘧啶系液晶、二氧雜 %己烷、聯5辰辛烷系液晶、Cuban系液晶等。又,於此等之 亦可使用添加販賣來作為例如氣化類固醇、類固 「c-1:)」「CB_15」(Merck公司製)的非對稱劑等。進一步,〇: '87 \ 370ό 1.DOC -52-200413441 The treatment of the liquid crystal alignment energy of the liquid crystal film can improve the visual characteristics of the liquid crystal display element. In addition, depending on the case, the coating film may be irradiated with polarized or unpolarized ultraviolet rays, or an ion beam without using polishing, and the liquid crystal alignment ability may be imparted. In addition, when manufacturing a liquid crystal display element of a vertical alignment type, it is not necessary to perform a polishing process', and the above-mentioned coating film can be directly used as a liquid crystal alignment film. (3) Two substrates for forming a liquid crystal alignment film are prepared as described above, and the polishing directions of the liquid crystal alignment film are set at specific angles respectively, and the two substrates are disposed opposite to each other through a gap (cell space), and a sealing agent is used. The peripheral parts of the two substrates are bonded together, and liquid crystal is injected into the substrate surface and the space between the cells separated by the sealant, and the liquid crystal cells are formed by sealing the injection holes. Then, the polarized light is bonded to the outer surface of the liquid crystal cell, that is, the other surface side of each substrate constituting the liquid crystal cell, so that the direction of polishing of the liquid crystal alignment film whose polarization direction is formed on one side of the substrate is consistent or orthogonal. Plate to obtain a liquid crystal display element. Here, as the sealant, for example, an epoxy resin containing an oxidized chain ball as a hardener and a spacer can be used. Examples of the liquid crystal include a nematic liquid crystal and a nematic liquid crystal. Among them, two rows of soil fluids are preferred. For example, Schiff base liquid crystals and azo oxide-based liquids can be mentioned: biphenyl-based liquid crystals, phenylcyclohexane-based liquid crystals, i-based liquid crystals, Tri-triphenyl-based liquid crystals, biphenyl-cyclohexane-based liquid crystals, pyrimidine-based liquid crystals, dioxane% hexane, bi-octane-based liquid crystals, Cuban-based liquid crystals, and the like. In addition, as an asymmetric agent such as gasified steroids, steroids "c-1 :)", "CB_15" (Merck), and the like can also be used for sale. further,

87\87061.DOC -53 - 200413441 亦可使用對-去甲矽烷氧基苯亞甲基-對胺基-2-甲基丁基肉 桂酸酯等之強介電性液晶。 又’貼合於液晶格室之外表面的偏光板,可舉例:使聚 乙烯醇延伸配向,並以醋酸纖維素保護膜挾住稱為可吸收 碘之Η膜的偏光膜之偏光板或由H膜本身所構成的偏光板。 實施例 以下,依實施例進一步具體地說明本發明,但本發明不 限於此等實施例。χ,在以下之實施例及比較例中,聚合 體液日日疋向劑、及液晶顯示元件之評估方法係如以下般。 &lt;液晶顯示元件之電壓保持率〉 對液晶顯示元件以60毫秒的施加時間、167毫秒之跨度施 加5 V的電壓後,從施加解除測定167毫秒後的電壓保持 率。測疋裝置係使用(股)東陽技術製Vhr- 1。 &lt;殘影消去時間&gt; 0)對液晶顯示元件施加1〇 V之直流電壓丨小時後,解除該電 壓的施加,藉目測觀顯示晝面,解除電壓之施加後,測定 至畫面上之殘影消失的時間(實施例^〜丨5及比較例6〜8)。 CD對液晶顯元件在l〇〇°C的環境溫度下施加丨7从之直流電 壓20小時後,解除該電壓之施加,在15分鐘= 和後,藉由殘留於液晶格室内之閃爍消失,求得殘留電 壓。殘留DC電壓愈少,殘影消失時間很短的液晶顯示元: 實施例22〜26及比較例11〜12)。 &lt;液晶顯示元件之前仰角&gt; 依據記載-於丁丄87 \ 87061.DOC -53-200413441 It is also possible to use strong dielectric liquid crystals such as p-desyloxybenzylidene-p-amino-2-methylbutyl meat laurate. Also, a polarizing plate attached to the outer surface of a liquid crystal cell can be exemplified by a polarizing film extending the alignment of polyvinyl alcohol and holding a polarizing film called a holmium film capable of absorbing iodine with a protective film of cellulose acetate. A polarizing plate composed of the H film itself. Examples Hereinafter, the present invention will be described more specifically based on examples, but the present invention is not limited to these examples. X. In the following examples and comparative examples, the evaluation method of the polymer fluid sun-repellent agent and the liquid crystal display element is as follows. &lt; Voltage retention of the liquid crystal display element> After applying a voltage of 5 V to the liquid crystal display element at an application time of 60 milliseconds and a span of 167 milliseconds, the voltage retention after 167 milliseconds was measured from the release. The radon measuring device uses Vhr-1 manufactured by Dongyang Technology. &lt; Residual image erasing time &gt; 0) After applying a DC voltage of 10V to the liquid crystal display element for one hour, the voltage was released, and the daytime surface was displayed by visual observation. After the voltage was released, the residual voltage on the screen was measured. Shadow disappearance time (Examples 5 to 5 and Comparative Examples 6 to 8). After applying the DC voltage to the liquid crystal display element at an ambient temperature of 100 ° C for 20 hours, the voltage is released from the application of the voltage. After 15 minutes, the flicker disappears in the liquid crystal cell. Find the residual voltage. The less the residual DC voltage, the shorter the disappearance time of the afterimage. Liquid crystal display elements: Examples 22 to 26 and Comparative Examples 11 to 12). &lt; Elevation angle before liquid crystal display element &gt;

Scheffer, et al·,J. Appl· Phys·,ν〇ι 19, O:\87\8706I.DOC -54. 200413441 2013 (1980)之方法,藉使用He-Ne雷射光之結晶旋轉法進行 測定。 〈液晶顯示元件之可靠性試驗&gt; 於70°C之恆溫槽中置入液晶顯示元件,以驅動波形產生 裝置「Function/arbitrary waveform generator」(Hewlett Packard么司製)連續驅動24小時後,確認明暗對比不均、顯 示缺陷之有無。 特定二胺化合物之合成實施例。 合成實施例1 (1) 石膽酸甲酯之合成 將石膽酸5 6 · 5 g (0 · 1 5莫耳)及濃硫酸3 mi加入〇 ·5升之甲醇 中,加熱回流6小時。所得到之溶液以旋轉蒸發器濃縮至1/2 量流,加至1升之純水而使生成物沉澱,進一步以吸引過濾 進行回收。此粗生成物以NaHC〇3飽和水溶液洗滌,中和所 附著之H2S〇4,同時並溶解除去未反應之石膽酸。再進一步 水洗、真空乾燥後,從乙醇進行再結晶,而得到石膽酸甲 S旨44g。分析結果表示於下。 W-NMRPMSDA j ppm) : 〇.6_21 (34H,m),3 6 (3H,s)。 (2) 石膽酸甲酯(3,5_二硝基苯甲酸酯)之合成 混合石膽酸甲酯1 9.6g (〇 苜:s:、 , . A 产 s 旲耳)、吡啶4 〇g及二氣甲烷 0.1 5 升,在室溫下溶解。—S/ ϋ V* 卸撹拌此溶液一面直接以固體 狀徐緩加入3,3-二硝基氯化笨甲醯u.5g(〇〇5莫耳),進一步 在室溫下攪拌。此混合液以旋轉蒸發器蒸發乾固,以水洗 淨所生成之H]⑮h /查後,真空乾燥而得到粗生成物。再進 0^,8737061.000 -55- 200413441 一步以丙自同再結晶,而得到石膽酸甲酯(3,5-二硝基苯曱酸 酯)25.5g。分析結果表示於下。 lH-NMR (CDC135 5 ppm) : 0.6-2.1 (34H, m)5 3.6 (3H5 s)5 9.1-9·2 (3H,d+t)。 (3) 石膽酸曱S旨(3,5- 一胺基苯甲酸g旨)之合成 將石膽酸甲酯(3,5-二硝基苯甲酸酯)9.6g與鈀活性碳 0.1 g加入1 00 ml之乙醇中,加熱回流。於此混合物中徐緩滴 下4 ml之聯氨1水合物,進一步繼續加熱回流2小時。熱時 過濾此反應溶液’除去銳活性碳,加入1升之水而使生成物 沉澱。此沉澱過濾水洗真空乾燥後,從乙醇進行再結晶, 而得到石膽酸甲酯(3,5-二胺基苯甲酸酯)6.7g。分析結果表 示於下。 1H-NMR(DMSO-D6, 5 ppm) : 0.6-2.1 (34H? m), 3.6 (3H? s), 4.9 (4H,s),6·0 (1H,t),6.4 (2H,d)。 合成實施例2 (4) 石膽酸丁酯之合成 將石膽酸56.5g (0.15莫耳)及濃硫酸0.3 ml加入1-丁醇44 g 與氯仿100 ml之溶液中,加熱回流6小時。所得到之溶液以 旋轉蒸發器濃縮至1 /2量流,加至1升之氯仿與1L之純水而 攪拌。使氣仿層分液,以NaHC03飽和水溶液洗滌,中和所 附著之H2S〇4,同時並溶解除去未反應之石膽酸。再進一步 水洗、以無水硫酸鎂乾燥、濾去硫酸鎂、濃縮溶液而得到 石膽酸丁酯52g。 (5) 石膽酸丁酯(3,5·二硝基苯甲酸酯)之合成 8706 l.DOC -56- 200413441 除使用石膽酸丁酯21.4g(0.05莫耳)、吡啶3 9§及二氯甲 烷0.1升,3,3-二硝基氯化苯甲醯il4g (〇〇5莫耳)以外,其 餘與(2)相同,而得到石膽酸丁酯(3,5_二硝基苯甲酸_ ) 26g 〇 (6) 石膽酸丁 g旨(3,5·二胺基苯甲酸g旨)之合成 除使用石膽酸丁酯(3,5-二硝基苯甲酸酯)9· 6g以外,其餘 與(3)相同,而得到石膽酸丁酯(3,5-二胺基苯甲酸酯)'〇g。 分析結果表示於下。 , W-NMR (DMSO-D6,5 ppm) : 0.6-2.1 (44H,m),4.0 (2H,t), 4.8 (1H,m),4·9 (4H,s),6.0 (1H,s,6.4 (2H,s)。 合成實施例3 (7) 石膽酸戊酯之合成 除使用1-戊醇39g以外,其餘與(4)相同,而得到石膽酸戊 酉旨54g。 (8) 石膽睃戊酯(3,5-二硝基苯甲酸酯)之合成 除使用石膽酸戊酯22g以外’其餘與(2)同樣,得到石膽酸 戊S旨(3,5 -二硝基苯甲酸醋)2 6 g。 (9) 石膽酸戊酯(3,5-二胺基苯甲酸酯)之合成 除使用石膽酸戊酯(3,5 -二石肖基笨甲酸酯)9 · 6g以外,其餘 與(3)相同,而得到石膽酸戊酯(3,5-二胺基苯曱酸酯)6.9g。 分析結果表示於下。 jH-NMR (DMSO-D6j(5 ppm) : 0.6-2.1 (46H, m), 4.0 (2H? t)5 4.8 (1H,m),4·9 (4H,s),6.0 (1H,s),6·4 (2H,s)。 合成實施例-4 O:\87.8706l.DOC -57 - 200413441 (10) 石膽酸十七烷酯之合成 除使用1-十七烷醇59g以外,其餘與(4)同樣而得到粗石膽 酸戊酯92g。再以管柱色層分析進行精製,得到石膽酸十七 炫醋8 3 g。 (11) 石膽酸十七烷基(3,5-二硝基苯甲酸酯)之合成 除使用石膽酸十七烷酯31 g以外,其餘與(2)同樣而得到石 膽酸十七烷基(3,5-二硝基苯甲酸酯)37g。 (12) 石膽酸十七烷基(3,5_二胺基苯甲酸酯)之合成 , 除使用石膽酸戊基(3,5 -二石肖基苯甲酸酉旨)9 · 6 g以外,其餘 與(3)同樣而得到石膽酸十七烷基(3,5_二胺基笨甲酸酯) 7.5g。分析結果表示於下。 b-NMR (CDC13, 5 ppm) : 〇·6-2·4 (70H,m),3·7 (4H,s),4.0 (2H,t),4.9 (1H,m),6·2 (1H,s),6.8 (2H,s)。 合成實施例5 (13) 石膽酸十八烷酯之合成 除使用1-十八烷醇61g以外,其餘與(1〇)同樣而得到石膽 酸十八烧酯7 6 g。Scheffer, et al., J. Appl. Phys., Νιι 19, O: \ 87 \ 8706I.DOC -54. 200413441 2013 (1980), measurement by He-Ne laser light crystal rotation method . <Reliability test of liquid crystal display element> The liquid crystal display element was placed in a 70 ° C thermostatic bath to drive the waveform generator "Function / arbitrary waveform generator" (manufactured by Hewlett Packard) for 24 hours. Uneven light and dark contrast, showing the presence or absence of defects. Examples of synthesis of specific diamine compounds. Synthesis Example 1 (1) Synthesis of methyl lithocholic acid 56. 5 g (0.15 mol) of lithocholic acid and 3 mi of concentrated sulfuric acid were added to 0.5 liter of methanol, and heated under reflux for 6 hours. The obtained solution was concentrated to 1/2 volume flow on a rotary evaporator, and the product was precipitated by adding 1 liter of pure water, and further recovered by suction filtration. This crude product was washed with a saturated aqueous solution of NaHC03 to neutralize the attached H2SO4, and at the same time dissolved and removed unreacted lithocholic acid. After further washing with water and vacuum drying, recrystallization was performed from ethanol to obtain 44 g of methyl lithocholic acid. The analysis results are shown below. W-NMRPMSDA j ppm): 0.621 (34H, m), 3 6 (3H, s). (2) Synthesis of methyl lithocholic acid (3,5-dinitrobenzoate) 1 9.6 g of methyl lithocholic acid (〇 alfalfa: s :,,.. 〇g and 0.1 5 liters of digas methane were dissolved at room temperature. —S / ϋ V * Dissolve this solution and slowly add 3,3-dinitrobenzyl chloride (5. 5 mol) as a solid directly, and stir at room temperature. This mixed solution was evaporated to dryness on a rotary evaporator, the generated H] ⑮h was washed with water, and then dried under vacuum to obtain a crude product. A further 0 ^, 8737061.000 -55- 200413441 was used to recrystallize it in one step to obtain 25.5 g of methyl lithocholic acid (3,5-dinitrophenylarsinate). The analysis results are shown below. lH-NMR (CDC135 5 ppm): 0.6-2.1 (34H, m) 5 3.6 (3H5 s) 5 9.1-9 · 2 (3H, d + t). (3) Synthesis of gadolinium lithocholic acid (3,5-monoaminobenzoic acid g) 9.6 g of methyl lithocholic acid (3,5-dinitrobenzoate) and 0.1 palladium activated carbon g is added to 100 ml of ethanol and heated under reflux. 4 ml of hydrazine monohydrate was slowly dripped into the mixture, and the mixture was further heated under reflux for 2 hours. When hot, the reaction solution was filtered to remove sharp activated carbon, and 1 liter of water was added to precipitate the product. This precipitate was filtered, washed with water, and dried under vacuum, and then recrystallized from ethanol to obtain 6.7 g of methyl lithocholic acid (3,5-diaminobenzoate). The analysis results are shown below. 1H-NMR (DMSO-D6, 5 ppm): 0.6-2.1 (34H? M), 3.6 (3H? S), 4.9 (4H, s), 6.0 (1H, t), 6.4 (2H, d) . Synthesis Example 2 (4) Synthesis of butyl lithocholic acid 56.5 g (0.15 mol) of lithocholic acid and 0.3 ml of concentrated sulfuric acid were added to a solution of 44 g of 1-butanol and 100 ml of chloroform, and heated under reflux for 6 hours. The resulting solution was concentrated on a rotary evaporator to a 1/2 flow, and added to 1 liter of chloroform and 1 L of pure water and stirred. The gas imitation layer was separated and washed with a saturated aqueous solution of NaHC03 to neutralize the attached H2SO4, and at the same time dissolved and removed the unreacted lithocholic acid. It was further washed with water, dried over anhydrous magnesium sulfate, filtered to remove magnesium sulfate, and the solution was concentrated to obtain 52 g of butyl lithocholic acid. (5) Synthesis of butyl lithocholic acid (3,5 · dinitrobenzoate) 8706 l.DOC -56- 200413441 Except the use of butyl lithocholic acid 21.4g (0.05 mole), pyridine 3 9§ And 0.1 m of methylene chloride and 4 g (0.05 mol) of 3,3-dinitrobenzyl chloride, the rest are the same as in (2) to obtain butyl lithochorate (3,5-dinitrate Benzoic acid _) 26g 〇 (6) Synthesis of butyl lithocholic acid g (3,5 · diaminobenzoic acid g) In addition to the use of butyl lithocholic acid (3,5-dinitrobenzoate) ) Except for 9.6 g, the rest are the same as (3), and butyl lithochorate (3,5-diaminobenzoate) is obtained. The analysis results are shown below. , W-NMR (DMSO-D6,5 ppm): 0.6-2.1 (44H, m), 4.0 (2H, t), 4.8 (1H, m), 4.9 (4H, s), 6.0 (1H, s , 6.4 (2H, s) Synthesis Example 3 (7) The synthesis of ammonium lithocholic acid is the same as (4) except that 39 g of 1-pentanol is used, and 54 g of pentamidine lithocholic acid is obtained. (8 ) Synthesis of ammonium lithocholic acid (3,5-dinitrobenzoate), except for using 22 g of ammonium lithocholic acid, the rest is the same as (2), and pentyl lithocholic acid is obtained (3, 5- Dinitrobenzoic acid vinegar) 26 g. (9) Synthesis of ammonium lithocholic acid (3,5-diaminobenzoate) In addition to the use of ammonium lithocholic acid (3,5-distone Except for 9.6 g, the rest is the same as (3), and 6.9 g of ammonium lithochlate (3,5-diaminophenylbenzoate) is obtained. The analysis results are shown below. JH-NMR (DMSO- D6j (5 ppm): 0.6-2.1 (46H, m), 4.0 (2H? T) 5 4.8 (1H, m), 4 · 9 (4H, s), 6.0 (1H, s), 6.4 (2H , S)。 Synthesis Example-4 O: \ 87.8706l.DOC -57-200413441 (10) The synthesis of heptadecyl lithocholic acid is the same as (4) except that 59 g of 1-heptadecanyl alcohol is used. 92 g of ammonium crude cholic acid was obtained. Purification by column chromatography analysis yielded 8 3 g of heptacholic acid heptaacetate. (11) Synthesis of heptadecyl lithocholic acid (3,5-dinitrobenzoate) Except for 31 g of heptadecyl ester, the rest is the same as (2) to obtain 37 g of heptadecyl lithocholic acid (3,5-dinitrobenzoate). (12) Heptadecyl lithocholic acid (3, Synthesis of 5-diaminobenzoate), except for the use of ammonium lithocholic acid (3,5-bis-stilkybenzoic acid) 9 · 6 g, the rest is the same as (3) to obtain ten lithocholic acid 7.5 g of heptaalkyl (3,5-diaminobenzylformate). The analysis results are shown below. B-NMR (CDC13, 5 ppm): 0.6 · 2 · 4 (70H, m), 3 · 7 (4H, s), 4.0 (2H, t), 4.9 (1H, m), 6.2 (1H, s), 6.8 (2H, s). Synthesis Example 5 (13) Stearyl cholestyrate The ester was synthesized in the same manner as (1) except that 61 g of 1-octadecanol was used to obtain 76 g of octadecyl lithocholic acid.

毆 S旨)7.6g ·。 其餘與(3)同樣而得到石膽酸十 )7.6 g。分析結果表示於下。B) S)) 7.6g ·. The rest is the same as (3) to obtain 7.6 g of lithocholic acid. The analysis results are shown below.

〇:'37'-87061.DOC -58 - 200413441 ^H-NMR (CDC13? 5 ppm): 0.6-2.4 (72H5 m)53.7(4H? s)? 4.0 (2H,t),4.9 (1H,m)5 6.2 (1H,s),6.8 (2H,s)。 實施例1 聚醯胺酸之合成 將石膽酸曱酯(3,5·二胺基苯甲酸酯)7.〇2g、對苯二胺 13.0g及2,3,5-三羧基環戊基醋酸二酐3〇.〇g溶解於N_甲基 -2-吡咯烷酮450g,在6(rc下反應6小時。然後,將反應溶液 注入於非常過剩之甲醇中而使反應生成物沉澱。其後,以 甲醇洗淨,在減壓、4(TC下乾燥15小時,以得到對數黏度 為〇·93 dl/g之本發明聚醯胺酸(以此作為「聚合物(la)」) 48.9g 〇 實施例2 酿亞胺化聚合物之合成 將聚合物(1 a) 25 · 0 g &gt;谷解於N-曱基-2 - p比u各燒酮45 〇g,於此 &gt;谷液中添加说°疋10 · 6 g與醋酸肝甜1 3 · 6 g,在11 5 °C下加熱4 小時使之脫水閉環反應。然後,將反應溶液注入於非常過 剩之甲醇中而使反應生成物沉澱。其後,以曱醇洗淨,在 減壓、40°C下乾燥15小時’以得到對數黏度為〇.85以仏之本 發明醯亞胺化聚合物(以此作為「聚合物(lb)」)21.2g。 實施例3 聚醯胺酸之合成 除使用石膽酸丁酯(3,5-二胺基苯曱酸酯)7.49g、對苯二 胺12.9g及2,3,5 -三叛基環戊基醋酸二gf29.6g取代石膽酸甲 酯(3,5-二胺基笨甲酸酯)入〇2§、對笨二胺13.〇§及2,3,5-三羧 0:'8r 37061.DOC 09- 200413441 基環戊基醋酸二酐3G.Gg以外,其餘與實施⑴相同,得到 對數黏度為G.84 dl/g之本發明㈣胺酸(以此作為「聚合物 (2a)」)47.6g 〇 實施例4 酿亞胺化聚合物之合成 除使用♦合物(2a) 24.7g取代聚合物(la) 25.〇g以外,其餘 &quot;灵匕例2同樣,得到對數黏度為〇·82 之本發明醯亞胺 化聚合物(以此作|「聚合物(2b)」)21々。 , 實施例5 聚醯胺酸之合成 除使用石膽酸戊醋(3,5-二胺基苯甲酸酯)7.65g、對苯二 胺12.8g及2,3,5-二敌基環戊基醋酸二酐”化取代石膽酸甲 醋(3,5-二胺基苯甲酸酉旨)7〇2§、對苯二胺i3〇g及2,3,5_三叛 基環戊基醋酸二酐3G.Gg以外,其餘與實施_相同,得到 對數黏度為0.88 dl/g之本發明聚醯胺酸(以此作為「聚合物 (3a)」)49.8g。 實施例6 釀亞胺化聚合物之合成 除使用聚合物(3a)24.7g取代聚合物(la)25 〇g以外,其餘 與貫施例2同樣’得到對數黏度為〇 86⑴^之本發明醯亞胺 化聚合物(以此作為「聚合物(3b)」)2]L3g。 實施例7 聚醯胺酸之合成 除使用石膽酸十七烷基(3,5·二胺基苯甲酸酯)9.45g、對 O:'S7、87061.DOC -60- 200413441 笨一fe 12.3g及2,3,5-三羧基環戊基醋酸二酐28 3§取代石膽 酉文甲酯(3,5-二胺基苯曱酸酯)7 〇2g、對苯二胺i3.〇g及2,久5_ 2羧基環戊基醋酸二酐30.0g以外,其餘與實施例丨相同, 得到對數黏度為〇·79 dl/g之本發明聚醯胺酸(以此作為「聚 合物(4a)」)49.9g。 實施例8 醯亞胺化聚合物之合成 除使用聚合物(4a) 23.5g取代聚合物(la) 25 〇g以外,其餘 與實施例2同樣,得到對數黏度為〇·76⑴化之本發明醯亞胺 化聚合物(以此作為r聚合物(4b)」)19 3g。 實施例9 聚醯胺酸之合成 除使用石膽酸十八烷基(3,5-二胺基苯甲酸酯)9.59g、對 苯二胺12.2g及2,3,5-三羧基環戊基醋酸二酐28.2g取代石膽 酸曱酯(3,5-二胺基苯甲酸酯)7.02g、對苯二胺l3.〇g及2,3,5- 二幾基環戊基醋酸二酐30.0g以外,其餘與實施例1相同, 得到對數黏度為0.76 dl/g之本發明聚醯胺酸(以此作為「聚 合物(5a)」)49.9g。 實施例10 醯亞胺化聚合物之合成 除使用聚合物(5a) 2 3.5g取代聚合物(ia) 25.0g以外,其餘 與實施例2同樣,得到對數黏度為0.73 dl/g之本發明醯亞胺 化聚合物(以此作為「聚合物(5 b)」)1 9 · 8 g。 比較例1 · 〇:'S7\87061.DOC -61 - 200413441 聚醯胺酸之合成 除使用4,4-二胺基二苯基甲烷19 8§及2,3,弘三羧基環戊 基醋酸二酐22.4g取代石膽酸甲酯(3,5_二胺基苯甲酸酯) 7.02g對笨一 及2,3,5-二羧基環戊基醋酸二酐3〇〇§ 以外,其餘與實施例1相同,得到對數黏度為丨.2〇 dl/g之聚 酉监胺酸(以此作為「聚合物(A a)」)4 0 · 2 g。 比較例2 醯亞胺化聚合物之合成 · 除使用聚合物(Aa) 25.0g取代聚合物(ia) 25.〇g,使用外匕 °疋4.5 g與醋酸酐5.8g取代p比唆1 〇.6g與醋酸酐1 3.6g以外,其 餘與實施例2同樣,得到對數黏度為1 ·2〇 dl/g之本發明醯亞 胺化聚合物(以此作為「聚合物(Ab)」)3〇lg。 比較例3 聚酿胺酸之合成 除使用對苯二胺12.80g及苯四甲酸二酐25.82g取代石膽 酸曱醋(3,5-二胺基苯曱酸酯)7.02g、對苯二胺i3.〇g及2,3,5-二羧基環戊基醋酸二酐30.Og以外,其餘與實施例1相同, 得到對數黏度為丨.1〇 dl/g之聚醯胺酸(以此作為「聚合物 (Ba)」)32.60g。 比較例4 聚醯胺酸之合成 除使用以上述(1〇)所示之二胺5.20g、4,4-二胺基二苯基曱 烧1 7.8g及2,3,5-三羧基環戊基醋酸二酐22.4g取代石膽酸甲 醋(3,5-二胺基苯甲酸酯)7.02g、對苯二胺13.0g及2,3,5-三羧 200413441 基環戊基醋酸二肝30.0g以外,其餘與實施例丨相同,得到 對數黏度為〇.95dl/g之聚醯胺酸(以此作為「聚合物(ca)」) 40.6g 〇 比較例5 醯亞胺化聚合物之合成 除使用聚合物(Ca)25.〇g取代聚合物(la)25()g,使用吨咬 4.5g與醋酸酐5.8g取代吡啶1〇.6§與醋酸酐^化以外,其餘 與實施例2同樣,得到對數黏度為G.96dl/g之酸亞胺化聚合 物(以此作為「聚合物(Cb)」)19.0g。 實施例11 (1) 液晶定向劑之調製: 使實施例2所得到之聚合物(丨b)溶解於γ _ 丁内酯而形成固 形分濃度2.5重量%的溶液,以孔徑丨μηι之過濾器過濾此溶 液而調製本發明的液晶定向劑。 (2) 液晶顯示元件之製作: ③由厚1 mm玻璃基板之一面所設置的ΙΤ〇膜所構成的透明 V電膜上,使用旋塗器塗佈如上述做法所調製之本發明液 晶定向劑,在18(TC下乾燥1小時,以形成乾燥膜厚8〇〇埃 (angstrom)的塗膜。 ®藉使用一具有卷繞耐隆製布之輥的研磨機器而研磨處理 所形成的塗膜面,製作液晶定向膜。於此,研磨處理條件 係輥的旋轉數500 rpm、分級的移動速度} cm/秒。 ◎如上述做法而製作形成液晶定向膜之基板2片,在各基板 之緣部,藉調版茚刷法塗佈一含有直徑17 μπι之氧化銘球的 〇:‘S7\87〇6l.D〇c -63 - 2UU41J441 系接著劑後,以各液晶定向膜,之研磨方向呈互 奔:、方式介由間隙對向配置2片基板,接觸外緣部而麼 黏’而使接著劑硬化。 、、主土板表面及藉外緣部之接著劑所區隔出之格室間距内 以/填向列型液晶「MLC-2G〇l」(Merck公司製),然後, ^ Μ接著㈣封注人孔而構成液晶格室。、繼而,在液 之外表面,以使其偏光方向與液晶定向膜之研磨方 向呈45户^ ' 『X ’且互相正交的方式’貼合偏光板,製作 /夜日日顯不元件。 CD如上述般所製作一 及解除〜 夜曰曰顯不…係在對液晶格室施加 又f &amp;守,看不出異常區域,而液晶之配向性良好。 率9〜彳卩角為丨.5度。又’液晶顯示元件之電壓保持 …、。,殘影消去時間極短至〇·4秒。 實施例12〜1 5 、 5物(2b)〜(5b)取代聚合物(lb)以外,其餘係鱼♦ 輝1_,而調製液晶定向劑,製作液晶顯示元件了二 :在作之液晶顯示元件中的液晶配向性、電壓保持 率及汉影消失時間。結果表示於表卜 表1〇: '37'-87061.DOC -58-200413441 ^ H-NMR (CDC13? 5 ppm): 0.6-2.4 (72H5 m) 53.7 (4H? S)? 4.0 (2H, t), 4.9 (1H, m ) 5 6.2 (1H, s), 6.8 (2H, s). Example 1 Synthesis of Polyammonium Acetate Lithium cholestyrate (3,5 · diaminobenzoate) 7.02 g, p-phenylenediamine 13.0 g, and 2,3,5-tricarboxycyclopentane 3.0 g of acetic acid dianhydride was dissolved in 450 g of N-methyl-2-pyrrolidone and reacted at 6 ° C for 6 hours. Then, the reaction solution was poured into a very excessive amount of methanol to precipitate a reaction product. After that, it was washed with methanol and dried under reduced pressure at 4 ° C for 15 hours to obtain a polyamic acid of the present invention having a logarithmic viscosity of 0.93 dl / g (as a "polymer (la)") 48.9 g 〇 Example 2 Synthesis of imidized polymer The polymer (1 a) 25 · 0 g &gt; disintegrated in N-fluorenyl-2-p ratio 450,000 g of each ketone, here &gt; Add 10 ° 6 g and 1 3 6 g of hepatic acetate to the cereal, and heat it at 11 5 ° C for 4 hours to dehydrate and close the ring. Then, inject the reaction solution into a very excess methanol to make The reaction product precipitated. After that, it was washed with methanol and dried under reduced pressure at 40 ° C for 15 hours to obtain the fluorinated imidized polymer of the present invention having a logarithmic viscosity of 0.85 (as " Polymer (lb) ") 21 .2g. Example 3 Synthesis of polyamidic acid except that butyl lithocholic acid (3,5-diaminophenylbenzoate) 7.49g, p-phenylenediamine 12.9g and 2,3,5-trial Gcyclopentyl acetate digf 29.6 g substituted methyl lithocholic acid (3,5-diamino stupid methylformate) 〇2§, p-diamine diamine 13.〇§ and 2,3,5-tricarboxylic acid 0: '8r 37061.DOC 09- 200413441 Except for 3G.Gg of cyclopentylacetic dianhydride, the rest is the same as that in the implementation of ⑴, and the glutamic acid of the present invention having a log viscosity of G.84 dl / g (as a "polymerization" (2a) ") 47.6g 〇 Example 4 Synthesis of imidized polymer except the use of compound (2a) 24.7g instead of polymer (la) 25.〇g, the rest of the same &quot; spiral example 2 To obtain the present invention (i.e., "Polymer (2b)") with a logarithmic viscosity of 0.28. Example 5, Synthesis of Polyphosphonic Acid (3,5-diaminobenzoate) 7.65g, p-phenylenediamine 12.8g, and 2,3,5-dienecyclopentylacetic dianhydride "substituted lithocholic acid methyl acetate (3,5 -Diaminobenzoic acid purpose) 702§, p-phenylenediamine i30g and 2,3,5-trisylcyclopentylacetic dianhydride 3G.Gg Except that, the rest is the same as that of the implementation, and 49.8 g of the polyamidic acid of the present invention (which is referred to as "polymer (3a)") having a log viscosity of 0.88 dl / g is obtained. Example 6 Synthesis of an imidized polymer Using 24.7 g of polymer (3a) instead of 25.0 g of polymer (la), the rest was the same as in Example 2 to obtain the 醯 imidized polymer of the present invention having a log viscosity of 86. (3b) ") 2] L3g. Example 7 Synthesis of Polyamidic Acid Except the use of heptadecanyl hexacholic acid (3,5 · diaminobenzoate) 9.45 g, p.O: 'S7, 87061.DOC -60- 200413441 12.3g and 2,3,5-tricarboxycyclopentylacetic dianhydride 28 3§ Substituted for cholestyryl methyl ester (3,5-diaminophenylbenzoate) 702g, p-phenylenediamine i3. Except 30.0 g of carboxyl cyclopentylacetic dianhydride and 2 g, 5-2 carboxycyclopentanedioic dianhydride, the rest was the same as in Example 丨, and the polyamidic acid of the present invention having a log viscosity of 0.79 dl / g (this was used as a "polymer (4a) ") 49.9g. Example 8 (Synthesis of imidized polymer) Except that 23.5 g of polymer (4a) was used instead of 25.0 g of polymer (la), the rest was the same as in Example 2 to obtain the present invention with a log viscosity of 0.76. 19 3 g of an imidized polymer (as this r polymer (4b) "). Example 9 Synthesis of Polyamidoacid Except for using 9.59 g of octadecyl lithocholic acid (3,5-diaminobenzoate), 12.2 g of p-phenylenediamine and 2,3,5-tricarboxyl ring 28.2 g of amyl acetic dianhydride substituted with ammonium lithocholic acid (3,5-diaminobenzoate) 7.02 g, 13.0 g of p-phenylenediamine and 2,3,5-dikicyclocyclopentyl Except for 30.0 g of acetic dianhydride, the rest was the same as in Example 1 to obtain 49.9 g of the polyamidic acid of the present invention (which is referred to as "polymer (5a)") with a log viscosity of 0.76 dl / g. Example 10 (Synthesis of imidized polymer) Except the use of polymer (5a) 2 3.5 g instead of polymer (ia) 25.0 g, the rest is the same as in Example 2 to obtain the present invention with a log viscosity of 0.73 dl / g. The imidized polymer (referred to as "Polymer (5 b)") 1 9 · 8 g. Comparative Example 1 · 〇: 'S7 \ 87061.DOC -61-200413441 Synthesis of polyamic acid except 4,4-diaminodiphenylmethane 19 8§ and 2,3, tritricyclocyclopentylacetic acid 22.4 g of dianhydride substituted methyl lithocholic acid (3,5-diaminobenzoic acid ester) 7.02 g of paraben and 2,3,5-dicarboxycyclopentylacetic dianhydride other than 〇§, the rest In the same manner as in Example 1, a polyglycolic acid (which is referred to as "polymer (A a)") having a logarithmic viscosity of 0.20 dl / g was obtained, which was 4 · 2 g. Comparative Example 2 Synthesis of imidized polymer. Except using 25.0 g of polymer (Aa) instead of 25.0 g of polymer (ia), 4.5 g and 5.8 g of acetic anhydride were used instead of p ratio 唆 1. .6 g except 3.6 g of acetic anhydride, the rest was the same as in Example 2 to obtain the fluorinated imidized polymer of the present invention having a logarithmic viscosity of 1.20 dl / g (this was referred to as "polymer (Ab)") 3 〇lg. Comparative Example 3 Synthesis of poly (vinylamine), except for the use of 12.80 g of p-phenylenediamine and 25.82 g of pyromellitic dianhydride in place of 7.02 g of lithocholic acid (3,5-diaminophenyl benzoate) and terephthalic acid Except for i.3.0 g of amine and 30.0 g of 2,3,5-dicarboxycyclopentylacetic dianhydride, the rest were the same as in Example 1 to obtain a polyamidic acid having a logarithmic viscosity of 1.1 dl / g (as This is referred to as "Polymer (Ba)") 32.60 g. Comparative Example 4 Synthesis of polyamidic acid except that 5.20 g of diamine shown in the above (10), 1 7.8 g of 4,4-diaminodiphenylsulfonium and 2,3,5-tricarboxy ring were used. 22.4 g of amyl acetic dianhydride 7.02 g of substituted lithocholic acid methyl ester (3,5-diamino benzoate), 13.0 g of p-phenylenediamine and 2,3,5-tricarboxylic acid 200413441 cyclopentyl acetic acid Except for 30.0 g of dihepatitis, the rest are the same as in Example 丨, and a polyamidic acid having a logarithmic viscosity of 0.95 dl / g (this is referred to as "polymer (ca)") 40.6 g. Comparative Example 5 In addition to the synthesis of the polymer, except that the polymer (Ca) 25.0 g was used to replace the polymer (la) 25 () g, 4.5 g of ton bite and 5.8 g of acetic anhydride were used instead of pyridine 10.6§ and acetic anhydride In the same manner as in Example 2, 19.0 g of an acid imidized polymer having a log viscosity of G.96 dl / g (this was referred to as "polymer (Cb)") was obtained. Example 11 (1) Preparation of liquid crystal aligning agent: The polymer (丨 b) obtained in Example 2 was dissolved in γ-butyrolactone to form a 2.5% by weight solid solution, and a filter with a pore size of μηι was used. This solution was filtered to prepare the liquid crystal aligning agent of the present invention. (2) Production of liquid crystal display elements: ③ On the transparent V electric film composed of ITO film provided on one surface of a 1 mm thick glass substrate, use a spin coater to apply the liquid crystal aligning agent of the present invention prepared as described above. And dried at 18 ° C for 1 hour to form a coating film having a dry film thickness of 800 angstroms. ® The coating film formed was ground by using a grinding machine having a roll wound with a roll of Nylon cloth. A liquid crystal alignment film is produced on the surface. Here, the grinding process conditions are the number of rotations of the roller 500 rpm, the moving speed of classification} cm / sec. ◎ As described above, two substrates forming a liquid crystal alignment film are produced, and the edges of each substrate are formed. After applying an indium oxide brush with a diameter of 17 μm, a 0: 'S7 \ 87〇6l.D〇c -63-2UU41J441 series adhesive was applied by the second edition indene brush method, and the orientation direction of each liquid crystal film was polished. Presenting each other: 1. The two substrates are arranged opposite to each other through the gap, and the adhesive is hardened by contacting the outer edge portion. 2. The surface of the main soil plate and the partition separated by the adhesive agent on the outer edge portion are hardened. Nematic liquid crystal "MLC-2GOL" (manufactured by Merck) is filled / filled in the inter-cell space, Then, ^ M is then filled with a manhole to form a liquid crystal cell. Then, on the outer surface of the liquid, the polarization direction of the liquid crystal and the polishing direction of the liquid crystal alignment film are 45 units ^ "" X "and orthogonal to each other Method 'Laminating polarizing plate, making / displaying elements at night and day. CD is made as above and released ~ Night is not visible ... It is applied to the LCD cell and f &amp; guard, no abnormal area can be seen And the alignment of the liquid crystal is good. The rate of 9 to 彳 卩 is 5 degrees. The voltage of the liquid crystal display element is maintained ..., and the afterimage erasing time is extremely short to 0.4 seconds. Example 12 to 15 5, 5 (2b) ~ (5b) instead of the polymer (lb), the rest of the fish ♦ 1_, and the liquid crystal alignment agent is prepared to produce a liquid crystal display element 2: the alignment of the liquid crystal in the liquid crystal display element, Voltage holding rate and disappearance time of Han Ying. Results are shown in Table 1

S7\8706I.DOC -64- 比較例6 二比較例2所得到之聚醯亞胺(Ab)取代聚合物⑽以 二:與實施例12同樣’而調製液晶定向 作液 日日顯不兀件。測定在 性、义彳彡&amp; 衣作之,夜日日頒不兀件中的液晶配向 刖仰角、電壓保持率、及殘影消失 表2。 及洩〜,肉夭4間。結果表示於 比較例7 之聚合物(Ba)取代聚合物〇b)以 樣,而調製液晶定向齊j,製作液 作之液晶顯示元件中的液晶配向 、及殘影消失時間。結果表示於 表2。 之聚合物⑽)取代聚合物⑽以 樣,而調製液晶定向劑,製作液 作之液晶顯示元件中的液晶配向 、及殘影消失時間。結果表示這 除使用比較例3所得到 外,其餘係與實施例12同 晶顯示元件。測定在所製 性、前仰角、電壓保持率 比較例8 除使用比較例5所得到 外,其餘係與實施例12同 晶顯示元件。測定在所製 性、刖仰角、電壓保持率 表2。 表2S7 \ 8706I.DOC -64- Comparative Example 6 Two polyimide (Ab) -substituted polymers obtained in Comparative Example 2 (2): Same as in Example 12, and the alignment of the liquid crystal alignment liquid is not obvious every day . Measure the liquid crystal alignment angle, voltage retention rate, and afterimage disappearance in liquid crystals, clothing, and clothing. Table 2. And bleed ~, 4 meat dumplings. The results are shown in the polymer (Ba) instead of the polymer OB) in Comparative Example 7, and the liquid crystal alignment was adjusted to prepare the liquid crystal alignment and the disappearance time of the afterimage in the liquid crystal display element prepared as a liquid. The results are shown in Table 2. The polymer (i) is used in place of the polymer (i), and a liquid crystal aligning agent is prepared to prepare the liquid crystal alignment in the liquid crystal display element as a liquid and the disappearance time of the afterimage. The results show that this is the same as that of Example 12 except that it was obtained by using Comparative Example 3. The measurement was performed on the manufacturing property, the elevation angle, and the voltage holding ratio. Comparative Example 8 Except that obtained by using Comparative Example 5, the rest were the same as those of Example 12 in the same isotropic display element. Table 2 shows the measured properties, elevation angle, and voltage retention. Table 2

0:37.87061.DOC -65- 200413441 實施例16 聚醯胺酸之合成 將作為四羧酸二酐之2,3,5-三羧基環戊基醋酸二酐 112.09g (0.5莫耳)、l,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二氧-3-呋喃基)-萘並[1,2- C ]呋喃_1,3-二酮157.15g (0.5莫 耳)及作為一胺化合物之石膽酸甲g旨(3,5 ·二胺基苯曱酸酉旨) 52.47g (0.1莫耳)、對苯二胺97.33g (0.9莫耳)溶解於N-甲基 -2-吡咯烷酮4500g,在60°C下反應6小時。然後,將反應溶 液注入於非常過剩之甲醇中而使反應生成物沉殿。其後, 以曱醇洗淨,在減壓、4(TC下乾燥15小時,以得到對數黏 度為0.64 dl/g、酸亞胺化率〇%之聚酸胺酸(以此作為「聚醯 胺酸(6a)」)410g。 實施例17 醯亞胺化聚合物之合成 將實施例16所得到之聚醯胺酸(6a) 30.0g溶解於N-甲基 比咯烷酮570g,於此溶液中添加吡啶29.2g與醋酸酐 3〇.2g,在n〇°C下加熱4小時使之脫水閉環反應。然後,將 反應〉谷液注入於非常過剩之曱醇中而使反應生成物沉殿。 其後,以曱醇洗淨,在減壓、40°C下乾燥15小時,以得到 對數黏度為0.24 dl/g、醯亞胺化率96%之酿亞胺化聚合物 (以此作為「醯亞胺化聚合物(6b)」)28.8g。 實施例1 8 酿亞鞍聚合物之合成 在實施例16中,除使二胺化合物為石膽酸丁酯(3,5-二胺0: 37.87061.DOC -65- 200413441 Example 16 Synthesis of Polyamic Acid will be 112.09g (0.5 mole) of 2,3,5-tricarboxycyclopentylacetic dianhydride as tetracarboxylic dianhydride, l, 3,3a, 4,5,9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furyl) -naphtho [1,2-C] furan_1, 157.15 g of 3-dione (0.5 mole) and g of lithocholic acid as a monoamine compound (3,5 · diaminophenylbenzoate) 52.47 g (0.1 mole), p-phenylenediamine 97.33 g (0.9 mol) was dissolved in 4500 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours. Then, the reaction solution was poured into a very excessive amount of methanol to sink the reaction product. Thereafter, it was washed with methanol and dried under reduced pressure at 4 ° C. for 15 hours to obtain a polyamic acid having a logarithmic viscosity of 0.64 dl / g and an acid imidization rate of 0%. 410 g of amino acid (6a) "). Example 17 Synthesis of fluorinated imidized polymer 30.0 g of polyamino acid (6a) obtained in Example 16 was dissolved in 570 g of N-methylpyrrolidone. 29.2 g of pyridine and 30.2 g of acetic anhydride were added to the solution, and the reaction was dehydrated and closed-looped by heating at no ° C for 4 hours. Then, the reaction> valley was poured into a very excessive amount of methanol to cause the reaction product to settle. After that, it was washed with methanol and dried under reduced pressure at 40 ° C for 15 hours to obtain a brewed imidized polymer having a logarithmic viscosity of 0.24 dl / g and a yield of 96%. 28.8 g as "fluorinated imidized polymer (6b)". Example 18 Synthesis of a saddle polymer In Example 16, except that the diamine compound was butyl lithocholic acid (3,5-di amine

0:^.8^87061.DOC -66 - 200413441 基苯甲酸酯)56.68g (0.1莫耳)、對苯二胺97.33g (0.9莫耳) 以外,其餘與實施例16相同而得到聚醯胺酸(以此作為「聚 醯胺酸(7a)」),進一步使用此而與實施例丨7相同進行醯亞 胺化反應,得到對數黏度為0.27 dl/g、醯亞胺化率97%之酿 亞胺化聚合物(以此作為「醯亞胺化聚合物(7b)」)27.6g。 實施例1 9 醯亞胺化聚合物之合成 在實施例16中,除使二胺化合物為石膽酸戊酯(3,5_二胺 基苯曱酸酯)58.09g (〇·ΐ莫耳)、對笨二胺97 33g (〇·9莫耳) 以外,其餘與實施例16相同而得到聚醯胺酸(以此作為「聚 胺酸(8a)」)’進一步使用此而與實施例17相同進行醯亞 胺化反應,付到對數黏度為0.22 dl/g、醯亞胺化率95%之醯 亞胺化聚合物(以此作為「醯亞胺化聚合物(8b)」)26.9§。 實施例20 醯亞胺化聚合物之合成 在貝施例1 6中,除使二胺化合物為石膽酸十七烷酯(3弘 ,胺基苯曱酸s旨)74.92g ((M莫耳)、對苯二胺97以(〇·9 莫耳)以外,其餘與實施例1 6相同 j 1J而侍到聚醯胺酸(以此作為 「聚隨胺酸(9a)」),進—舟你田lL μ 運 /使用此而與實施例17相同進行 酉&amp;亞胺化反應,得到對數點序么η 」了數黏度為0.23 dl/g、醯亞胺化率98% 之酿亞胺化聚合物(以此作A「 忭局 醱亞胺化聚合物(9b) 26.3g 〇 實施例2 1 醯亞胺化聚合物之合成0: ^. 8 ^ 87061.DOC -66-200413441 benzoate) 56.68 g (0.1 mol), p-phenylenediamine 97.33 g (0.9 mol), the rest were the same as in Example 16 to obtain polyfluorene Amino acid (as "Polyamido acid (7a)"), further using this and carrying out the fluorene imidization reaction in the same manner as in Example 丨 7, the log viscosity was 0.27 dl / g, and the fluorene imine ratio was 97% 27.6 g of brewed imidized polymer (this is referred to as "醯 imidized polymer (7b)"). Example 1 9 Synthesis of fluorene imidized polymer In Example 16, except that the diamine compound was ammonium lithocholic acid (3,5-diaminophenyl benzoate) 58.09 g (〇 · ΐ 莫尔). Except for 33 g (0.9 mol) of bendiamine, the rest was the same as in Example 16 to obtain polyamic acid (as "polyamic acid (8a)"). 17 The same fluorene imidization reaction was performed, and a fluorene imidized polymer having a logarithmic viscosity of 0.22 dl / g and a fluorene imidization rate of 95% (as a "fluorene imidized polymer (8b)") 26.9 §. Example 20 Synthesis of fluorinated imidized polymer In Example 16 except that the diamine compound was heptadecyl lithocholic acid (3, amine phenylphosphonic acid s) 74.92 g ((M Mo Ear), p-phenylenediamine 97 except (0.99 moles), the rest is the same as in Example 16 and served as a polyamic acid (as a "polyacrylic acid (9a)"). -Zhou Youtian lL μ This is the same as in Example 17 and the ammonium &amp; imidization reaction is performed to obtain the logarithmic point order. Η ”The brew with a number viscosity of 0.23 dl / g and an imidization rate of 98% Imidized polymer (this was used as "A" 26.3 g of imidized polymer (9b) 〇 Example 2 1 Synthesis of imidized polymer

O:\srS706I.DOC -67 - 200413441 在貝鈀例16中,除使二胺化合物為石膽酸十八烷酯(3,5_ :胺基苯甲酸,)76_32g (〇]莫耳)、對苯二胺97.33g (〇·9 旲耳)以外,其餘與實施例16相同而得到聚醯胺酸(以此作為 水I胺酉夂(1 〇a)」),進一步使用此而與實施例工7相同進行 酸亞胺化反應,得到對數黏度為〇·24,、酉藍亞胺化率95% 之酏亞胺化聚合物(以此作《「醯亞胺化聚合物(i〇b)」) 28.1g 〇 比較例9 ' 釀亞胺化聚合物之合成 在實施例16中’除使二胺化合物為以上述式所示之二 胺4^6^0.08莫耳)、對苯二胺137 82g(〇92莫耳)以外,其 餘與實施例16相同而得到聚醯胺酸(以此作為「聚醯胺酸 (Da)」),進一步使用此而與實施例17相同進行醯亞胺化反 應,得到對數黏度為0.26 dl/g、心胺化率96%之酿亞胺化 聚合物(以此作為「醯亞胺化聚合物(Db)」)27lg。 比較例10 醯亞胺化聚合物之合成 在貫施例16中,除使二胺化合物為對苯二胺1〇8i4g(i〇 莫耳)以外,其餘與實施例16相同而得到聚醯胺酸(以此作為 「聚醯胺酸(Ea)」),進一步使用此而與實施例丨7相同進行 醯亞胺化反應,得到對數黏度為〇.41以/§、醯亞胺化率97% 之醯亞胺化聚合物(以此作為「醯亞胺化聚合物(Eb)」) 26.7g 〇O: \ srS706I.DOC -67-200413441 In Example 16 of palladium palladium, except that the diamine compound is octadecyl lithocholic acid (3,5_: aminobenzoic acid,) 76_32g (〇) mol), Except for phenylenediamine 97.33 g (0.99 旲), the rest was the same as in Example 16 to obtain polyamino acid (this was used as water I amine hydrazone (10a) "). This was further used in this example. In the same way, the acid imidization reaction was performed in the same way as in Example 7 to obtain a fluorene imidized polymer with a log viscosity of 0.24 and a cyanine imidization rate of 95%. ) ") 28.1g 〇 Comparative Example 9 'Synthesis of imidized polymer In Example 16, except that the diamine compound is a diamine represented by the above formula (4 ^ 6 ^ 0.08 mole), p-phenylenediamine Except for 137 82 g (0 92 moles) of amine, the remainder was the same as in Example 16 to obtain polyamic acid (this was referred to as "polyamic acid (Da)"). Further, this was carried out in the same manner as in Example 17 The amination reaction yielded 27 lg of a brewed imidized polymer with a logarithmic viscosity of 0.26 dl / g and a heart amidation rate of 96% (this is referred to as "醯 imidized polymer (Db)"). Comparative Example 10 Synthesis of fluorinated imidized polymer In Example 16, except that the diamine compound was p-phenylenediamine 108i4g (10 moles), the rest was the same as in Example 16 to obtain polyfluorene. Acid (as "Polyamidoacid (Ea)"), further using this and carrying out the imidization reaction in the same manner as in Example 丨 7, the logarithmic viscosity was 0.41 //, the imidization ratio was 97 % Of fluorene imidized polymer (this is referred to as "fluorene imidized polymer (Eb)") 26.7g.

參考合成iW -68 - 200413441 聚酿胺酸之合成 在實施例16中,除使四羧酸二酐為苯四曱酸酐9.〇6g(〇5 莫耳)及環丁烷四羧酸二酐98.06g (0.5莫耳),並使二胺為 4,4-二胺基二苯基曱烷198 27g(1〇莫耳)以外,其餘與實施 例16相同而得到對數黏度為2·41 dl/g、醯亞胺化率〇%之聚 驢胺酸(以此作為「聚醯胺酸(Za)」)。 實施例22 將實施例1 7所得到之醯亞胺化聚合物(6b)與上述參考合 成例所得到之聚醯胺酸(Za),以醯亞胺化聚合物:聚醯胺 酸=1 ·· 4 (重量比)之比率方式,溶解於^曱基_2_吡咯烷酮/ 丁基溶纖維/γ-丁内酯(1/1/8)混合溶劑中,而形成固形分濃 度4重置%的溶液,使用孔徑丨μιη之濾過器過濾此溶液,調 製液晶定向劑。上述液晶定向劑利用旋塗器而塗佈於由ΙΤ〇 膜所構成的附透明電極之玻璃基板之透明電極面,在2〇(rc 之熱板上乾燥10分鐘,形成乾燥平均膜6〇〇埃的塗膜。於此 塗膜上藉由具有卷繞著嫘縈製的布之輥的研磨機器,以輥 之旋轉數400 rpm、分級之移動速度3 cm/秒、毛邊押入長度 〇_4 mm進行研磨處理。使上述定向膜塗佈基浸潰於異丙醇 中1分鐘後,使雙方之基板在1〇(rc之熱板上乾燥5分鐘。其 次,在具有一對被研磨處理之基板的液晶定向膜之各外 緣’塗佈含直徑5·5脾之氧化鋁球的環氧樹脂接著劑後, 液晶定向膜面會相對,且以研磨方向呈9〇度扭轉的狀態重 疊而壓黏,使接著劑硬化 '然後,從液晶注人π於-對基 板間充填向·列型液晶(Merck公司製,MLc⑽2卜_ (s剛)Reference Synthesis iW -68-200413441 Synthesis of Polyamino Acid In Example 16, except that the tetracarboxylic dianhydride was benzenetetrahydroacid anhydride 9.06g (〇5 mol) and cyclobutane tetracarboxylic dianhydride Except for 98.06 g (0.5 mole) and the diamine being 4,4-diaminodiphenylphosphorane 198 27 g (10 mole), the rest was the same as in Example 16 to obtain a log viscosity of 2.41 dl / g, polydonine amino acid with an imidization rate of 0% (this is referred to as "polyamino acid (Za)"). Example 22 The fluorene imidized polymer (6b) obtained in Example 17 and the polyfluorinated acid (Za) obtained in the above reference synthesis example were used as the fluorinated polymer: polyfluorinated acid = 1 ·· 4 (weight ratio) ratio method, dissolved in ^ 曱 _2-pyrrolidone / butyl soluble fiber / γ-butyrolactone (1/1/8) mixed solvent to form a solid content concentration of 4 reset% The solution was filtered with a filter having a pore size of 1 μm to prepare a liquid crystal aligning agent. The above-mentioned liquid crystal aligning agent was applied on a transparent electrode surface of a glass substrate with a transparent electrode made of an ITO film by a spin coater, and dried on a hot plate of 20 ° C for 10 minutes to form a dry average film of 600 °. A coating film of Angstrom. On this coating film, a grinding machine having a roll around which a woven cloth is wound, the rotation speed of the roller is 400 rpm, the moving speed of classification is 3 cm / sec, and the length of the burr is pushed in. _4 mm for polishing treatment. After immersing the above-mentioned oriented film coating base in isopropanol for 1 minute, the substrates of both sides were dried on a hot plate at 10 ° C for 5 minutes. Second, a pair of Each outer edge of the liquid crystal alignment film of the substrate is coated with an epoxy resin adhesive containing alumina balls with a diameter of 5 · 5 spleens, and the liquid crystal alignment film faces are opposite, and overlapped in a state where the grinding direction is twisted by 90 degrees. Pressure-bonding and hardening the adhesive, and then injecting π from the liquid crystal into the substrate and filling the nematic liquid crystal (Merck, MLc⑽2) _ (sgang)

O:\8^S7061.DOC -69- 200413441 後,以壓克力系光硬化接著劑嘧封液晶注入〇,在基板之 外側兩面貼上偏光板,製作液晶顯示元件。殘留DC電壓會 顯示低至400 mV之值,看不到可靠性試驗後、明亮對比不 均、顯示缺陷。此等之結果表示於表3。 實施例23〜26 除使用實施例18〜21所得到之醯亞胺化聚合物外,與實施 例22同樣做法而製作液晶顯示元件。結杲表示於表3中。O: \ 8 ^ S7061.DOC -69- 200413441, and then inject the liquid crystal with acrylic light-curing adhesive, and seal the liquid crystal with 0, and attach polarizing plates on the two outer sides of the substrate to make a liquid crystal display element. The residual DC voltage will show a value as low as 400 mV. After the reliability test, uneven brightness and unevenness will not be seen, and defects will be displayed. These results are shown in Table 3. Examples 23 to 26 A liquid crystal display device was produced in the same manner as in Example 22 except that the fluorene imidized polymers obtained in Examples 18 to 21 were used. The results are shown in Table 3.

除使用比較例9,1 〇所得到之醯亞胺化聚合物外,與實施 例22同樣做法而製作液晶顯示元件。結果表示於表4中。 表4 實施例 聚合物 液晶配向性 殘留DC電壓 (mV) 可靠性試驗 (顯不缺陷之有無) 11 (Db)n-(Za) 良好 900 益 12 (Eb)+(Za) 良好 900 益 如以上般’若依本發明,可提供新穎之二胺化合物,從 此所得到且較宜使用於液晶定向劑之聚醯胺酸及醯亞胺化 聚合物。 依本發明之液晶定向劑所形成之液晶定向膜,係較適合 0:-8^87061.000 -70- 200413441 使用於用以構成TN型液晶顯示元件、STN型液晶顯示元 件、垂直配向型液晶顯示元件等之各種液晶顯示元件。又 ,、備舌亥液晶定向膜之、、右曰g 一 _ 狀 &lt;,夜晶顯不兀件,係液晶之^…一一 1 罪性亦優且可有效用 〆、盡#地使用 令双用於各種裝置中,例如,町適田 來作為桌上型計管 %、文書處 尘寸才機、手錶、時鐘、計數顯系旅 理機、個人雷日 〉夜晶電視等之顯示裝置。A liquid crystal display device was produced in the same manner as in Example 22 except that the fluorinated polymer obtained in Comparative Example 9 and 10 was used. The results are shown in Table 4. Table 4 Example Residual DC voltage (mV) of polymer polymer liquid crystals Reliability test (with or without defects) 11 (Db) n- (Za) Good 900 Benefit 12 (Eb) + (Za) Good 900 Benefits are as above In general, according to the present invention, a novel diamine compound can be provided, and the polyamidic acid and the fluorenimide polymer obtained from this and more suitable for use in a liquid crystal aligning agent can be provided. The liquid crystal aligning film formed by the liquid crystal aligning agent according to the present invention is more suitable for 0: -8 ^ 87061.000 -70- 200413441 and is used to form TN type liquid crystal display elements, STN type liquid crystal display elements, and vertical alignment type liquid crystal display elements. And other various liquid crystal display elements. In addition, the preparation of the liquid crystal alignment film of the tongue, the right g-shape &lt;, the night crystal is inconspicuous, is the liquid crystal ^ ... 1-1 1 is also excellent in sin and can be effectively used 〆 、 尽 # 地 用Let Shuang be used in various devices, for example, Machida as a desktop meter, a computer, a computer, a watch, a clock, a counting display, a personal computer, a personal thunderstorm, and a night crystal TV. Display device.

Claims (1)

200413441 拾、申請專利範圍: 1. 一種二胺化合物,其係至少1種選自包括:以下述式⑴ H^-G^a^D^CO-B1- (E1) ⑴ I a nh2 (其中,D1係包含脂環之碳數5〜30的2價烴基,G1係3價之 有機基,A1係單鍵或2價之結合基,B1為單鍵、-〇-、-N(H)-或 / -N \ ,E1為1價之有機基,a為1或2) 所示之化合物及以下述式(Π) H2N-G2-A2~D2-CO-B2- (E2) b (π) I A2 - G2-NH2 (其中,D2係包含脂環之碳數5〜30的3價烴基,G2係2價之 有機基,A2係單鍵或2價之結合基,B2為單鍵、-〇-、-N(H)-或 一 N \ ,E2為1價之有機基,b為1或2) 所示之化合物所構成之群。 200413441 2. 如1申請專利範圍第丨項之二胺化合物,其中在上述式⑴中 D1所示之基、或在上述式(11)中D2所示之基為含類固醇骨 架之烴基。 y 3. —種聚醯胺酸,其係如申請專利範圍第丨項之二胺化合物 的至少一種、與以下述式(ΠΙ)200413441 The scope of patent application: 1. A diamine compound, at least one of which is selected from the group consisting of: H ^ -G ^ a ^ D ^ CO-B1- (E1) ⑴ I a nh2 (wherein, D1 is a divalent hydrocarbon group containing 5 to 30 carbon atoms, G1 is a trivalent organic group, A1 is a single bond or a divalent bonding group, and B1 is a single bond, -0-, -N (H)- Or / -N \, E1 is a monovalent organic group, a is a compound represented by 1 or 2) and the following formula (Π) H2N-G2-A2 ~ D2-CO-B2- (E2) b (π) I A2-G2-NH2 (where D2 is a trivalent hydrocarbon group containing 5 to 30 carbon atoms, alicyclic, G2 is a divalent organic group, A2 is a single bond or a divalent bonding group, B2 is a single bond,- 〇-, -N (H)-or -N \, E2 is a monovalent organic group, and b is a group of compounds represented by 1). 200413441 2. The diamine compound according to item 1 of the patent application range 1, wherein the group represented by D1 in the above formula (1) or the group represented by D2 in the above formula (11) is a hydrocarbon group containing a steroid skeleton. y 3. A polyamidic acid, which is at least one diamine compound according to item 丨 of the patent application scope, and is represented by the following formula (ΠΙ) (III)(III) (其中,G4為4價之有機基) 所示之四羧酸二酐的至少一種所得之反應生成物。 4. -種醯亞胺化聚合物,其係使如中請專利範圍第3項之聚 醯胺酸脫水閉環而得到者。 5. —種液晶定向劑,其係含有至少一種選自包括如申請專 利範圍第3項之聚醯胺酸、及如申請專利範圍第4項^醯(Wherein G4 is a tetravalent organic group) a reaction product obtained by at least one of the tetracarboxylic dianhydrides shown. 4. A kind of fluorene imidized polymer, which is obtained by dehydrating and closing the polyfluorine acid as described in the patent claim No. 3. 5. A liquid crystal aligning agent, which contains at least one selected from the group consisting of polyamic acid such as item 3 of the patent application, and item 4 of patent application ^ 醯 亞胺化聚合物而構成的。 6/種液晶定向劑,其係含有一具有至少—種選自包括以 下述式(XI)〜(xiv)Made of imidized polymers. 6 / liquid crystal aligning agents, which contain at least one kind selected from the group consisting of the following formulae (XI) to (xiv) …(XI)... (XI) \G4/C〇〇H 、C—NH—G- ii 0 ...(XII) 200413441\ G4 / C〇〇H, C-NH-G- ii 0 ... (XII) 200413441 (其中,A1、A2、B1、B2、D1、D2、E1、E2、G1、G2、G4、 a及b之定義如同前述般) 分別所示之重複單元的聚合物而構成的。 7 ·如申睛專利範圍第6項之液晶定向劑,其中進一步含有一 不具有以上述式(XI)〜(XIV)之任一者所示重複單元的聚 醯胺酸及驢亞胺化聚合物。 8·如申請專利範圍第7項之液晶定向劑,其中含有:具有以 上述式(XIII)所示之重複單元及/或以(χιν)所示之重複單 元的聚合物、與不具有以上述式(XI)〜(XIV)之任一者所干 之重複單元的聚驢胺酸。 9· 一種液晶顯示元件,其係具備由如申請專利範圍第5至8 項中任一項之液晶定向劑所形成的液晶定向膜。 200413441 染、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件代表符號簡單說明:(Wherein A1, A2, B1, B2, D1, D2, E1, E2, G1, G2, G4, a, and b have the same definitions as described above) and are each a polymer of repeating units shown. 7. The liquid crystal aligning agent according to item 6 of the Shenyan patent, which further contains a polyamic acid and donkey imidization polymerization which do not have a repeating unit represented by any of the above formulae (XI) to (XIV) Thing. 8. The liquid crystal aligning agent according to item 7 of the patent application scope, comprising: a polymer having a repeating unit represented by the above formula (XIII) and / or a repeating unit represented by (χιν); A polydonyl acid of a repeating unit dried by any one of the formulae (XI) to (XIV). 9. A liquid crystal display element comprising a liquid crystal alignment film formed of a liquid crystal alignment agent as set forth in any one of claims 5 to 8. 200413441 Dyeing and designated representative map: (I) The designated representative map in this case is: (none) (II) The component representative symbols of this representative map are simply explained: 捌、本案若有化學式時,請揭示最能顯示發明特徵的化學式:捌 If there is a chemical formula in this case, please disclose the chemical formula that can best show the characteristics of the invention: 0 II NH—C、 HOOC / ;G 4/ COOH 、C- II 〇 • NH A1—D1 — CO — -i1-- ...(XI)0 II NH—C, HOOC /; G 4 / COOH, C- II 〇 • NH A1—D1 — CO — -i1-- ... (XI) Ο ·Λ3 7\8706l.DOCΟ · Λ3 7 \ 8706l.DOC
TW092120689A 2002-07-29 2003-07-29 Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display TW200413441A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002219517 2002-07-29
JP2003112426 2003-04-17

Publications (2)

Publication Number Publication Date
TW200413441A true TW200413441A (en) 2004-08-01
TWI319770B TWI319770B (en) 2010-01-21

Family

ID=31190314

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092120689A TW200413441A (en) 2002-07-29 2003-07-29 Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display

Country Status (4)

Country Link
KR (1) KR100882706B1 (en)
AU (1) AU2003252265A1 (en)
TW (1) TW200413441A (en)
WO (1) WO2004011528A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI468435B (en) * 2008-09-18 2015-01-11 Jsr Corp Liquid crystal aligning agent, liquid crystal display element and compound

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4415740B2 (en) * 2004-04-20 2010-02-17 Jsr株式会社 Vertical alignment type liquid crystal aligning agent and liquid crystal display element
JP4605376B2 (en) * 2005-06-06 2011-01-05 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
CN107111190A (en) * 2014-10-28 2017-08-29 日产化学工业株式会社 Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal represent element
KR101879834B1 (en) 2015-11-11 2018-07-18 주식회사 엘지화학 Prapapation method of liquid crystal alignment film, liquid crystal alignment film using the same and liquid crystal display device
WO2021065933A1 (en) 2019-10-02 2021-04-08 日産化学株式会社 Liquid crystal light control element

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3593684B2 (en) * 1994-10-20 2004-11-24 Jsr株式会社 Liquid crystal alignment agent and liquid crystal display device
JP3612832B2 (en) * 1995-12-28 2005-01-19 Jsr株式会社 Method for producing imide group-containing polyamic acid and liquid crystal aligning agent
JP3840717B2 (en) * 1996-10-25 2006-11-01 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP2001500897A (en) * 1997-06-10 2001-01-23 ジエンザイム コーポレイション Cationic amphiphilic compositions for intracellular delivery of therapeutic molecules
TW591274B (en) * 1997-12-03 2004-06-11 Jsr Corp Manufacturing method of liquid crystal alignment film
JP2002155138A (en) * 2000-11-21 2002-05-28 Jsr Corp Polymer, its manufacturing method, liquid crystal orientating agent and liquid crystal orientated film

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI468435B (en) * 2008-09-18 2015-01-11 Jsr Corp Liquid crystal aligning agent, liquid crystal display element and compound

Also Published As

Publication number Publication date
KR20050025124A (en) 2005-03-11
KR100882706B1 (en) 2009-02-06
AU2003252265A1 (en) 2004-02-16
TWI319770B (en) 2010-01-21
WO2004011528A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
JP6288412B2 (en) Liquid crystal alignment agent
JP5057056B2 (en) Liquid crystal aligning agent, method for producing liquid crystal aligning film, polyamic acid, polyimide and diamine compound
JP5477572B2 (en) Liquid crystal aligning agent and method for forming liquid crystal aligning film
TWI648579B (en) Compound, polymer, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5177450B2 (en) Liquid crystal aligning agent, method for forming liquid crystal aligning film, and liquid crystal display element
CN107022358B (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer, and diamine
KR101520970B1 (en) Liquid crystal aligning agent and liquid crystal display device
KR101530720B1 (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device
JP5013105B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP2012128372A (en) Liquid crystal orientation agent, liquid crystal orientation membrane and liquid crystal display element
TW200413441A (en) Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display
KR20150086230A (en) Liquid crystal orientation agent, liquid crystal orientation membrane and method for manufacturing same, and liquid crystal display element
JP2008107814A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display element
JP5045913B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR101397293B1 (en) Liquid crystal aligning agent and liquid crystal display device
JP2008242444A (en) Liquid crystal aligning agent and liquid crystal display element
JP4978434B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP6547565B2 (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal element
KR101502629B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP5088563B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP4168442B2 (en) Diamine compound, polyamic acid, imidized polymer, liquid crystal aligning agent, and liquid crystal display element
JP4636238B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5316752B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP4973847B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5099351B2 (en) Liquid crystal aligning agent and liquid crystal display element

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees